Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 29
|
ICEECE2012
|
Next issue
15th International & 14th European Congress of Endocrinology
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Programme
Volume Editors
Abstracts
Abstract Book
Contents
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
Tackling obesity: lessons from genetics
ea0029eje1
The European Journal of Endocrinology Prize Winner
ea0029eje1biog
The Geoffrey Harris Prize Lecture
Glucocorticoid metabolism and the brain, from fetal programming to senescence
ea0029gh1
The Geoffrey Harris Prize Winner
ea0029gh1biog
The Fondation IPSEN Prize Lecture
Common Threads: Epigenetics, Metabolism and the Clock
ea0029ifpl1
The Fondation IPSEN Prize Winner
ea0029ifpl1biog
Plenary Lectures
Red wine Endocrinology
New insights into the roles of sirtuins in metabolic decline and disease of aging
ea0029pl1
Testosterone more than sex
Testosterone: more than sex
ea0029pl2
Mating, sex and the immune system in humans and fish
Mating, sex and the immune system in humans and fish.
ea0029pl3
Lecture by Endocrine Society President
Abstract unavailable
ea0029pl4
Why your bones break - from childhood to old age
Why your bones break: from childhood to old age
ea0029pl5
Maternal nutrition, metabolism and fetal programming
Abstract unavailable
ea0029pl6
Diabetes as a gut disease
Diabetes as a gut disease
ea0029pl7
Novel molecular link between the circadian clock and hypertension
Novel molecular link between the circadian clock and hypertension
ea0029pl8
Symposia
Molecular mechanisms of differentiated thyroid cancer
Molecular consequences of deregulated RNA genes in papillary thyroid carcinoma
ea0029s1.1
Correlation between the BRAF V600E mutation, TGF[beta] pathway and tumour invasiveness in papillary thyroid carcinomas
ea0029s1.2
Abstract unavailable
ea0029s1.3
40 years of male hormonal contraception research and no product
Abstract unavailable
ea0029s2.1
Clinical trials in male hormonal contraception to date
ea0029s2.2
Acceptability of male hormonal contraception by the pharmaceutical industry and by the consumer
ea0029s2.3
Absolute fracture risk assessment with FRAX
Abstract unavailable
ea0029s3.1
Use of FRAX in Asian populations
ea0029s3.2
Beyond FRAX[Ograve]
ea0029s3.3
The gut nutrient sensing in energy metabolism
Bile acid metabolism for the control of metabolic disease
ea0029s4.1
Taste receptors in gut regulate endocrine function
ea0029s4.2
Gut microbiome and energy metabolism: the concept of MicrObesity
ea0029s4.3
Transition from paediatric to adult care - do we have progress?
GH use in Prader-Willi syndrome (PWS): an evidence-based approach to a clinical practice guideline (CPG), on behalf of the GH Research Society (GRS) and Workshop Participants
ea0029s5.1
Fertility options for adults with panhypopituitarism
ea0029s5.2
Sex steroid replacement in young males and females
ea0029s5.3
Subclinical adrenal diseases
Diagnosis and treatment of subclinical Cushing's syndrome (SCS)
ea0029s6.1
Abstract unavailable
ea0029s6.2
Subclinical Addison's disease
ea0029s6.3
Hormones, metabolism and cancer: more than coincidences?
An epigenetic switch linking inflammation to cancer and the use of metformin as an anti-cancer drug
ea0029s7.1
The insulin-like growth factor system and cancer: what are the implications?
ea0029s7.2
Obesity and cancer
ea0029s7.3
Global phenotypes of endocrine disease
Abstract unavailable
ea0029s8.1
Ethnic specific PCOS
ea0029s8.2
Obesity and diabetes in Asian Indians
ea0029s8.3
The risk and benefits of tight glycaemic control
What do type 2 diabetes outcome trials tell us about the CV risks and benefits of intensive glycaemic control
ea0029s9.1
Abstract unavailable
ea0029s9.2
Time course of the glucose legacy effect
ea0029s9.3
Thyroid: From fetal life to adulthood
Placental transport of thyroid hormone
ea0029s10.1
Abstract unavailable
ea0029s10.2
Thyroid hormones and fetal neurological development
ea0029s10.3
Novel genetic and endocrine insights in the Klinefelter's syndrome
Klinefelter mouse (41XXY): model for human Klinefelter syndrome
ea0029s11.1
Endocrine changes in KS and the effects on growth, bone and body composition
ea0029s11.2
The Muenster EXAKT project: epigenetic regulation of the supernumerary X chromosome and its escapee genes
ea0029s11.3
Determinants of peak bone mass
Epidemiology of peak bone mass, structure and strength in males as assessed by high resolution peripheral quantitative CT (HR-pQCT). A cross-sectional study
ea0029s12.1
The contribution of genetic factors to bone mass
ea0029s12.2
Estrogens as regulators of bone growth and bone mass
ea0029s12.3
Novel therapies for protecting beta cell function at diagnosis of type 1 diabetes
Abstract unavailable
ea0029s13.1
Abstract unavailable
ea0029s13.2
Abstract unavailable
ea0029s13.3
Wnt/Beta-catenin in pituitary development and disease
[beta]-catenin deficiency disrupts patterning of the ventral diencephalon, causing adenohypophysis over growth and dysmorphology
ea0029s14.1
Wnt/beta-catenin signalling in craniopharyngioma
ea0029s14.2
Wnt signalling in oestrogen-induced lactotroph proliferation
ea0029s14.3
Adrenal cancer
Molecular pathogenesis of adrenocortical cancer
ea0029s15.1
Imaging of adrenocortical cancer
ea0029s15.2
Genetics of micronodular hyperplasias (associated with Cushing syndrome)
ea0029s15.3
Understanding growth
From Galton to GWAS (and beyond): what we have learned about the genetics of human height?
ea0029s16.1
Genes and the investigation of idiopathic short stature (ISS): are we ready for prime time?
ea0029s16.2
Abstract unavailable
ea0029s16.3
Hormonal control of pregnancy
Hormone signalling between mother and fetus
ea0029s17.1
What controls labour in humans?
ea0029s17.2
Placental hormones as putative markers of gestational diseases
ea0029s17.3
Molecular mechanisms in autoimmune thyroid disease
Predictors of relapse of Graves' disease after antithyroid drug withdrawal
ea0029s18.1
Genotype-phenotype correlations in GD
ea0029s18.2
Regulatory cells, Th17 lymphocytes, and dendritic cells in autoimmune thyroid disease
ea0029s18.3
Controversies in testosterone replacement
Abstract unavailable
ea0029s19.1
Late onset hypogonadism: who should receive testosterone?
ea0029s19.2
Testosterone for women: why when and how?
ea0029s19.3
Signalling to and from osteoclast
Efferent signalling by osteoclasts
ea0029s20.1
Immune signaling in osoteoclasts
ea0029s20.2
Coupling of bone resorption and formation
ea0029s20.3
Obesity and reproduction
Integrating hypothalamic regulation of energy homeostasis and reproduction
ea0029s21.1
Impact of obesity on male reproduction
ea0029s21.2
Lifestyle modification and fertility
ea0029s21.3
Pituitary tumorigenesis
Molecular mechanisms: the genes involved in pituitary tumorigenesis
ea0029s22.1
Tracing back a Gene's influence
ea0029s22.2
Abstract unavailable
ea0029s22.3
Advances in regulation of aldosterone synthesis
Regulation of aldosterone synthase expression in normal adrenal and primary aldosteronism
ea0029s23.1
Extra-adrenal aldosterone biosynthesis
ea0029s23.2
Role of N-type calcium channel blockers in aldosterone biosynthesis
ea0029s23.3
ManagemDiabetes in children
Abstract unavailable
ea0029s24.1
Hypotheses explaining the increase in type 1 diabetes
ea0029s24.2
Abstract unavailable
ea0029s24.3
Reproductive hormone action
GnRH receptor signalling
ea0029s25.1
Light on the structural communication in gonadotropin hormone receptors: implications in genetic diseases
ea0029s25.2
Extragonadal FSH action- facts and dreams
ea0029s25.3
TSH Receptor
Low molecular weight antagonists of the TSH receptor
ea0029s26.1
Learning from how antibodies interact with the TSH receptor
ea0029s26.2
Structure and function of TSH receptor
ea0029s26.3
Are endogenous testosterone levels predictors of cardiovascular events?
Androgen action on the cardiovascular system
ea0029s27.1
Abstract unavailable
ea0029s27.2
Endogenous androgens, diabetes, and cardiovascular disease in women: the Rancho Bernardo study
ea0029s27.3
Osteoporosis treatment in 2012 and beyond
Controversial issues with bisphosphonate treatment
ea0029s28.1
Sclerostin: a key bone regulatory molecule
ea0029s28.2
Other emerging therapies
ea0029s28.3
Are we ready for novel therapies in obesity?
Abstract unavailable
ea0029s29.1
Growth hormone replacement and metabolic syndrome in GH deficient adults
ea0029s29.2
GLP-1 and analogues in obesity
ea0029s29.3
New developments in pituitary adenomas
Symposium 30: new developments in pituitary adenoma cytokines and other new genes in pituitary adenomas
ea0029s30.1
'Dopastatin': an evolving story
ea0029s30.2
The use of temozolomide in pituitary tumours
ea0029s30.3
Progress in treatment in primary aldosteronism
Abstract unavailable
ea0029s31.1
Abstract unavailable
ea0029s31.2
Abstract unavailable
ea0029s31.3
Disorders of sex development (DSD)
Genetics of disorders of sex development
ea0029s32.1
Psychosocial and psychosexual outcome in DSD
ea0029s32.2
Abstract unavailable
ea0029s32.3
Pollution Related Acromegaly
Pollution mediated acromegaly
ea0029s33.1
Exposure to endocrine disrupting chemicals may interfere with reproductive development in humans and affect timing of puberty
ea0029s33.2
Effect of iodine intake on thyroid diseases in China
ea0029s33.3
Effects of thyroid hormone derivatives
Pathways of thyroid hormone (TH) metabolism
ea0029s34.1
Thyroid hormone mimetic compounds
ea0029s34.2
Abstract unavailable
ea0029s34.3
Endocrinology and the Olympics: Will hormones help to win?
Does the high performance athlete need hormone replacement?
ea0029s35.1
Can an endocrine patient participate in high performance sports?
ea0029s35.2
Hormone abuse in sports: the knowns and unknowns
ea0029s35.3
Bone and metabolism
Leptin and bone signaling
ea0029s36.1
Insulin-bone axis
ea0029s36.2
Functions and mode of action of osteocalcin
ea0029s36.3
Diabetes and cancer
Abstract unavailable
ea0029s37.1
Abstract unavailable
ea0029s37.2
Goiter throughout the pediatric ages
ea0029s37.3
Craniopharyngioma: Hypothalamic complications
Childhood Craniopharyngioma
ea0029s38.1
Hypothalamic disorders in Clinical practice; relevance to clinical practice
ea0029s38.2
Management of hypothalamic obesity in patients with craniopharyngioma
ea0029s38.3
Adrenal insufficiency
Abstract unavailable
ea0029s39.1
Molecular pathomechanisms of steroidogenetic adrenal disorders
ea0029s39.2
New developments in the immunology of Addison's disease
ea0029s39.3
New familial endocrine cancer syndromes: pathophysiology and counselling
DICER1 mutations characterize a novel syndrome with endocrine features
ea0029s40.1
The paediatric patient with paraganglioma syndrome
ea0029s40.2
Li-Fraumeni Syndrome: A paradigm of genetic testing to clinical surveillance for pediatric endocrine tumors
ea0029s40.3
The endocrinology of adipose tissue
Physiological and neuronal determinants of brown adipose tissue-mediated thermogenesis in small mammals and humans
ea0029s41.1
'Obesity and insulin resistance: the cross-talk macrophage-adipocyte view'
ea0029s41.2
Abstract unavailable
ea0029s41.3
Novel insights into regulation of puberty
Central networks controlling the timing of puberty
ea0029s42.1
Re-wiring the hypothalamus with new peptides to control puberty
ea0029s42.2
Novel insights into regulation of puberty: lessons from human genetics
ea0029s42.3
Graves' orbitopathy (GO)
Immunopathogenesis of Graves' orbitopathy
ea0029s43.1
How to restore euthyroidism in the presence of Graves' orbitopathy? Is there a best way?
ea0029s43.2
Progress in immunosuppressive treatment of GO (selenium, steroid dosage, rituximab)
ea0029s43.3
Genome wide studies in reproduction
Genome-wide association study of endometriosis identifies a locus at 7p15.2 with pleiotropic effects
ea0029s44.1
Cytogenetic analysis and genome-wide association study (GWAS) in chinese women with premature ovarian failure (POF)
ea0029s44.2
Genetics of (In)fertility
ea0029s44.3
Bone quality and bone strength
Abstract unavailable
ea0029s45.1
Finite element analysis in osteology
ea0029s45.2
Abstract unavailable
ea0029s45.3
Chronic inflammation and insulin resistance
AIMing at metabolic syndrome: towards development of novel therapies for modern metabolic diseases via macrophage-derived AIM
ea0029s46.1
Macrophage regulation of adipocyte biology
ea0029s46.2
The inflammatory-adipokine hypothesis and stem cell abnormalities
ea0029s46.3
Cushing's syndrome
Abstract unavailable
ea0029s47.1
Abstract unavailable
ea0029s47.2
Learnings from ERCUSYN: the first 500 patients
ea0029s47.3
Pathogenesis of primary aldosteronism
Genomic profile in primary aldosteronism
ea0029s48.1
Integrating genetics and genomics in primary aldosteronism
ea0029s48.2
Potassium channels in primary aldosteronism
ea0029s48.3
Genetic breakthroughs in reproductive pathology and physiology
Abstract unavailable
ea0029s49.1
Abstract unavailable
ea0029s49.2
RANK ligand mediates hormone induced mammary epithelial proliferation and carcinogenesis
ea0029s49.3
Circadian regulation of metabolism
Basic mechanisms of circadian regulation in the brain
ea0029s50.1
Abstract unavailable
ea0029s50.2
Circadian rhythms in adipose tissue
ea0029s50.3
Recent management of pheochromocytoma/paraganglioma syndrome
Recent progress in biochemical testing for pheochromocytoma
ea0029s51.1
Prevalence of SDH gene mutations in pheochromocytoma
ea0029s51.2
Treatment of malignant pheochromocytoma
ea0029s51.3
Thyroid & Pregnancy
Outcome of the controlled antenatal thyroid screening study
ea0029s52.1
The case for thyroid screen in pregnancy
ea0029s52.2
Treatment of hyperthyroidism in pregnancy
ea0029s52.3
Genetic polymorphism in reproduction
Genetic variation of the androgen receptor: from gene regulation to prostate cancer
ea0029s53.1
Abstract unavailable
ea0029s53.2
Genetic complexity of FSH receptor function
ea0029s53.3
Vitamin D
Vitamin D is a multifunctional hormone Roger Bouillon Clinic and laboratory of experimental medicine and endocrinology
ea0029s54.1
Vitamin D and primary hyperparathyroidism
ea0029s54.2
Abstract unavailable
ea0029s54.3
The fatty liver as an endocrine disease
Pathogenesis of fatty liver disease
ea0029s55.1
Abstract unavailable
ea0029s55.2
Fatty liver disease in childhood
ea0029s55.3
Pituitary development transcription factors: stem cells and beyond
The GPS niche of stem cells in the pituitary
ea0029s56.1
LHX3: an insightful model of pituitary hormone deficiency
ea0029s56.2
Transcriptional and epigenetic mechanisms for cell fate choice in pituitary
ea0029s56.3
What's new in congenital adrenal hyperplasia (CAH)?
Congenital adrenal hyperplasia: counselling from birth to the next generation
ea0029s57.1
CAH and adulthood
ea0029s57.2
Abstract unavailable
ea0029s57.3
Best Clinical Practice
Towards a European Guideline for the treatment of hyponatremia
ea0029s58.1
Abstract unavailable
ea0029s58.2
Abstract unavailable
ea0029s58.3
Obesity and thyroid function
Obesity and thyroid function
ea0029s59.1
Abstract unavailable
ea0029s59.2
Type 2 deiodinase in muscle during health and disease
ea0029s59.3
Performance enhancing hormones in sports
The spectrum of hormones in sports doping
ea0029s60.1
GH and testosterone: do they work?
ea0029s60.2
Erythropoietin and its derivatives
ea0029s60.3
New insights in thyroid cancer diagnosis
BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status
ea0029s61.1
Abstract unavailable
ea0029s61.2
Abstract unavailable
ea0029s61.3
Early Development and Treatment of PCOS
Early hormonal abnormalities in children born to women with PCOS
ea0029s62.1
Early development and pubertal prevention of polycystic ovary syndrome
ea0029s62.2
Hyperandrogenism in obese girls: what is the significance?
ea0029s62.3
Emerging ideas about phosphate metabolism
Abstract unavailable
ea0029s63.1
FGF23 and tumor-induced osteomalacia
ea0029s63.2
FGF23 in chronic renal failure
ea0029s63.3
Endoplasmic Reticulum Stress, Obesity and Metabolic Homeostasis
Abstract unavailable
ea0029s64.1
Abstract unavailable
ea0029s64.2
Abstract unavailable
ea0029s64.3
Somatostatin receptors in pituitary
Imaging somatostatin activity in live pituitary
ea0029s65.1
Is somatostatin receptor expression in adenomas related to pharmacological response?
ea0029s65.2
Somatostatin receptors and filamin: a developing story
ea0029s65.3
HPA axis, stress metabolism and adaptation
Neuroendocrine and (epi)genetic impact on HPA function
ea0029s66.1
Abstract unavailable
ea0029s66.2
Modulation of cortisol action
ea0029s66.3
Central regulation of energy homeostasis
CNS control of energy and glucose metabolism
ea0029s67.1
Gut hormones: history, physiology and therapeutic opportunities
ea0029s67.2
Abstract unavailable
ea0029s67.3
European network for the study of adrenal tumours (ENSAT)
Genetics for pheochromocytoma and paraganglioma in 2012
ea0029s68.1
Abstract unavailable
ea0029s68.2
Abstract unavailable
ea0029s68.3
Current progress in the management of thyroid cancer
TSH suppression in differentiated thyroid cancer: how low should we go?
ea0029s69.1
Abstract unavailable
ea0029s69.2
Abstract unavailable
ea0029s69.3
Young Active Researchers Symposium (YAR)
New mechanisms underlying the role of the mTORC1 pathway in the hypothalamic control of energy balance
ea0029s70.1
Abstract unavailable
ea0029s70.2
DNA methylation of the body weight-regulating proopiomelanocortin gene: functional and ontogenetic aspects
ea0029s70.3
Mineralocorticoid receptor antagonism counters metabolic dysfunctions induced by high fat diet in mice
ea0029s70.4
A four-week fat overfeeding study in constitutional thin women: a human model of weight gain resistance
ea0029s70.5
Endocrine Nurse Symposium
(1)
Puberty induction in males and females
ea0029en1.1
The role of the endocrine nurse in puberty induction
ea0029en1.2
Abstract unavailable
ea0029en1.3
Choosing the right sex steroid replacement option for patients: the role of the endocrine nurse
ea0029en1.4
Diagnosis and management of Cushing's syndrome
ea0029en2.1
The role of the endocrine nurse in the diagnosis and management of the patient with Cushing's syndrome
ea0029en2.2
Diagnosis and management of prolactinoma
ea0029en2.3
Abstract unavailable
ea0029en2.4
Abstract unavailable
ea0029en3.1
The role of nurse prescribing in the care of endocrine patients
ea0029en3.2
JOE/JME Prize Presentation Sponsored by <emphasis role="italic">Journal of Endocrinology</emphasis>
(1)
Melanocortin receptor accessory proteins (MRAPs) in adrenal gland physiology and beyond
ea0029jp1
Meet the Expert Sessions
(1)
Adrenal incidentaloma and subclinical Cushing's syndrome
ea0029mte1
Approach to the patient with Cushing's disease after pituitary surgery failure
ea0029mte2
Abstract unavailable
ea0029mte3
Challenges of transsphenoidal pituitary surgery
ea0029mte4
Meet the expert: discussion of common but difficult thyroid cancer cases
ea0029mte5
Clinical management of adrenocortical carcinoma
ea0029mte6
Pregnancy and pituitary disorders
ea0029mte7
Abstract unavailable
ea0029mte8
Diagnosis and management of SIADH
ea0029mte9
Elastosonography in the evaluation of thyroid and parathyroid lesions
ea0029mte10
Diagnosis and treatment considerations in autoimmune polyendocrine syndrome type 1
ea0029mte11
Abstract unavailable
ea0029mte12
Graves' ophthalmopathy
ea0029mte13
Hirsutism
ea0029mte14
Pituitary tumours in adolescents and adults
ea0029mte15
Management of non-functioning pituitary adenomas
ea0029mte16
Multiple endocrine neoplasia type 2
ea0029mte17
Normocalcemic primary hyperparathyroidism
ea0029mte18
Abstract unavailable
ea0029mte19
The diagnosis and treatment of secondary osteoporosis in children
ea0029mte20
Autoimmune hyperthyroidism: initiation and duration of thionamide therapy
ea0029mte21
Clinical management in transgender sex hormone treatment
ea0029mte22
Subclinical hypothyroidism
ea0029mte23
Approach to the management of the infertile couple
ea0029mte24
Pituitary incidentalomas
ea0029mte25
Abstract unavailable
ea0029mte26
Differential diagnosis of Cushing's syndrome
ea0029mte27
Abstract unavailable
ea0029mte28
Management of bone loss induced by cancer treatment in early breast and prostate cancer
ea0029mte29
Treatment of vitamin D deficiency
ea0029mte30
Cryptorchidism
ea0029mte31
Management of GEP-NET tumors
ea0029mte32
Oral Communications
Pituitary Clinical I
Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study
ea0029oc1.1
Patients with Cushing's disease achieve normal urinary cortisol with LCI699, a potent 11[beta]-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study
ea0029oc1.2
Efficacy and safety of long-term treatment with pegvisomant in acromegaly: Italian pegvisomant observational study (ACROSTUDY)
ea0029oc1.3
A multi-centre audit of the prevalence of cardiac valvulopathy in patients treated with dopamine agonists for hyperprolactinaemia
ea0029oc1.4
Initial hypothalamic involvement is the major risk factor for impaired prognosis and quality of life in childhood craniopharyngioma regardless of chosen treatment strategies: results of KRANIOPHARYNGEOM 2000
ea0029oc1.5
Normal weight adult patients with Prader-Willi syndrome are not protected from insulin resistance during treatment with GH: results from a 12 month prospective study
ea0029oc1.6
Thyroid Clinical I
Overt hyperthyroidism is associated with increased mortality: a nationwide register-based study of disease discordant Danish twins
ea0029oc2.1
Identification and functional analysis of DUOX2 variants: biallelic mutations are associated with permanent congenital hypothyroidism
ea0029oc2.2
Thyroid hormone levels in euthyroid young men are associated with body composition and metabolic parameters
ea0029oc2.3
The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis
ea0029oc2.4
Thyroid spongiform nodules are the best candidates for percutaneous laser ablation. A 5 year follow-up study in 72 patients
ea0029oc2.5
Concurrent presence of nonendocrine autoimmune diseases with Hashimoto's thyroiditis: a systematic assessment on more than 5000 consecutive patients
ea0029oc2.6
Diabetes Clinical
Common variants of monogenic diabetes genes may affect [beta] cell functional mass in patients with newly diagnosed type 2 diabetes
ea0029oc3.1
Weight-loss independent metabolic benefits of gastric bypass surgery? Experiences from the Swedish obese subjects (SOS) study
ea0029oc3.2
Diabetic ketoacidosis at diagnosis influences complete remission after treatment of hematopoietic stem cell transplantation in adolescents with type 1 diabetes
ea0029oc3.3
Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes
ea0029oc3.4
Study of toll like receptor 2 and 4 expression in monocytes in type 1 diabetes mellitus with and without micro-vascular complications
ea0029oc3.5
Glucose disorders exert a detrimental effect on total brain volume in the elderly: a 2-year prospective MRI study
ea0029oc3.6
Pituitary Basic
Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in primates and mice
ea0029oc4.1
Transcriptional regulation of prolactin by oestrogen in vivo
ea0029oc4.2
miR-26a targets PRKCD in ACTH pituitary adenoma
ea0029oc4.3
Identification of coupling specificity between somatostatin receptor 5 (SST5) and G proteins by a bioluminescence resonance energy transfer (BRET) technique: the role of GoA protein
ea0029oc4.4
Targeting the IGF-IR system in pituitary tumors in vitro: antiproliferative action [amp] pitfalls
ea0029oc4.5
Cell cycle G2/M transition is modulated by microRNAs in pituitary adenomas
ea0029oc4.6
Obesity Basic
GH ameliorates impaired glucose tolerance in obese mice by modifying the visceral fat condition through adiponectin
ea0029oc5.1
Production of galectin-1, -3, -9 and -12 in adipose tissue of lean and obese mice
ea0029oc5.2
Insulin action in brown adipose tissue is compromised during diet-induced obesity
ea0029oc5.3
Bile acid binding resin shows anti-obese effect through the modifications of intestinal microbiota
ea0029oc5.4
Development of leptin deficient Lepmkyo/Lepmkyo rat-evidence for its superiority over Lepob/Lepob mouse as a model for human obesity
ea0029oc5.5
Semaphorin 3C-a novel adipokine modulating human adipose tissue plasticity in weight change
ea0029oc5.6
Female Reproductioin Basic
GnRH release failure in hyperprolactinemia is caused by a Kisspeptin deficiency
ea0029oc6.1
Ghrelin modulates fertilization, early embryo development and implantation
ea0029oc6.2
LH and hCG produce different responses in human granulosa lutein cells in vitro
ea0029oc6.3
Female fertility and activin-stimulated Fshb expression do not require SMAD2/3 in murine gonadotropes
ea0029oc6.4
Dihydrotestosterone treatment in mice induces a persistent polycystic ovary syndrome phenotype
ea0029oc6.5
Kit ligand-c-kit interaction regulates estradiol production by rat granulosa cells via oocyte factors
ea0029oc6.6
Adrenal Clinical
Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year
ea0029oc7.1
Activation of the PKA pathway triggers formation of an illicit serotonergic regulatory loop in primary pigmented nodular adrenal disease (PPNAD) tissues associated with Cushing's syndrome
ea0029oc7.2
Ribonucleotide reductase large subunit (RRM1) gene expression predicts efficacy of adjuvant mitotane in adrenocortical cancer
ea0029oc7.3
Differential diagnosis of primary aldosteronism by peripheral plasma levels of 18-oxo-cortisol: a noninvasive method with a high specificity
ea0029oc7.4
Continuous subcutaneous hydrocortisone infusion (CSHI) as replacement therapy in Addison's disease (AD)
ea0029oc7.5
Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study
ea0029oc7.6
Bone
Hypophosphatasia: enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults
ea0029oc8.1
Comparison of high protein and normal protein weight loss diets on bone density in overweight post-menopausal women
ea0029oc8.2
Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts
ea0029oc8.3
Radiological vertebral fractures in hospitalized elderly patients with heart failure
ea0029oc8.4
Pathogenetic chromosomal rearrangements in a large series of patients with pseudohypoparathyroidism type I
ea0029oc8.5
Simultaneous gain and loss of methylation at imprinted loci in a subset of patients with pseudohypoparathyroidism type 1b and GNAS epimutations
ea0029oc8.6
Endocrine Tumours & Translation
Temozolomide therapy for progressive metastatic paraganglioma/pheochromocytoma: SDHB mutation as a prognosis biomarker for efficacy
ea0029oc9.1
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells
ea0029oc9.2
The central role of estrogen receptor [alpha] in IGF2 dependent adrenocortical carcinoma (ACC) cell proliferation suggests the use of selective estrogen receptor modulators (SERMs) for the treatment of ACC
ea0029oc9.3
Functional characterization of mutations in the multiple endocrine neoplasia type 1 (MEN1) gene suggest therapeutic strategies
ea0029oc9.4
Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients
ea0029oc9.5
First in vitro study of human gastroenteropancreatic-neuroendocrine tumors: comparative effect of octreotide and pasireotide
ea0029oc9.6
Pituitary Clinical 2
Predictors of morbidity and mortality in acromegaly: an Italian survey on behalf of the Italian study group of acromegaly
ea0029oc10.1
Food intake regulating hormones in adult craniopharyngioma patients
ea0029oc10.2
Pathophysiology of renal calcium handling in acromegaly revisited
ea0029oc10.3
Higher glucocorticoid supplementation doses are associated with increased overall mortality in patients with non-functioning pituitary adenoma
ea0029oc10.4
Once-weekly, CTP-modified hGH (MOD-4023) is effective in growth hormone deficient adults: a phase II, dose and frequency finding study
ea0029oc10.5
Second neoplasms in childhood cancer survivors with growth hormone deficiency treated or not treated with GH
ea0029oc10.6
Thyroid Clinical 2
Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor alpha mutation
ea0029oc11.1
Subclinical thyroid disease and risk of new-onset atrial fibrillation
ea0029oc11.2
Is overt hypothyroidism associated with increased mortality? A nationwide register-based study of disease discordant Danish twins
ea0029oc11.3
Prevalence of TSH receptor mutation and clinical characteristics among 84 patients with hyperthyroidism with diffuse goiter and negative TBII
ea0029oc11.4
Thyroid hormones and male sexual function
ea0029oc11.5
Is age a risk factor for hypothyroidism in pregnancy? An analysis of 5223 pregnant women
ea0029oc11.6
Obesity Clinical
Circulating endocannabinoids are associated to cardiometabolic alterations independently from adiposity
ea0029oc12.1
Lipid-induced insulin resistance is associated with a reduction of IGF1 bioactivity independent of changes in IGFBP-1 and -2 in humans
ea0029oc12.2
Transient increase of beta-cell first phase secretion after smoking cessation: a possible contributor to carbohydrate craving and body weight gain?
ea0029oc12.3
Genetic susceptibility, birth weight and obesity risk in young chinese
ea0029oc12.4
Brown adipose tissue activation is inversely related with central obesity and metabolic parameters in adult human
ea0029oc12.5
Eating speed and the risk of type 2 diabetes mellitus: a case-control study
ea0029oc12.6
Adrenal Basic
Targeting multiple signalling pathways showed high anti-tumour potential in two mouse phaeochromocytoma cell lines
ea0029oc13.1
VSNL1 is upregulated in aldosterone producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis
ea0029oc13.2
Cortisol secretion is dependent on intraadrenal production of ACTH in macronodular bilateral adrenal hyperplasia causing Cushing's syndrome
ea0029oc13.3
A genome-wide methylation study of adrenocortical tumors shows specific alterations linked to gene expression, revealing new aspects of the molecular classification of adrenal carcinomas
ea0029oc13.4
KCNJ5 mutations in Japanese patients with aldosterone-producing adenomas
ea0029oc13.5
GATA-4 overexpression induces adrenocortical tumorigenesis and ectopic expression of luteinizing hormone receptor in C57Bl/6J mice
ea0029oc13.6
Male Reproduction
X chromosome-linked copy number variations in male infertility
ea0029oc14.1
Deficient expression of genes involved in the endogenous defense system against transposons in cryptorchid boys with impaired mini-puberty
ea0029oc14.2
Comparison of serum testosterone and estradiol levels in 3174 European men as measured by a platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men
ea0029oc14.3
The prevalence of hypogonadism in men on methadone maintenance
ea0029oc14.4
The muenster EXAKT project: X-inactivation in klinefelter patients
ea0029oc14.5
Erectile dysfunction after liver transplantation
ea0029oc14.6
Thyroid Basic
PATZ1 is a new candidate tumour-suppressor gene in thyroid cancer
ea0029oc15.1
Ligand bound-thyroid hormone receptor contributes to reprogramming of pancreatic exocrine cells to insulin-producing cells via induction of Ngn3 and MafA
ea0029oc15.2
Radioiodine therapy of non-thyroidal cancer following systemic sodium iodide symporter (NIS) gene transfer using Transferrin-receptor (Tfr) targeted non-viral gene delivery vectors
ea0029oc15.3
The DNA methylation as a predisposition factor in the pathogenesis of congenital hypothyroidism in premature infants
ea0029oc15.4
Lymphatic endothelial markers podoplanin and Prox1 in differentiated thyroid tumors
ea0029oc15.5
Thyroglobulin induces thyroid cell growth through suppression of miR-16 and miR-195
ea0029oc15.6
Female Reproduction Clinical
The association between birth weight and PCOS in adult life. A register-based study on 523, 757 Danish women born 1973-1991
ea0029oc16.1
The first missense mutation of BMP15 mature domain identified in a Chinese family with primary ovarian insufficiency causes defective production of the bioactive protein
ea0029oc16.2
Anti-mullerian hormone as a predictor of ovarian response to weight loss in overweight women with polycystic ovary syndrome
ea0029oc16.3
Epidemiological survey on the prevalence of hyperandrogenic states in adolescent and young women
ea0029oc16.4
Urinary glucocorticoid metabolite excretion is associated with insulin resistance independent of body mass index (BMI) in patients with polycystic ovary syndrome
ea0029oc16.5
Kisspeptin-10 stimulation of gonadotropin secretion in women is modulated by sex steroid feedback
ea0029oc16.6
Diabetes Basic
Pdk1/Foxo1 pathway regulates macrophage migration, polarization, and insulin sensitivity
ea0029oc17.1
Placental restriction co-ordinately alters hepatic expression of microRNAs and targets related to non alcoholic fatty liver disease, in adult male sheep
ea0029oc17.2
Caerulin precursor fragment (CPF-AM1): a novel insulinotropic peptide from the skin secretion of the clawed frog, Xenopus amieti
ea0029oc17.3
Syntaxin-3 regulates recruitment and exocytosis of newcomer insulin granules and granule-granule fusion during biphasic glucose-stimulated insulin secretion in pancreatic [beta]-cells
ea0029oc17.4
Glucocorticoid receptor [alpha] expression is downregulated in gluteal subcutaneous adipose tissue of black South African women and associates with increased metabolic risk
ea0029oc17.5
Meta-analysis of differentially expressed microRNAs in type 1, type 2 and gestational diabetes mellitus
ea0029oc17.6
Paediatric Endocrinology
Mutations in the NR5A1 gene in patients with 46,XY disorders of sex development (DSD): high frequency of familial multi-generational occurrence
ea0029oc18.1
Clinical profile, gender choice and long term follow up of subjects with 5 alpha-steroid reductase 2 deficiency
ea0029oc18.2
Effects of vitamin D insufficiency and its correction on insulin sensitivity and serum osteocalcin concentration in obese children
ea0029oc18.3
Mortality in GH-treated (Tx) patients (pts) enrolled in the global genetics and neuroendocrinology of short stature international study (GeNeSIS)
ea0029oc18.4
Earlier reactivation of the hypothalamo-pituitary-gonadal axis and advancement of puberty in boys under labour stress
ea0029oc18.5
Functional characterization of a new mutation in the NKX2.1 in patients with thyroid-lung-brain syndrome
ea0029oc18.6
Cardiovascular Endocrinology
Both EPA/AA ratio and absolute AA levels constitute an independent risk factor for coronary atherosclerosis in type 2 diabetic patients
ea0029oc19.1
Increased arterial stiffness is independently associated with cerebral infarctions and white matter lesions in patients with type 2 diabetes despite good blood pressure and lipid control
ea0029oc19.2
Copeptin and adrenomedullin in a large cohort of patients with coronary heart disease and newly diagnosed glucose intolerance ('Silent diabetes study')
ea0029oc19.3
Oxytocin is cardioprotective hormone
ea0029oc19.4
Circulating adrenomedulin levels are associated with atrial natriuretic peptide and brain natriuretic peptide levels in heart failure patients
ea0029oc19.5
Endothelial progenitor cells in acromegaly are reduced and responsive to treatment with somatostatin analogues
ea0029oc19.6
Nurses Abstracts
(1)
Clinical practice guideline on linear growth measurement of children
ea0029n1
The nurse's role in establishing modern testosterone replacement therapy in an endocrine clinic
ea0029n2
Interdisciplinary risk assessment and patient discharge management: combining biomarker [amp] clinical scores, medical [amp] nursing aspects
ea0029n3
Effect of metformin in teenagers with metabolic syndrome
ea0029n4
Translation and cultural adaptation of the Brazilian version of patient assessment of chronic illness care: Pacic-Brazil
ea0029n5
Perception of quality of care in patients with pituitary disorders
ea0029n6
Neutralization of Flightless I (Flii) using Flii-specific monoclonal antibodies accelerates impaired healing in diabetic wounds through improved cell proliferation
ea0029n7
Diabetes nurse leadership group: a forum for improving diabetes care in Brooklyn, NY
ea0029n8
Childhood osteoporosis: screening, prevention, treatment and safe handling practices in a tertiary care pediatric hospital
ea0029n9
Endocrine and exocrine function changes in acute pancreatitis
ea0029n10
A prospective study of growth and development of children recently adopted from orphanage care
ea0029n11
Improving the efficiency and safety of managing children with diabetic keto-acidosis
ea0029n12
Socio-demographic factors associated with pediatric diabetic ketoacidosis admissions in Southern West Virginia
ea0029n13
Failure to thrive due to inherited congenital isolated growth hormone deficiency
ea0029n14
Diabetic foot in jordan: a qualitative content analysis of self-treated problems
ea0029n15
Planning for the future: preparing the endocrine specialist nurse of tomorrow
ea0029n16
The Swedish pituitary registry
ea0029n17
Molecular genetics in turner syndrome
ea0029n18
An Internet based protocol for examining transitional experiences of 16-26 year olds with Turner syndrome (TS)
ea0029n19
Self care practice among diabetic patients attending metropolyclinic, Kathmandu
ea0029n20
Abstract unavailable
ea0029n21
Eat, Pray, Love...Yourself
ea0029n22
Dance for health: implementation of a dance program to improve physical activity of children
ea0029n23
Self-care competence in the case of Brazilian patients with diabetes mellitus in a multiprofessional educational programme
ea0029n24
Primary hyperparathyroidism, vitamin D deficiency and quality of life
ea0029n25
Evaluation of self management and diabetes education newly diagnosed with Type 2 diabetic patients in Mongolia
ea0029n26
Individuals with Addison's disease and their experiences of onset and self-care: new knowledge?
ea0029n27
A survey of knowledge related to cystic fibrosis related diabetes
ea0029n28
Poster Presentations
Adrenal cortex
Targeting mutated [beta]-catenin in vitro and in vivo inhibits cell proliferation and stimulates apoptosis: a promising therapeutic target in adrenocortical carcinoma
ea0029p1
Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism
ea0029p2
The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in the diagnosis of subclinical hypercortisolism (SH) in patients with adrenal incidentaloma (AI).
ea0029p3
Semen parameters in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxilase deficiency (21-HD)
ea0029p4
Non-radioactive strategies on the diagnosis of congenital adrenal hyperplasia due to 21 hydroxylase deficiency (CAH - 21OHD).
ea0029p5
Diagnostic value of urinary steroid profiling in the evaluation of adrenal incidentaloma.
ea0029p6
The combined use of nocturnal salivary cortisol and urinary cortisol to creatinine ratio in the evaluation of cycling in patients with Cushing's syndrome
ea0029p7
Defining 17[alpha]-hydroxylase in zebrafish: expression pattern of two paralog genes (zCyp17a1; zCyp17a2) and comparative in vitro and in silico analysis
ea0029p8
Progressive adrenal insufficiency in a patient with 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene
ea0029p9
The mTOR-pathway in normal and tumoral human adrenocortical tissues
ea0029p10
Measurement of cortisol in scalp hair can be a new tool in the diagnosis and follow-up of patients with Addison's Disease and (cyclic) Cushing's Syndrome
ea0029p11
Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension
ea0029p12
Influence of unilateral adrenalectomy on set point of Hypothalamic-pituitary-adrenal-axis in long-term survivors of childhood nephroblastoma and neuroblastoma
ea0029p13
PET-tracers for differential diagnosis in primary hyperaldosteronism - in vitro studies
ea0029p14
Role of Endogenous Somatostatin and Cortistatin in Regulating Adrenal Gland Function
ea0029p15
Cyclical Cushing's syndrome masquerading as Polycystic Ovarian Syndrome - pitfalls in diagnosis
ea0029p16
Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy
ea0029p17
Use of the 250 mcg short synacthen test in the diagnosis of primary aldosteronism
ea0029p18
Evaluation of sexual function and psychological attitudes in adult women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase Deficiency (21-HD)
ea0029p19
Role of adrenal vein sampling in primary aldosteronism. Impact of different diagnostic criteria on subtype diagnosis
ea0029p20
Predicting factors of the post-surgical decline in renal function in patients with primary aldosteronism
ea0029p21
Specialized surgery for adrenocortical carcinoma in The Netherlands: analysis of national cancer registry data
ea0029p22
Long term follow-up of patients with adrenal incidentalomas - a prospective study
ea0029p23
Effects of sugar cane extract (SCE) supplementation on steroidogenesis of the adrenal cortex in male rats
ea0029p24
Evaluation of renal function of primary aldosteronism between pre- and post-treatment
ea0029p25
Follow-up of nonsurgical nonfunctioning adrenal adenomas at five years
ea0029p26
Importance of the genetic study in fertile women with nonclassical congenital adrenal hyperplasia
ea0029p27
Aldosterone-producing cells regenerated from mesenchymal stem cells
ea0029p28
The ACTH-independent macronodular adrenal hyperplasia gene hunt: from candidate genes to a pangenomic strategy
ea0029p29
Superselective adrenal venous sampling for intra-adrenal localization of aldosterone hypersecretion.
ea0029p30
Analysis of the glucocorticoid receptors polymorphism in patients with adrenal incidentaloma and patients with Cushing's syndrome.
ea0029p31
KCNJ5 Mutations in European Families with Non-Glucocorticoid Remediable Familial Hyperaldosteronism
ea0029p32
Applicability of the guideline for the diagnosis of primary hyperaldosteronism in patients with hypertension in Japan (PHAS-J2): Prospective multi-center study of national hospital organization
ea0029p33
Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways.
ea0029p34
Differential DNA methylation of the CYP11B1 and CYP11B2 genes in association with human adrenal zonation
ea0029p35
Super-selective ACTH-stimulated adrenal venous sampling can discriminate the main lesion from the normal tissue for doing partial adrenalectomy in unilateral aldosterone-producing adenoma
ea0029p36
Deletion of TASK3 K+ channels leads to hyperaldosteronism in neonatal mice
ea0029p37
Expression of kisspeptin and its receptor in aldosterone-producing adrenal adenomas
ea0029p38
Reduction of the 10-year probability of fracture predicted by FRAX[reg] and bone mass recovery in patients with Cushing's Syndrome after 24 months from cure of hypercortisolism
ea0029p39
The Wnt/Beta-catenin and Ras/Raf/MEK/ERK signaling pathways alterations in adrenocortical tumors
ea0029p40
Cancer induces adrenal and pituitary alterations during the development of cachexia-anorexia syndrome
ea0029p41
A revolution in the diagnosis of adrenal disorders: rapid multiplex quantitation of serum steroids by means of tandem mass spectrometry (MSMS)
ea0029p42
Outcome of 232 patients with monolateral adrenal incidentaloma from a single centre
ea0029p43
Female patients with primary aldosteronism are diagnosed earlier and have a better outcome
ea0029p44
Influencing factors on quality of life in patients with Addison's disease
ea0029p45
Differential methylation signature in benign and malignant cortisol producing adrenocortical tumors
ea0029p46
18-Hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.
ea0029p47
MicroRNA profiling of benign and malignant adrenocortical tumors reveals potential biomarkers of recurrence
ea0029p48
Prevalence and Characteristics of Familial Hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino - GENetic forms).
ea0029p49
Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modelling
ea0029p50
Cornell product left ventricular hypertrophy in electrocardiogram in patients with primary aldosteronism
ea0029p51
Efficacy of long-term treatment with retinoic acid in patients with Cushing's disease
ea0029p52
Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort
ea0029p53
Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency
ea0029p54
Urinary cortisol metabolites in corticotroph and adrenal tumours
ea0029p55
Soundwave's effect on hematic cortisol level: a pilot study
ea0029p56
Reevaluation of the 4 mg intravenous dexamethasone suppression test for differentiation of Cushing's disease from pseudo-Cushing's syndrome
ea0029p57
Treatment with mineralocorticoid receptor antagonists in 'subclinical' cases with adrenal adenomas and autonomous aldosterone secretion
ea0029p58
The effects of the acute administration of alprazolam, a benzodiazepine, in patients with subclinical Cushing's syndrome
ea0029p59
Is isolated secondary adrenal insufficiency more frequent than autoimmune Addison's disease?
ea0029p60
Dyslipidemia in patients with adrenal incidentaloma with and without subclinical hypercortisolism and diabetes mellitus.
ea0029p61
Prevalence of primary aldosteronism in Chinese patients with resistant hypertension
ea0029p62
Genetic, anthropometric and metabolic features of adult norwegian patients with 21-hydroxylase deficiency
ea0029p63
Relationship between plasma dexamethasone level and cortisol in the overnight dexamethasone suppression test
ea0029p64
Mechanisms of gastroprotective action of corticotropin-releasing factor (CRF): involvement of CRF receptor subtypes 1 and 2
ea0029p65
Comparison of salivary cortysol by chemiluminensce and mass spectometry in hypercortilosism
ea0029p66
Renin-angiotensin-aldosterone system and inflammation - new aspects of an old system: results from the study of health in pomerania
ea0029p67
MGMT expression in human adrenocortical carcinoma cell lines and tissues and effects of temozolomide on tumor cell growth.
ea0029p68
New quick cortisol assay during adrenal vein sampling in patients with primary aldosteronism
ea0029p69
Primary aldosteronism is very frequent in resistant hypertension and is associated to early renal vascular damage
ea0029p70
Enhanced small dense LDL-subfractions, triglycerides and chemerin as early metabolic alterations in young patients with classic CAH due to 21-hydroxylase deficiency
ea0029p71
ACTH and cortisol responses to the combined DEXA-CRH test in patients with adrenal incidentalomas
ea0029p72
Idiopathic primary hyperaldosteronism frequently undergoes spontaneous remission: frequence and predictors
ea0029p73
Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study
ea0029p74
Drug prescription pattern in patients with autoimmune addison's disease in Sweden
ea0029p75
Dosing regimens for glucocorticoid replacement therapy - a worldwide patient survey
ea0029p76
Significance of ACTH stimulation test in the diagnosis of an aldosterone-producing adenoma
ea0029p77
An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency
ea0029p78
Malignant adrenal incidentalomas: clinical analysis of 2300 patients with adrenal incidentalomas registered at a single endocrinological center
ea0029p79
RRM1 Gene expression affects metabolization and activity of mitotane in adrenocortical cancer cell lines.
ea0029p80
The routine application of the current clinical recommendations for adrenal incidentalomas the management is highly inefficient
ea0029p81
The Effect of Glucocorticoid Receptor Polymorphisms on the Sensitivity to Cortisol in Addison's disease
ea0029p82
Impact of reference values and published thresholds on clinically relevant cut-offs
ea0029p83
Hormonal and metabolic features in patients with adrenal incidentalomas according to 1 mg overnight dexamethasone suppression test
ea0029p84
Therapy with steroidogenesis inhibitors in Cushing's syndrome: a reappraisal
ea0029p85
Ectopic Cushings and Nocardia series
ea0029p86
Laparoscopic adrenalectomy for large adrenal tumors
ea0029p87
Adiponectin gene polymorphisms in primary aldosteronism and their relation to the metabolic syndrome
ea0029p88
Primary aldosteronism associated with subclinical Cushing syndrome
ea0029p89
Primary aldosteronism during 2007-2011 in Iceland
ea0029p90
Low SLC26A2 expression in adrenal cells is associated with high aldosterone output
ea0029p91
Three-dimensional contrast-enhanced sonography in the diagnosis of incidentally discovered asymptomatic adrenal masses
ea0029p92
Evaluation of uni- and bilateral adrenal incidentalomas with (131I) 6[beta]-iodomethyl-norcholesterol scintigraphy.
ea0029p93
The confirmatory Tests of primary aldosteronism should be selected in each countries - the analysis of 83 patients in our hospital
ea0029p94
ACTH stimulation improves the sensitivity of aldosterone to rennin ratio (ARR) for detecting inappropriate aldosterone secretion
ea0029p95
Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
ea0029p96
Diagnosis of Cushing's syndrome by automatic face classification using frontal and side-view photographs
ea0029p97
Cushing disease remission is independent of size tumor. twenty years experience in surgical treatment a Mexican Center
ea0029p98
Cushing's disease - limitations and boundaries
ea0029p99
Exogenous corticosteroids: guilty or innocent?
ea0029p100
Pediatric Cushing disease: case report
ea0029p101
Proteomic approach to human adrenocortical cancer biology
ea0029p102
GH deficiency in patients with hypoadrenalism
ea0029p103
The functional assessment and growth rates of adrenal incidentalomas: a single center experience
ea0029p104
Adrenal venous sampling: local experience in Asian population
ea0029p105
Comparison of four immunoassays for measurement of cortisol levels
ea0029p106
Tertiary adrenal insufficiency: case report
ea0029p107
A case of HIV presenting as primary adrenal lymphoma
ea0029p108
Ketoconazole in surgery preparation and follow-up of Cushing's disease - our experience
ea0029p109
Utility of CGM for the determination of optimal glucocorticoid replacement method in patients with adrenal insufficiency
ea0029p110
A case of subclinical Cushing's syndrome who developed pseudo-aldosteronism caused by green juice
ea0029p111
Adrenal masses as the first demonstration of non endocrine tumors metastatic disease
ea0029p112
Usefulness of FDG-PET for detecting primary aldosteronism in patient who have bilateral adrenal incidentaloma
ea0029p113
Adrenal medulla
Next generation sequencing is a cost effective and time saving method in clinical genetic screening of patients with pheochromocytomas
ea0029p114
Pheochromocytomas: a single centre experience
ea0029p115
Removal of the dominantly secreting adrenal lateralized by bilateral adrenal venous sampling (BAVS) with glucagon stimulation significantly alleviated hypertension in patients with bilateral adrenal pheochromocytoma
ea0029p116
Neuroendocrine markers in biochemical vs pathology diagnosis of pheochromocytoma
ea0029p117
Geranylgeraniols are essential for adrenal catecholamine secretion
ea0029p118
Neither classical symptoms of phaeochromocytoma nor elevated urinary catecholamines are always seen in patients with histologically verified phaeochromocytoma
ea0029p119
The unique case of adrenal malignant non-functioning oncocytic pheochromocytoma
ea0029p120
A rare case of adrenocorticotropic hormone-producing Pheochromocytoma
ea0029p121
A Novel SDHC mutation associated with Head-Neck Paraganglioma
ea0029p122
Features at presentation of adrenal pheochromocytomas in castilla la mancha (spain). Is the clinical spectrum changing ?
ea0029p123
Incidentally discovered pheochromocytoma (PH)
ea0029p124
Pheochromocytoma incidentally discovered after thyroid surgery manifesting dramatic hypertensive crisis induced by metoclopramide
ea0029p125
A case of adrenoleukodystrophy presenting as progressive cerebellar dysfunction
ea0029p126
Clinical peculiarities of pheochromocytoma in a MEN2A family
ea0029p127
Pheochromocytoma in neurofibromatosis type 1
ea0029p128
Bone & Osteoporosis
Unilateral and bilateral adrenal incidentaloma: comparing clinical and biochemical features
ea0029p129
Bone mineral density is associated with BsmI vitamin D receptor's polymorphism in adult patients with epilepsy
ea0029p130
Vitamin D and estrogen receptors' polymorphisms in postmenopausal women
ea0029p131
Osteoporosis and vitamin D deficiency in patients with lipid storage disease
ea0029p132
De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient
ea0029p133
Osteogenesis imperfecta: phenotypic characteristics and response to treatment in an Irish cohort
ea0029p134
Bone mineral density in diabetic postmenopausal women with bone fracture
ea0029p135
Evidence for vitamin D deficiency and increased fractures' prevalence in autoimmune bullous skin diseases
ea0029p136
A correlation between bone mass density and body mass index and the lipid profile?
ea0029p137
Vertebral fracture risk and bone metabolism in patients with addison's disease
ea0029p138
Bone mineral density and muscle mass in women with multiple sclerosis
ea0029p139
Teriparatide: effects on cortical bone microstructure
ea0029p140
Serum soluble RANKL levels are related to breast arterial calcification and hypertension in Japanese osteoporotic postmenopausal women
ea0029p141
BMP-3b inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling
ea0029p142
Glucocorticoid - treatment in the adrogenital syndrome due to deficit of 21-hydroxylase: long-term bone side effects
ea0029p143
Polymorphism of the vitamin D3 receptor gene and bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment
ea0029p144
Altered bone mineral density in unilaterally orchiectomized subjects
ea0029p145
Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria and recurring renal calcium lithiasis
ea0029p146
Bone mineral density in patients with thalassaemia major in the UK
ea0029p147
Abstract unavailable
ea0029p148
Both high- and low levels of procollagen type 1 amino-terminal propeptide are associated with increased risk of hip fracture in elderly women. Norwegian Epidemiologic Osteoporosis Studies
ea0029p149
Alendronate inhibits adipocyte differentiation in 3T3-L1 through a Vitamin D receptor mediated effect
ea0029p150
Genetic predispositions do not explain short- and long-term effects of hormonal therapy on bone mineral density in girls with functional hypothalamic amenorrhea
ea0029p151
Improved assessment of bone turnover by the PTH-(1-84)/ large C-PTH fragments ratio in dialysis patients
ea0029p152
Comparaison of serum PTH concentrations obtained with a second and a third generation assay in a cohort of hemodialysis patients according to the KDIGO guidelines
ea0029p153
Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in Korean postmenopausal women
ea0029p154
Functional hypoparathyroidism is a risk factor for bone fragility of postmenopausal women with vitamin D insufficiency
ea0029p155
Platinum nanoparticle reduces ovariectomy-induced bone loss by decreasing osteoclastogenesis
ea0029p156
The level of Osterix expression in osteoblasts is important to prevent IL6-induced inflammatory-prone state
ea0029p157
Osteopenia/osteoporosis in patients with calcium nephrolithiasis
ea0029p158
No effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy
ea0029p159
Bone cross-sectional geometry and strength parameters at the radius by pQCT in male obese adolescents
ea0029p160
Osteonecrosis of the jaw (ONJ) with superimposed osteomyelitis related to actinomyces in a patient with multiple myeloma receiving thalidomide and intravenous zoledronic acid
ea0029p161
Effect of alcohol consumption on bone mineral density in healthy elderly Spanish males
ea0029p162
Effect of alendronate on bone mineral density in primary hyperparathyroidism
ea0029p163
Association of monocyte chemoatractant protein-1 and adiponectin with bone mineral density and osteocalcin in postmenopausal women
ea0029p164
Age-dependent and sexual features of bone mineral density changes in rats with hyperthyroidism
ea0029p165
Sinomaxillary myopericytoma associated with oncogenic osteomalacia
ea0029p166
Body composition in postmenopausal women with vertebral fractures
ea0029p167
Bone mineral density in relation to metabolic syndrome in postmenopausal women with diabetes type 2
ea0029p168
Assessment of bone turnover and vitamin D levels in women with postmenopausal osteoporosis and type 2 diabetes mellitus
ea0029p169
Osteoblast and adipocyte differentiation from human adipose tissue-derived cells
ea0029p170
Denosumab increases BMD in primary hyperparathyroidism
ea0029p171
Relationship between bone metabolism markers, bone mineral density and insulinresistance in healthy and diabetic postmenopausal women
ea0029p172
The relation between quantitative characteristics of smoking and level of female skeleton damage
ea0029p173
The assessment of the behavior of the interleukins IL1[beta] and IL6 and bone mineral density (BMD) and bone metabolism (IBM) in women of postmenopausal age
ea0029p174
Correction of bone mineral density losing in female rats with exogenous thyrotoxicosis with calcium and alendronate preparations
ea0029p175
Reference intervals for serum N-MID osteocalcin concentration measured with the IDS-iSYS automated system
ea0029p176
Prevalence of morphometric vertebral fractures and bone quality measured by spinal deformity index in type 1 diabetic patients
ea0029p177
Clinical evaluation of a new specific 1-84 PTH automated platform
ea0029p178
Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
ea0029p179
Investigating recurrent hypophostaemia
ea0029p180
Ovariectomy modulates the effect of phytoestrogens on creatine kinase specific activity in skeletal organs in female rats
ea0029p181
Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats
ea0029p182
Adiponectin and bone mineral density in obese postmenopausal women
ea0029p183
The body mass index and heel quantitative ultrasound analyze in 300 women
ea0029p184
Cimetidine (histamine H2-receptor antagonist and antiandrogenic drug) exerts a beneficial effect in the injured tissues by periodontal disease in male rat molars
ea0029p185
Age-dependent and sexual features of bone mineral density changes in rats in remote terms after hyperthyroidism abolition
ea0029p186
Features of bone mineral density losing in ukranian woman of different ages with thyrotoxicosis
ea0029p187
Comparison of the effects of hormone replacement therapy on bone mineral density, lipid profiles, and biochemical markers of bone metabolism
ea0029p188
Bone mass in diabetic patients measured by lumbar spine and hip densitometry
ea0029p189
Efficacy, safety and adherence to treatment of teriparatide: an observational study
ea0029p190
Thyroxin treatment of multinodular and normofunctional goiter and bone mass.
ea0029p191
Vitamin D status in patients treated with intravenous ibandronate: a cohort study
ea0029p192
Correlations between the bone matrix markers and bone mineral density in postmenopausal osteoporosis
ea0029p193
Zoledronic acid treatment improve bone strenght parameters assessed by BMD
ea0029p194
Therapeutical management in hypogonadal osteoporosis
ea0029p195
Calcium & Vitamin D metabolism
PTH levels are associated with insulin resistance in PCOS women
ea0029p196
Dietary effect of calcium and vitamin D on the gene expressions of tight junction in the duodenum and kidney of calbindin-D9k, -D28k and -D9k/D28k knockout mice
ea0029p197
Serum IGF1 concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D
ea0029p198
Incidence of diabetes and vitamin D deficiency: a prospective cohort study
ea0029p199
Tissue-specific expression of transcellular calcium transport and paracellular tight junction genes in the placentas of calbindin-D9k, -D28k, and -D9k/D28k knockout mice
ea0029p200
Gitelman's syndrome presenting with hypercalcaemia due to severe primary hyperparathyroidism
ea0029p201
Vitamin D pathway in non-functioning pituitary adenomas
ea0029p202
A new cause of malignancy associated hypercalcemia (MAH): PTH releasing breast cancer
ea0029p203
Two cases of alendronate induced atypical fracture of femur shaft
ea0029p204
Vitamin D levels and carbohydrate metabolism
ea0029p205
A single metastatic lesion in the leg of a parathyroid carcinoma
ea0029p206
Pseudohypoparathyroidism type Ia, hypothyroidism and insulin resistance
ea0029p207
A diagnostic conundrum associated with hypercalcaemia
ea0029p208
Expression of 25-hydroxyvitamin D3-1[alpha]-hydroxylase and 24-hydroxylase in human vascular smooth muscle cells
ea0029p209
Longitudinal changes in serum 25-hydroxyvitamin D levels of older persons during 6 and 13 years of follow-up
ea0029p210
Primary hyperparathyroidism, vitamin D deficiency and quality of life
ea0029p211
Cinacalcet treatment in MEN1-associated hyperparathyroidism: a clinical trial
ea0029p212
Serum levels of soluble secreted [alpha]-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis
ea0029p213
Lack of effects of high dose colecalciferol (D3) on insulin sensitivity and metabolic markers in type 2 diabetic patients: a double-blind, randomised, placebo-controlled trial
ea0029p214
Blood pressure after parathyroidectomy in patients with primary hyperparathyroidism and hypertension
ea0029p215
Serum cystatin C is a reliable predictor of renal function and cardiometabolic risk in primary hyperparathyroidism
ea0029p216
Usefulness of MS-MLPA for detection of genetic and epigenetic states of GNAS complex in Pseudohypoparathyroidism type1b
ea0029p217
Pathophysiological changes in extracellular pH regulate calcium-sensing receptor responsiveness in HEK-293 and isolated parathyroid cells but not as a result of altered histidine residue ionisation
ea0029p218
Normocalcemic hyperparathyroidism: a personal experience
ea0029p219
Cardiac structure and functions in patients with asymptomatic primary hyperparathyroidism
ea0029p220
Perioperative management difficulties in parathyroidectomy for primary vs secondary and tertiary hyperparathyroidism
ea0029p221
Evaluation of glucose metabolism in primary hyperparathyroid patients
ea0029p222
The prevalence of hypocalcaemia with low parathyroid hormone level in Polish elderly population
ea0029p223
Obesity, carbohydrate, lipid metabolism and polymorphisms (Fok, Bsm) of vitamin D receptor gene in aging population: POLSENIOR study
ea0029p224
Quality of life in premenopausal women with vitamin D deficiency and vitamin D insufficiency
ea0029p225
Intraoperative parathormone monitoring allows successful minimally invasive parathyroidectomy in patients with non concordant preoperative imaging
ea0029p226
Vitamin D status, chronic kidney disease and secondary hyperparathyroidism in Polish elderly population
ea0029p227
Vitamin D status in primary hyperparathyroidism: a 'Southern European' observational study
ea0029p228
Vitamin D and rheumatoid arthritis
ea0029p229
The prevalence of primary hyperparathyroidism in Polish elderly population
ea0029p230
Markers of bone turnover and polymorphism of vitamin D receptor gene in aging population: POLSENIOR study
ea0029p231
Endothelial functions of the patients with hyperparathyroidism
ea0029p232
The importance of citrate and the calcium/citrate ratio in patients with calcium renal lithiasis and severe lithogenesis
ea0029p233
The diagnostic values of serum intact parathyroid hormone, calcium and phosphorus for the prediction of vitamin D deficiency
ea0029p234
Vitamin D and gestational diabetes
ea0029p235
Bone biomarkers, body composition and metabolic profile in patients with primary hyperparathyroidism
ea0029p236
The daily calcium intake is associated with sarcopenia in older, non-obese koreans: the fourth korea national health an nutrition examination surveys (KNHANES IV) 2009
ea0029p237
Role of chromogranin-A in the truncation of parathyroid hormone in cultured parathyroid cells from patients of the secondary hyperparathyroidism
ea0029p238
Correlations between vitamin D supply and PTH-intact and PTH-bio-intact levels in dialysis patients
ea0029p239
Relationship among time outside, sun exposure, clothing worn, adiposity and serum 25(OH)D in overweight and obese adults
ea0029p240
Prospects of patients with oligosymptomatic primary hyperparathyroidism
ea0029p241
Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA centaur vitamin D assay
ea0029p242
Primary hyperparathyroidism: association of imaging and pathology
ea0029p243
Vitamin D modulates composition of extracellular matrix in cultured human vascular cells
ea0029p244
Vitamin D level and ALT level in Chinese-American patients with chronic hepaitits B in the new york city downtown area
ea0029p245
High levels of parathormone after parathyroidectomy in primary hyperparathyroidism patients does not always mean disease recurrence...
ea0029p246
Sporadic pseudohypoparathyroidism with osteitis fibrosa cystica
ea0029p247
Vitamin D supply in healthy blood donors: is there relationship with the use of oral contraceptives?
ea0029p248
Chronic hypercalcemia, an unusual presentation in Q1011E heterozygous CaSR polymorphism
ea0029p249
Quantification of serum 25-hydroxyvitamin D: a comparison among immunoassay, HPLC-UV, and HPLC-MS
ea0029p250
Vitamin D deficiency and insufficiency and secondary hyperparathyroidism in Ukrainian population
ea0029p251
Prevalence of hypovitaminosis D in adult patients with hypopituitarism
ea0029p252
Treatment of vitamin D insufficiency with oral loading doses of cholecalciferol
ea0029p253
A 10-year study of vitamin D in Moldova
ea0029p254
25-Hydroxi-vitamin-D levels in clinical conditions with low plasma albumin
ea0029p255
The impact of different vitamin D preparations for the treatment of vitamin D deficiency in primary hyperparathyroidism (PTHP)
ea0029p256
Identification of a novel mutation in the calcium sensing receptor gene in FHH
ea0029p257
Vitamin D status in patients with musculoskeletal symptoms in Haryana, India
ea0029p258
Evaluation of the platelet functions in hyperparathyroid patients
ea0029p259
The relation between endocrine and radiological changes in adolescents with vitamin D deficiency
ea0029p260
Remember calcium! Fahr's syndrome diagnosed after repeated generalized seizures: a case report
ea0029p261
Assessment of vitamin D 3 status in general population
ea0029p262
Unrecognized severe vitamin D deficiency
ea0029p263
Evaluation of clinical and laboratory findings of our primary hyperparathyroid patients
ea0029p264
Experience in the treatment of primary hyperparathyroidism with cinacalcet: Preliminary data
ea0029p265
Primary hypoparathyroidism presenting as adult onset seizure: a report of two cases
ea0029p266
Vitamin D status in primary hyperparathyroidism
ea0029p267
Vitamin D deficiency repletion in patients with co-existing vitamin D deficiency and primary hyperparathyreoidism: pro for early postoperative or preoperative treatment: case reports
ea0029p268
Cardiovascular Endocrinology and Lipid Metabolism
Testosterone replacement therapy inhibits key enzymes of fatty acid synthesis in mouse liver
ea0029p269
Effect of testosterone on hepatic liver X receptor and ApoE expression as a potential mechanism of atheroprotection in the testicular feminised mouse
ea0029p270
The effect of potassium supplementation on the endothelium, the renin-angiotensin-aldosterone system (RAAS) and blood pressure in patients at moderate cardiovascular disease risk
ea0029p271
(Pro)renin Receptor is essential for filtration barrier in glomerular podocyte
ea0029p272
Testosterone replacement therapy: a safety audit of clinical practice including men with Type 2 diabetes and cardiovascular disease
ea0029p273
Thyroid axis hormones and cortisol are associated with subjective fatigue in patients with coronary artery disease
ea0029p274
Familiar hypercholesterolemia: effects of treatment with rosuvastin
ea0029p275
Metabolic and glycaemic profile in patients with acute coronary syndrome
ea0029p276
Impact of 6-month course of 1 mg finasteride tablets on levels of lipid profile in men with androgenic alopecia
ea0029p277
Transient glucocorticoid excess does not cause persisting metabolic changes in mice
ea0029p278
Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in accordance with amelioration of metabolic abnormalities, visceral adiposity and atherosclerosis
ea0029p279
The role of testosterone activation of liver X receptor in a human macrophage cell line and its implications for the treatment of type 2 diabetes and atherosclerosis
ea0029p280
Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human coronary arterial wall and pericoronary adipose tissue in correlation with atherosclerosis
ea0029p281
Six loci associated with high-density lipoprotein cholesterol or triglycerides in Chinese pregnant women
ea0029p282
Development of primary hyperparathyroidism is closely associated with the onset of dyslipidemia and insulin resistance in a large family harboring a MEN1 gene mutation
ea0029p283
Level of adiponectin and vaspin, and adiponectin/vaspin ratio is associated with insulin resistance and clinical expression of metabolic syndrome in type 2 diabetic patients
ea0029p284
Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial
ea0029p285
The role of [beta]-arrestin proteins in CB1 cannabinoid receptor endocytosis
ea0029p286
Abstract unavailable
ea0029p287
Plasma aldosterone to plasma renin ratio on an automated analyzer using two novel chemiluminescence immunoassays
ea0029p288
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
ea0029p289
Testosterone and cardiovascular risk in patients with erectile dysfunction
ea0029p290
Oxytocin stimulates cardiomyogenesis and cardioprotection via stem cells activation
ea0029p291
Metabolism of angiotensin II and angiotensin III in HAC15 cells
ea0029p292
Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human aortic wall and periaortic adipose tissue in correlation with atherosclerosis
ea0029p293
In primary aldosteronism, plasma aldosterone concentration is an independent risk factor for albuminuria, and the higher baseline urinary albumin excretion predicts the less glomerular filtration rate after treatment
ea0029p294
Relationships between insulin resistance and cardiovascular risk factors in primary hyperparathyroidism
ea0029p295
Allosteric effects between the protomers of AT1 angiotensin receptor homodimer: role of the conserved DRY motif
ea0029p296
Effect of triiodothyronine and angiotensin-II on expression of (pro)renin receptor in the human erythroid cell line, YN-1
ea0029p297
The combined use of serum interleukin 6 and C-reactive protein is better than either alone in predicting cardiovascular events in a Chinese population
ea0029p298
Short-term detraining cannot reverse insulin sensitivity improvement and serum retinol binding protein 4 in spontaneously hypertensive rats previously submitted to aerobic exercise
ea0029p299
Multiple cardiovascular risk factors in patients with myotonic dystrophy type 1 and 2
ea0029p300
Role of peroxisome proliferator-activated receptor-[gamma] (PPAR[gamma]) in regulation of glucocorticoid metabolism in vascular smooth muscle cells
ea0029p301
Recombinant erythropoietin treatment enhances mitochondrial function in human skeletal muscle
ea0029p302
Association of IL4 receptor gene polymorphisms with high density lipoprotein cholesterol
ea0029p303
Cardiovascular risk factors in a large cohort of children with GH deficiency
ea0029p304
Lipid profile in children with persistent idiopathic subclinical hypothyroidism
ea0029p305
Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population
ea0029p306
MRTF-A, a rho-dependent co-activator of SRF, regulates phenotypic modulation of vascular smooth muscle cells and plays an important role in vascular remodeling
ea0029p307
Association of PON-1 activity and other anti-oxidative enzymes with long-chain fatty acids profile in T2DM
ea0029p308
Risk factors of metabolic syndrome in adolescent with classical congenital adrenal hyperplasia
ea0029p309
Alterations of protein expression profiles in 3T3-L1 adipocytes by interleukin 4
ea0029p310
Anti-Mullerian hormone may be a hormonal regulator of the cardiovascular system
ea0029p311
Anti-oxidataive actions of urocortin on HL-1 cardiomyocytes
ea0029p312
Adipokine expression profile in pericoronary and periaortic adipose tissue in correlation with coronary and aortic atherosclerosis
ea0029p313
Fatty liver index and lipid accumulation product index as markers of liver steatosis in premenopausal women with nonalcoholic fatty liver disease
ea0029p314
Effects of long-term treatment of hypogonadal men with testosterone undecanoate on blood pressure, fasting glucose, HbA1c and C-reactive protein
ea0029p315
Dysregulation of tissue renin-angiotensin-aldosterone system in obese hypertensive rats
ea0029p316
The relationship between 25(OH)D levels and markers of atherosclerosis and inflammation in type 2 diabetic patients
ea0029p317
Plasma total homocysteine levels in transsexuals after cross-sex hormonal treatment
ea0029p318
Body composition and association to NT-proBNP and myostatin levels in heart failure patients
ea0029p319
Subclinical atherosclerosis and arterial stiffness are associated with levels of circulating androgens in healthy recently menopausal women
ea0029p320
Metabolic syndrome, hormone levels and inflammation in patients with erectile dysfunction
ea0029p321
Duration effect of statin therapy on bone metabolism in dyslipidemic patients
ea0029p322
Coronary flow reserve is inversely related to urinary cortisol in Cushing's syndrome
ea0029p323
Myeloperoxidase is not associated with applications of coronary artery disease and type 2 diabetic patients
ea0029p324
Analysis of hyponatremia in a tertiary hospital during a 5 year period
ea0029p325
Effect of melatonin supplementation on lipid peroxidation and on the enzymes of antioxidative system in patients with chronic coronary artery disease.
ea0029p326
N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with non-ST-elevation myocardial infarction (NSTEMI) compared to patients with unstable angina (UA) in a lot of patients admitted for non-ST-elevation acute coronary syndrome (NSTE-ACS)
ea0029p327
Effect of medical therapy on 24-h blood pressure profile in acromegaly
ea0029p328
Polycystic ovary syndrome induces leukocyte/endothelial cell interactions
ea0029p329
Effect of weight loss on C3 and C4 components of complement in obesity
ea0029p330
Vitamin D serum levels and cardiovascular risk factors in postmenopausal women
ea0029p331
Sympathetic over-activity and low adrenocortical responses to hypoglycemia in patients in early stage of hypertension
ea0029p332
The effect of thyroxine replacement on reduction of small dense low-density lipoprotein (sdLDL) in patients with primary hypothyroidism.
ea0029p333
Metabolic consequences of obesity in children and adolescents
ea0029p334
Study on the DHEA-S secretion dynamics in elderly pacients with cardiovascular diseases
ea0029p335
Testosterone and androstane-3[alpha], 17[beta]-diol glucuronide correlate with coronary disease
ea0029p336
Cardiovascular function and IGF1 deficit (IGF1-D) in [beta]-thalassemia major
ea0029p337
Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors
ea0029p338
The importance of HDL cholesterol to predict adiponectin and retinol binding protein 4 concentration after one session resistance exercise
ea0029p339
Intrinsic myocardial disease in adults with GH deficiency is characterised by subclinical left ventricular longitudinal dysfunction revealed by tissue Doppler
ea0029p340
Paraoxonase, malondialdehyde and lipids in subjects with asymptomatic gallstones
ea0029p341
Cardiac hormones are dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor
ea0029p341.1
Clinical case reports - Pituitary/Adrenal
Localization of occult adrenal tissue with cosyntropin-stimulated 18F-FDG-PET/CT in a patient with metachronous adrenocortical tumor who presented with persistently elevated SDHEA after bilateral adrenalectomy
ea0029p342
A case of pheochromocytoma which represented multiple myeloma like change
ea0029p343
Reactivation of Takayasu arteritis in two patients with Cushing's disease after normalization of cortisol secretion.
ea0029p344
Delayed presentation of late onset CSF rhinorrhoea following dopamine agonist therapy for giant prolactinoma
ea0029p345
ACTH-dependent Cushing's syndrome secondary to an ectopic source of ACTH/CRH: three clinical cases with different prognosis and outcome
ea0029p346
Hyponatraemia assessment and outcomes in acute medically ill patients
ea0029p347
A clinical case of a 21 years old man with inborn pituitary dystopia
ea0029p348
A case of acromegaly without clear evidence of pituitary adenoma or ectopic GH/GHRH secreting tumors
ea0029p349
Evaluation on clinical application and long term outcomes of microwave endometrial ablation
ea0029p350
Familial central diabetes insipidus due to a novel mutation in exon 3 of the arginine vasopressin gene
ea0029p351
Successful pregnancy during use of octreotide and pegvisomant in an acromegalic patient
ea0029p352
Long-term efficacy and safety of pasireotide in Cushing's disease: a 36-month case report
ea0029p353
Control of acromegaly in an era where it is technically feasible in almost every patient, is by no means invariable even in a specialist unit
ea0029p354
A case of adrenocortical carcinoma with fever of unknown origin and elevated serum IL6 level
ea0029p355
Desmopressin and non steroidal anti-inflammatory drugs: a case report of severe water intoxication during replacement therapy and review of the literature
ea0029p356
Germ cell tumor of the pituitary-hypothalamic region: case series and clinical experience in the Hospital Universitario Virgen del Rocio
ea0029p357
Adrenal venous sampling for two cases with primary pigmented nodular adrenocortical disease
ea0029p358
Cyclic Cushing's syndrome due to occult ectopic ACTH secretion
ea0029p359
Use of tolvaptan for delayed hyponatremia after transsphenoidal surgery for pituitary adenoma: a case report
ea0029p360
Familial isolated pituitary adenoma cases in Hungary
ea0029p361
Hypopituitarism in an adult patient as the first sign of langerhans cell histiocytosis
ea0029p362
A case of cyclic Cushing's syndrome which was induced remission dramatically by dopamine agonist
ea0029p363
Antinociceptive effect of pasireotide on octreotide-resistant acromegaly-related headache
ea0029p364
Giant cystic pheochromocytoma in an asymptomatic man
ea0029p365
Unusual presentation of hypopituitarism
ea0029p366
Rhabdomyolysis and myopathy in Addison's disease: is there a connection?
ea0029p367
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury
ea0029p368
A rare case of primary tubercular pituitary abscess in a diabetic patient
ea0029p369
Central diabetes insipidus as first sign of progression to accelerated phase in a chronic myeloid leukemia patient
ea0029p370
Contrast-enhanced ultrasound supports diagnosis in a patient with paravesical paraganglioma
ea0029p371
Pituicytoma and meningeoma presenting as suprasellar tumor: case report
ea0029p372
A clinical case report of an successful spontaneous pregnancy in acromegaly
ea0029p373
Childhood onset hypopituitarism and central apnea: looking beyond hormonal replacement
ea0029p374
Cystic pituitary macroadenoma complicated by recurrent mucocoeles: a rare case report
ea0029p375
A patient with TSH-secreting pituitary macroadenoma, after previous thyroid ablation, successfully treated with long-acting octreotide formulation (octreotide-LAR) and transsphenoidal surgery
ea0029p376
Synchronous papillary and medullary thyroid carcinoma in an acromegaly patient
ea0029p377
Pregnancy in an acromegalic woman: a case report
ea0029p378
Acromegaly, primary hyperparathyroidism and renal cell carcinoma
ea0029p379
Late diagnosis of adrenal tuberculosis
ea0029p380
Spontaneous remission of acromegaly due to pituitary apoplexy: case report
ea0029p381
Oligosymptomatic paraganglioma in the setting of neurofibromatosis type 1
ea0029p382
Histiocytosis X-manifested with insipid diabetes clinical case
ea0029p383
A case history as example for diagnostics and treatment of acromegaly: started and ended with pregnancy
ea0029p384
Adrenal neurilemoma
ea0029p385
A case of autoimmune polyglandular syndrome type II presenting with adrenal crisis
ea0029p386
Elephantiasis nostras verrucosa as a presenting cause of Cushings' disease
ea0029p387
Syndrome of inappropriate secretion of antidiuretic hormone in a elderly women affected with herpes zoster infection: a case report
ea0029p388
Hyponatremia and cytolysis as first signs of decompensated pituitary insufficiency: case report
ea0029p389
Acromegaly and pregnancy: two acromegalic patients treated with somatostatin analogues
ea0029p390
Particular course of a case of acromegaly associated with Waldenstrom's macroglobulinaemia
ea0029p391
A case of acromegaly with nephrogenic adenoma of the bladder: a rare association?
ea0029p392
Recovery of prolactin function following spontaneous pregnancy in a patient with Sheehan's syndrome
ea0029p393
Giant macroprolactinoma: recidive after 12 years (case report)
ea0029p394
An uncommon cause of hypoglycaemia: a case report
ea0029p395
Central diabetes insipidus: about two clinical cases
ea0029p396
Macroprolactinomas: therapy compliance (case report)
ea0029p397
Endocrine hypertension due to primary aldosteronism
ea0029p398
Unusual association between pheochromocytoma, adrenocortical nodular hyperplasia and empty sella: case report
ea0029p399
Clinical case reports - Thyroid/Others
New diabetic emergency; acute rhabdomyolysis complicating hyperglycemic hyperosmolar coma successful management and insight into pathogenesis
ea0029p400
Laminopathy and auto-immune sclerodermia: chance or necessity?
ea0029p401
Pendred's syndrome: genetics and phenotypic variability
ea0029p402
A rare case of vanishing fetal goiter and role of colour doppler ultrasound in the diagnosis
ea0029p403
Gastrostomy solves severe hypoglycemias after bariatric surgery
ea0029p404
Pubertal induction with testosterone of a boy with bilateral anorchia guided by the development of his monozygotic twin brother
ea0029p405
Pseudohypoparathyroidism type Ib: a case of occult familial disease
ea0029p406
Considering familial benign hypocalciuric hypercalcemia on differential diagnosis of primary hyperparathyroidism
ea0029p407
The diagnostic challenge of a parathyroid adenoma undetectable by Tc-99m Sestamibi scintigraphy or computed tomography in a patient with newly diagnosed sarcoidosis and hypercalcaemia
ea0029p408
Severe gestational hypothyroidism due to anti-TSH receptor blocking antibodies
ea0029p409
A case of refractory hypoglycemia
ea0029p410
Double jeopardy in pregnancy: a case of autoimmune polyglandular syndrome type 2 in a pregnant patient
ea0029p411
Pseudo malabsorption of levothyroxine
ea0029p412
Vitamin D deficiency and elevation of para-thyroid in Thalassemia minor: a case study
ea0029p413
Study of hormone and thyroid antibodies of auto-immune thyroid disorders
ea0029p414
New insulin receptor mutation in a patient with primary amenorrhea
ea0029p415
Plasmapheresis therapy in a case with recurrent pancraetitis attacks as a consequence of hypertryglyceridemia
ea0029p416
Association of thyroid hormone resistance and hypogonadotropic hypogonadism
ea0029p417
5-Alpha reductase type 2 deficiency: a case report
ea0029p418
Subacute or hashimoto thyroiditis? a diagnostic dilemma: case report
ea0029p419
True hermaphroditism with a rare 46,XX/47,XXY Klinefelter's mosaicism: a new unique case and review of previous reports
ea0029p420
Genetics of HLA-identical monozygous twins with different manifestations of polyglandular autoimmune syndrome
ea0029p421
Papillary thyroid-type carcinoma arising from struma ovarii: a case report
ea0029p422
Hypothyroidism with extensive pericardial effusion: different therapeutical approaches
ea0029p423
Abstract unavailable
ea0029p424
A case of persistent hypoglycemia in the setting of connective tissue disease
ea0029p425
Successful pregnancy in a patient with biologically inactive LH or partial LHCGR resistance
ea0029p426
Quadruple metachronous malignancy in a single patient with multiple sclerosis: case report
ea0029p427
Hungry bone syndrome in a patient with McCune-Albright syndrome after total thyroidectomy: case report
ea0029p428
A case with thyroid metastasis from small cell lung carcinoma
ea0029p429
Central hypothyroidism following peripheral hyperthyroidism: a brief case report
ea0029p430
Impact of glibenclamide therapy in a patient with neonatal diabetes and intermediate DEND syndrome with the V59M mutation in the KCNJ11 gene
ea0029p431
Parkinson-like syndrom as a unusual manifestation of primary hypoparathyroidism: case report
ea0029p432
Van Wyk e Grumbach syndrome: case report
ea0029p433
Primary hyperparathyroidism associated with autoimmune polyglandular syndrome type III and isolated IgA deficiency
ea0029p434
Reversible Hashimoto's thyroiditis: clinical, hormonal, autoimmune and ultrasonographic evidence
ea0029p435
Hypoparathyroidism - a rare cause of heart failure
ea0029p436
Hypogonadism with subsequent multi-organ involvement: a mystery solved
ea0029p437
Thyrotoxicosis-associated acute myocardial infarction and ventricular fibrillation in a patient with normal epicardial coronary arteries
ea0029p438
A case of papillary thyroid carcinoma with esophageal invasion treated by targeting PEI and transesophageal argon plasma coagulation
ea0029p439
Association between diabetes mellitus and sarcoidosis: a case report
ea0029p440
Noninsulinoma pancreatogenous hypoglycemia syndrome as a rare cause of hyperinsulinemic hypoglycemia: case report
ea0029p441
A case of pneumomediastinum and tracheomalasia in thyroid storm with longstanding goiter
ea0029p442
A case of pancytopenia with hyperthyroidism
ea0029p443
Struma ovarii and the thyroid surgeon
ea0029p444
Multiple myeloma associated with primary hyperparathyroidism
ea0029p445
Graves' disease with a transient lung mass
ea0029p446
Combination of recombinant TSH (rhTSH) and lithium overcomes amiodarone-induced low radioiodine uptake in a thyrotoxic female
ea0029p447
Primary hypoparathyroidism presenting as recurrent TIAs with intracranial calcification
ea0029p448
Ampullary NET presenting as Virchow's node
ea0029p449
Unusual cause of hypokalemic paralysis
ea0029p450
Paraneoplastic severe hyponatremia in a patient with GIST: case report
ea0029p451
Papillary thyroid carcinoma in two patients with primary hyperparathyroidism
ea0029p452
Marked improvement of gastrointestinal pseudo-obstruction after debulking surgery of malignant pheochromocytoma by Intravenous administration of [alpha]-blocker phentolamine
ea0029p453
Primary and secondary hyperparathyroidism coexisting in patient with liver cirrhosis and coeliac disease: efficiency of preoperative treatment with vitamin D
ea0029p454
Primary hyperparathyroidism and metastatic breast cancer: a simultaneous presentation
ea0029p455
Insulinoma presenting as post-prandial hypoglycaemia
ea0029p456
Malignant, ectopic ACTH secreting occult neuroendocrine tumor: a case report
ea0029p457
Noonan Syndrome in adulthood: two cases reports
ea0029p458
Unusual course of Amiodarone-induced hypothyroidism: case report
ea0029p459
Anaplastic thyroid carcinoma: case report
ea0029p460
'Collision tumor' of the thyroid: a case report
ea0029p461
Unknown reason of continuing hypercalcemia after successful extirpation of parathyroid gland
ea0029p462
Catastrophic bone deformities associated with primary hyperparathyroidism in a middle-aged man
ea0029p463
Severe fetal and neonatal hyperthyroidism following radioiodine therapy in a woman with Graves' disease
ea0029p464
Hypercalcaemia in pregnancy
ea0029p465
Ectopic Cushing's syndrome and thymic hyperplasia
ea0029p466
Synchronous papillary thyroid cancer and astrocytoma: case report
ea0029p467
Exogenous thyrotoxicosis by consumption of pork sausage
ea0029p468
Ovarian hyperstimulation syndrome and autoimmune primary hypothyroidism in two members of a family
ea0029p469
Novel treatment option in the management of SIADH related Hyponatremia: two case reports
ea0029p470
Growth hormone: 'beginning of a new life'
ea0029p471
Severe amiodaron: induced thyrotoxicosis
ea0029p472
Thyreotoxic periodic paralysis in a Caucasian man after corticosteroid administration
ea0029p473
Adrenal crisis due to unusual cause: case report
ea0029p474
Persistently abnormal thyroid function in a 26 year old Afro-Caribbean man: a diagnostically challenging case
ea0029p475
Asymptomatic hypocalcemia in elderly
ea0029p476
Thyroid nodule: dormant, but lethal
ea0029p477
Morbid obesity: what can be and should be done?
ea0029p478
Sever Grave's disease and diabetes melitus
ea0029p479
Secondary hypertension: a case presentation
ea0029p480
Developmental endocrinology
Regulation of trophoblast 11[beta]-hydroxysteroid dehydrogenase type 2 expression and role of corticotropin-releasing hormone
ea0029p481
Dimensional profiles of male to female gender identity disorder: an exploratory research
ea0029p482
GH replacement therapy in patients with primary paediatric brain tumours
ea0029p483
The effect of educational program based on BASNEF model on diabetic (type II) control blood sugar
ea0029p484
The timing of the onset of adrenarche in Pakistani boys
ea0029p485
Post prandial gut hormones: novel activators and regulators of innate immune function
ea0029p486
Opposite effect of LXR on myelination process in the central and peripheral nervous systems and interplay with Wnt pathway
ea0029p487
Increased oxidative stress associated with angiogenic growth factors in preeclampsia
ea0029p488
Congenital hypothyroidism influences hepatic gene expression of suppressors of cytokine signaling (SOCS) in adulthood
ea0029p489
Characterization of a mouse model of paediatric combined hormone deficiency
ea0029p490
DHEA attenuated mature adipocyte proliferation
ea0029p491
Oestradiol and its biochemical precursor levels decline in men around the age of their late twenties, what may determine the conclusion of bone maturation
ea0029p492
The origins and lineages of somatic cells during the formation of the mammalian ovary
ea0029p493
Childhood maltreatment in subjects with male to female gender identity disorder
ea0029p494
Post prandial responses of insulin and free fatty acids following consumption malaysian vs mediterranean-like meals among healthy subjects
ea0029p495
Evaluation of cognitive, affective and relational skills of adolescents treated with testosterone for 47XXY klinefelter syndrome
ea0029p496
The development of endocrinologic dysfunction after allogeneic HSCT in children.
ea0029p497
46 XX Male syndrome: is there any relationship with dysembryoplastic neuroepithelioma?
ea0029p498
Diabetes
Selective suppression of slow wave sleep does not affect insulin sensitivity in patients with type 1 diabetes
ea0029p499
Evidence that abscissic acid participates in the response to hyperglycemia in humans
ea0029p500
Mitochondrial biogenesis is not significantly impaired in non obese asian indians with type 2 diabetes
ea0029p501
Iron overload induces visceral adipose tissue insulin resistance
ea0029p502
Comprehensive evaluation of type 2 diabetes susceptibility loci in the Japanese population by using 1000 Genomes Project data
ea0029p503
Glycoalbumin is the best indicator for glycemic variability assessed by continuous glucose monitoring
ea0029p504
Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese
ea0029p505
Altered Mitochondrial Bioenergetics Does Not Explain Increased Ros Production In Non-Obese Asian Indians With Type 2 Diabetes (T2D)
ea0029p506
QRFP43 and its fragment 26RFa both promote [beta]-cell survival but differently regulate insulin secretion and glucose uptake in pancreatic [beta]-cells and human pancreatic islets
ea0029p507
Influences of the 2011 Tohoku Earthquake on glycemic control in patients with diabetes mellitus in Tokyo
ea0029p508
The impact of pioglitazone administration on circulating endothelial progenitor cells, inflammation and endothelial function of diabetic patients with and without coronary artery disease
ea0029p509
The redution hypothalamic PP2A expression improve peripheral insulin sensitivity
ea0029p510
The new combination of risk factors determining a high risk of gestational diabetes mellitus
ea0029p511
Glycemic control influences CA19-9, CEA and ferritin levels in type 2 diabetes.
ea0029p512
Effects of perindopril on circulating endothelial progenitor cells, inflammation and endothelial function of diabetic patients with and without coronary artery disease
ea0029p513
Glycemic control in type 1 diabetic patients experience of a university hospital in tunis
ea0029p514
Progression to impaired fasting glucose, impaired glucose tolerance and diabetes in urban population during 8 years follow up
ea0029p515
The role of sex hormone-binding globulin in the risk of incident metabolic syndrome: further evidence from a longitudinal population-based sample of adult men.
ea0029p516
Fracture predictors in diabetic postmenopausal women without hyperparathyroidism
ea0029p517
Characteristics and prevalence of latent autoimmune diabetes in adults (LADA) in a diabetic population
ea0029p518
Non Governmental Organizations [NGO's] [amp] Diabetes- Advocacy for support services in resource-poor nations
ea0029p519
Mesenchymal stem cells-derived microvesicles modulate cellular immune response to islet antigen GAD in type 1 diabetes.
ea0029p520
Prevalence of autoimmune diseases in a Type 1 diabetic population
ea0029p521
Relation of glycemic control to Easter and summer holiday times
ea0029p522
Change in quality of life by multiple education program in type 1 diabetic patients
ea0029p523
Cystatin levels in diabetic and prediabetic patients
ea0029p524
Psychoemotional state of diabetic women with fracture
ea0029p525
Hypoglycemic and hyperglycemic patients in emergency room
ea0029p526
Diabetes risk in relation to weight loss, weight stability and degree of obesity - The Swedish Obese Subjects (SOS) study
ea0029p527
The role of Insulin Receptor in Cancer
ea0029p528
Local effects of cytokine TNF-alpha on glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg
ea0029p529
Increased nuclear translocation of GAPDH in peripheral blood mononuclear cells (PBMCs) of diabetic patients.
ea0029p530
Conserved mitochondrial coupling and adaptive substrate control in inuit and caucasians: acclimatization to active life styles in the arctic winter
ea0029p531
Association of adiposity trajectories with insulin sensitivity and glycemic deterioration: a longitudinal study of rural chinese twin adults
ea0029p532
Direct metabolic effects of locally administered lipopolysaccharide in the placebo controlled bilaterally infused human leg; decreased insulin sensitivity and insulin signaling with unaltered lipid and protein metabolism
ea0029p533
Suppressive effect of hyperinsulinemia on serum interleukin 18 concentration in young healthy subjects
ea0029p534
The Association of the severity of nonalcoholic fatty liver disease with development of type 2 diabetes: A 4-year longitudinal study
ea0029p535
Predictive ability of prediabetes defined by fasting plasma glucose and HbA1c for progression to diabetes in Koreans
ea0029p536
Relationship between serum levels of 1-84 parathormone (PTH1-84) and obesity, HOMA insulin-sensitivity or beta-cells function (HOMA-B) in type 2 diabetic patients
ea0029p537
The burden of disease in elderly people with IFG
ea0029p538
GABA A receptor gene regulatory networks in peripheral blood TCD4+, TCD8+ AND CD14+ cells of recently diagnosed type 1 diabetes mellitus
ea0029p539
Diagnosis of Metabolic syndrome in Saudi Arabia: implications for the importance of local criteria
ea0029p540
Comparison of plasma osteoprotegerin and related factors in two groups of pregnant women
ea0029p541
Protein from Hevea brasiliensis latex rubber tree enhances wound healing in diabetic rats
ea0029p542
Prevalence of Microalbuminuria in Galicia (NW Spain) and its association with risk factors: Hypertension, Type 2 diabetes mellitus and Pre-diabetes.
ea0029p543
Sarcopenic phenotype in patients with newly diagnosed type 2 diabetes
ea0029p544
Type 2 diabetes mellitus and Ramadan fasting: a continuous glucose monitoring (CGM) study of glucose excursions in a group of patients with good glycaemic control
ea0029p545
Abstract unavailable
ea0029p546
High GADA titre: a marker of insulin dependence in adult onset autoimmune diabetes
ea0029p547
Aerobic and resistance exercise have different short-term effects on glucose levels in type 2 diabetes subjects
ea0029p548
Regulation of somatostatin/cortistatin and ghrelin systems under diet induced obesity conditions at the mouse endocrine pancreas
ea0029p549
Influence of iron metabolism indices on HbA1c in non-diabetic pregnant women with and without iron-deficiency anemia: effect of iron supplementation
ea0029p550
Both [beta]-cell dysfunction and insulin resistance are primary determinants of diabetes mellitus in patients with liver cirrhosis candidate to organ transplant
ea0029p551
The effects of fat distribution and some adipokines on insulin resistance in prediabetic patients
ea0029p552
New fast and reversible leptin antagonist-induced mice model of metabolic syndrome and T2DM
ea0029p553
High-fructose diet, an animal model of insulin resistance, causes mitochondrial dysfunction by altering the activity of respiratory chain complex I
ea0029p554
Does the presence of thyroid antibodies affect the course and outcome of pregnancy in type1 diabetic women?
ea0029p555
The association between insulin-like-growth-factor I and insulin resistance: a general population study in danish adults
ea0029p556
Abstract unavailable
ea0029p557
Alterations in fecal lactobacillus and bifidobacterium species are associated with differences in cholesterol metabolism in type 2 diabetic patients
ea0029p558
Low testosterone is associated with decreased expression of glut-4 and hexokinase 2 in muscle of the testicular feminised mouse
ea0029p559
Serum visfatin is differentially regulated by insulin and non-esterified fatty acids in healthy men
ea0029p560
Mitochondrial impairment and oxidative stress in leukocytes from type 2 diabetic patients
ea0029p561
High prevalence of autoimmunity in adult onset diabetes subjects with high GADA titre
ea0029p562
Testing of type 2 diabetes risk locus rs7578597 in THADA gene in the czech population
ea0029p563
Impact of diabetes on length of stay and inpatient mortality for elderly patients presenting with proximal fracture of the femur
ea0029p564
Screening of latent autoimmune diabetes in insulin requiring diabetic adults
ea0029p565
Epidemiological study of patients attended the pediatric outpatient clinic of national institute of diabetes [amp] endocrinology
ea0029p566
Clinical and histopathology tumor characteristics of patients with invasive breast carcinoma on insulin glargine compared with other types of basal insulin
ea0029p567
Evaluation of clinical care in young type 1 diabetes subjects: a nationwide multicenter study in brazil
ea0029p568
Abstract unavailable
ea0029p569
DNA methylation influenced [beta]-arrestin 2 expression in type 2 diabetes patients
ea0029p570
Innervation and vascularization into islets of langerhans in the presence or absence of proglucagon-derived peptides
ea0029p571
Expression of ghrelin and its receptor genes is tissue specific in streptozotocin treated piglets
ea0029p572
Empowering patients with diabetes: a qualitative study focusing on knowledge of self-care behaviors amongst asians in south florida
ea0029p573
Circulating ghrelin and leptin concentrations in metabolic disorders of obese and lean piglets
ea0029p574
Effective utilization of anti-GAD measurement
ea0029p575
The relationship between the level of knowledge of physicians on guidelines and the degree of glucometabolic control in type 2 DM patients in Turkey
ea0029p576
Previous history of gestational diabetes mellitus and flow mediated dilation of brachial artery
ea0029p577
Frequency and outcome of follow-up testing after a positive gestational diabetes screen
ea0029p578
Relationship vitamin D levels and glycemic control in type 2 diabetic patient
ea0029p579
Association between educational level with glycemic and risk factor control in type 1 diabetes: results from DIACAM 1 study
ea0029p580
Basal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of various treatments
ea0029p581
Measles and new onset type 1 diabetes presented with bilateral facial paralysis: report of a case
ea0029p582
Identification of dipeptidyl peptidase-4 inhibitors among boioactive peptides derived from whey proteins
ea0029p583
Decreased sucrose preference in humans and rodents with diabetes
ea0029p584
Regulatory T cells number and function in patients with LADA
ea0029p585
Depression as a predictive factor for glycemic control and family functioning in Japanese patients Swith type 2 diabetes: a 6-month follow-up study
ea0029p586
What arises from the decrease of visceral adiposity in Japanese diabetic patients with visceral fat accumulation?
ea0029p587
Outcome of a young adolescent diabetes transition clinic in an inner city ethnic population in Birmingham: an audit
ea0029p588
Microcirculatory disorders in adolescents with type 1 diabetes mellitus
ea0029p589
Screening for unknown diabetes mellitus or IFG in a population of South Italy
ea0029p590
Adiponectin among markers of low grade inflammation in gestational diabetes mellitus
ea0029p591
Comparative analysis of adiponectin isoforms distribution in pregnant women with gestational diabetes mellitus and after delivery
ea0029p592
Three novel mutations in maturity-onset diabetes of the young genes in Spain
ea0029p593
Proteomic identification of plasma biomarkers in type 1 diabetes mellitus: an implication of hemopexin overexpression in diabetes mellitus
ea0029p594
Comparative incidence of type 1 diabetes mellitus in school-aged children between immigrated families and the background population living in Piedmont or in Morocco, 2005-2009: a role for vitamin D?
ea0029p595
HbA1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome
ea0029p596
Non-HDL and LDL cholesterol in type 2 diabetes mellitus patients at tertiary care hospital of Pakistan
ea0029p597
Prevalence of diabetes-associated antibodies and impaired insulin response to glucose in first degree relatives of diabetic patients Ebtissam M. Salah*, Hesham El-Hafnawy**, Mona Anwar*, Samar M. E. Salem*, Mai M. Youssef*, Atef Bassyoni** and Marry Aziz**
ea0029p598
Is there a seasonal variation in the incidence of gestational diabetes mellitus?
ea0029p599
We can do better: activity report of ambulatory educative sessions for the patients treated with external pumps
ea0029p600
Diagnostic value of cytogram analysis of different types of oral cavity mucous epithelium in type 2 diabetes mellitus elderly patients
ea0029p601
Socio-demographic factors associated with pediatric diabetic ketoacidosis admissions in Southern West Virginia
ea0029p602
Hypersomatotropism and glucose metabolism disorders
ea0029p603
Questionnaire survey about a hospital adolescent transition diabetic clinic
ea0029p604
Celiac disease, autoimmune thyroiditis, vitamin B12 deficiency and adrenal failure among adult Turkish patients with type 1 diabetes mellitus
ea0029p605
Correlation of fasting blood glucose with menopausal status in middle aged women with their obesity status
ea0029p606
Insulin resistance and C reactive protein level
ea0029p607
The antropometric characteristic of type 1 diabetic patients in Kragujevac
ea0029p608
Resolution of type 2 diabetes following IFN-[alpha]; therapy for chronic hepatitis C
ea0029p609
Art and its role in therapeutic patient education
ea0029p610
The antropometric characteristic of type 2 diabetic patients in Kragujevac
ea0029p611
Prevalence of microvascular complications in youth with type 2 diabetes: systematic review and meta-analysis
ea0029p612
The intake of fiber suppresses the high fat high carbohydrate meal induced endotoxemia, oxidative stress and inflammation
ea0029p613
Blocking Notch pathway improves wound healing in diabetic mice
ea0029p614
The role of AMP-activated protein kinase in myocardial tolerance to ischemia in rats with diabetes mellitus type 2 and its relation to metformin therapy
ea0029p615
A novel case of diabetes mellitus and aniridia in a Caucasian family
ea0029p616
Experience of diabetic dyslipidemia correction in patients with ischemic heart disease and type 2 diabetes mellitus using [apha]-lipoic acid in combination therapy
ea0029p617
Changes of NO concentration in the cause of streptozotocin diabetes mellitus and under action of different NOS inhibitors in streptozotocin rats
ea0029p618
Cardiac dyssynchrony as a pathophysiological mechanism of heart failure development and progression in type 2 diabetic patients
ea0029p619
Possible risk factors of type 2 diabetes and role of long term oral hypoglycemic agent, metformin
ea0029p620
Complex ventricular arrhythmias with early repolarization in type 2 diabetes mellitus
ea0029p621
Diabetic nephropathy in pregnant women with type 1 diabetes mellitus
ea0029p622
Effects of chronic administration of Vardenafil on endothelial function in patients with type 2 diabetes mellitus. A longitudinal, randomized, placebo-controlled, double blind, non-sponsored clinical trial
ea0029p623
Pattern of chronic complications among Nigerian patients with DM: the need for focused prevention initiatives
ea0029p624
The correlation between metabolic syndrome and albuminuria in type 2 diabetes mellitus
ea0029p625
Diabetic nephropathy and risk factors associated with DM in newly diagnosed type 2 diabetics
ea0029p626
Clinical experience of gel testosterone in men with diabetes type 2 and late-onset hypogonadism
ea0029p627
Influence of planning pregnancy in pregestational diabetes
ea0029p628
Diabetic nephropathy and retinopathy: complications in pregnancy and labor
ea0029p629
Quality of life of people with diabetes living in rural area
ea0029p630
Insulin resistance: policy plan to address burning issue by NGO from rural India
ea0029p631
Seeking a new identity: the empowerment process in Iranian people with diabetes
ea0029p632
Prevalence of Charchot arthropathy after the introduction of electronic foot ulcer patient record
ea0029p633
Development of a high-sensitive urinary albumin immunosensor based on MCM-41-PVA nanocomposite and AuNPs
ea0029p634
Metformin-associated lactic acidosis: prevention is the real challenge!
ea0029p635
Oxidative stress and histopathological differences on the skin of diabetes mellitus compromised rats
ea0029p636
Relationships between hyperglycemia and the oxidative stress in type 2 diabetes
ea0029p637
Somatostatin eye drops prevent retinal neurodegeneration in experimental diabetes
ea0029p638
Serum high sensitivity c-reactive protein as predictor of metabolic syndrome and its relationship with albuminuria in type 2 diabetes mellitus
ea0029p639
Relationship between hyponatremia and diabetes mellitus
ea0029p640
The relationship between daytime, nighttime and total heart rate with albumin and protein excretion in newly diagnosed type 2 diabetic patients
ea0029p641
Cystatin C and TGF-[alpha] as a biomarker of diabetic nephropathy in normo and microalbuminuric patients
ea0029p642
The impact of hyperinsulinemia on the serum IL12p40 subunit concentration
ea0029p643
Association of cardio-ankle vascular index with diabetes mellitus-related peripheral arterial disease in chronic hemodialysis patients
ea0029p644
Pituitary function in patients with autoimmune type 1 diabetes evaluated by CRH test
ea0029p645
Microvascular complications in type 1 diabetes mellitus: prevalence and associated risk factors in DIACAM 1 study
ea0029p646
Urinary pentosidine concentration in patients with type 2 diabetes and risk of vascular complications
ea0029p647
The mechanisms of anemia development in patients with early stages of diabetic nephropathy
ea0029p648
Non-alcoholic fatty liver disease and cardiovascular disease in type 2 diabetic patients with metabolic syndrome
ea0029p649
Microalbuminuria and blood pressure in normotensive subjects with type 2 diabetes mellitus
ea0029p650
The relationship Between Self-Reported Nocturnal Sleep Duration, Daytime Sleepiness and 24-hour urinary Albumin and Protein Excretion in Newly Diagnosed Type 2 Diabetic Patients
ea0029p651
Office hypertension and masked hypertension and their association with left ventricular hypertrophy and diastolic dysfunction in patients with type 2 diabetes and hypertension
ea0029p652
Dynamics of insulin-like growth factor-1 concentrations during diabetic ketoacidosis
ea0029p653
Diabetic peripheral arterial occlusive disease is associated with microvascular complications but coronary atherosclerosis might not be associated with them
ea0029p654
Predictors of Cardiovascular Risk: Metabolic Syndrome vs. Diabetes Mellitus and Hypertension
ea0029p655
Risk Factors and Therapeutic Management of type 2 Diabetes in Georgia
ea0029p656
Effects of Hyperglycemia on Oxidative Stress and Antioxidant Potential in Patients with Type 2 Diabetes
ea0029p657
Serum vitamin D and parathormone (PTH) concentrations as predictors of the development and severity of diabetic retinopathy.
ea0029p658
Epidemiology of Diabetic Ketoacidosis in National Institute of Diabetes and Endocrinology (NIDE) by:Bassyouni, A.; El Ebrashy, I.; El Hefnawy, H
ea0029p659
Evaluation of capillary Beta-hydroxybutyrate measurement In diabetic ketoacidosis By: Hesham El Hefnawy By:El Hefnawy, H.*; Bassyouni, A.** and Emara, I.*** From: *Pediatric, **Internal Medicine and ***Biochemistry departments, National Institute of Diabetes [amp] Endocrinology (NIDE)
ea0029p660
Clinical characteristics of diabetic peripheral neuropathy in past and present in Korea
ea0029p661
The effects of metoprolol,diltiazem and pilocarpine in Prolonged QTc interval caused by insulin induced hypoglycemia in rats
ea0029p662
Proximal upper and lower extremities severe pain, muscle weakness in a young diabetic male with multiple chronic complications. A rare and unusual clinical presentation
ea0029p663
Risk factors for cardiovascular diseases in T1DM
ea0029p664
Relationship Between HbA1c and Asymptomatic Coronary Artery Disease in Type 2 Diabetes Patients
ea0029p665
Treating depression in type 2 diabetic patients improves depressive symptoms and quality of life but not metabolic control
ea0029p666
Cardiorespiratory fitness is decreased and not correlated with C-Reactive Protein levels in adults with Diabetes Mellitus
ea0029p667
Evaluation of Brainstem Auditory Evoked Potential in Diabetics
ea0029p668
The Loss of Work Productivity in Type 2 Diabetes Mellitus in Turkey
ea0029p669
The Relationship between Cognitive Function and Microalbuminuria in Elderly Type 2 Diabetic Patients
ea0029p670
Is skin tag associated with diabetic macro and microangiopatyh? Preliminary Report
ea0029p671
Incidence and mortality of diabetic ketoacidosis in Benghazi-Libya
ea0029p672
Drugs or insulin used in diabetics not associated with increased risk of malignancy
ea0029p673
Polyneuropathy in diabetic patients based on the clinical and paraclinical findings
ea0029p674
Not all neuropathies in people with diabetes are due to diabetic neuropathy - a case of chronic inflammatory demyelinating polyneuropathy(CIDP) in a type 1 diabetic
ea0029p675
High burden of comorbid disease and complications in underprivileged type 1 diabetes children
ea0029p676
Effects of acute hyperglycaemia on ANP levels in diabetic patients
ea0029p677
Hyperhomocysteinemia as Risk's Factor of Diabetic Nephropathy in the Patients with Diabetes Mellitus Type 1 and Depression
ea0029p678
No influence of the chronic poor clycaemic control on ANP levels in diabetics with microvascular illness
ea0029p679
Nephropathy could be a main factor in the increased levels of ANP in diabetes
ea0029p680
Quality of life and its dimensions among the type2 diabetes patients referred to the diabetes center of Zanjan University of medical science (Vali-e-Asr Hospital)-2010
ea0029p681
Sexual weakness: Different demographic and clinical features [amp] cost-effective management
ea0029p682
Role of education in prevention and delay of complications in type 2 diabetic patients
ea0029p683
Structured outpatient education and treatment program in type 1 diabetes patients during preconception care and pregnancy
ea0029p684
A Randomized controlled trial of the effect of internet based mentoring program for type 1 diabetes patients with inadequate glycemic control
ea0029p685
Type 1 diabetic women treated with insulin pumps or multiple daily injections of insulin: pregnancy outcome and glycemic control
ea0029p686
DPP-4 inhibitor vildagliptin reduces urinary albumin excretion in type 2 diabetic patients with microalbuminuria
ea0029p687
Insulin protocol for hospital management of diabetes: a retrospective evaluation one year after the implementation
ea0029p688
Analysis of fasting glycemia variability in patients with type 1 diabetes mellitus undergoing different types of basal insulin therapy: glargine vs. NPH
ea0029p689
To evaluate and compare the outcome of pregnancies in women with type 1 diabetes treated with continuous subcutaneous insulin pump or multiple insulin injections
ea0029p690
Antihyperglycemic effects of sodium orthovanadate and Trigonella foenum graecum in diabetic rats
ea0029p691
Therapy with analogous of glp 1 and basal insulin in patients with diabetes mellitus type 2. Our experience.
ea0029p692
Variations in insulin daily dose and weight with continuous subcutaneous insulin infusion therapy
ea0029p693
Insulin therapy requirement in ESRD patients (Our experience)
ea0029p694
Comprehensive approach to Paediatric diabetes management: NGO initiatives in developing country India.
ea0029p695
Renal sodium dependent glucose co-transporter 2 (SGLT2): A neoteric target for treatment of type2 diabetes mellitus
ea0029p696
Management of Diabetes in Hospital
ea0029p697
Relation between glucose daily profile (CGMS) and graft function after islet transplantation for type 1 diabetes mellitus
ea0029p698
Evolution of macro-angiopathy 5-years after islet transplantation (IT) in type 1 diabetes
ea0029p699
Sustained Exendin-4 secretion through gene therapy targeting salivary glands in Zucker fa/fa rats and high fat diet fed mice.
ea0029p700
A Hydrophilic Derivative of Probucol, Probucol-(glutaric branched-triglycerol)2 (ProBGL2) Ameliorates Glucose Tolerance and Insulin Sensitivity by Independent Mechanism of the Canonical Potency of Probucol in HFD-fed mice.
ea0029p701
Simultaneous Pancreatic Kidney Transplant Experience in The South West of Ireland between 2001-2011
ea0029p702
Implementation of the principles of the personalized medicine in the clinical practice: a pilot study for type 2 diabetes
ea0029p703
Pathway Integration of Pro-Inflammatory Cytokines, 12-Lipoxygenase and NADPH Oxidase in Beta Cell Dysfunction; Protection by Novel Selective 12-Lipoxygenase Inhibitors.
ea0029p704
GLP-1 agonists enhance stress-induced corticosterone release
ea0029p705
Bile acid binding resins affect diverse molecules to improve metabolic control.
ea0029p706
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes
ea0029p707
The Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Does Not Alter ECG Endpoints in a Thorough QT (TQT) Study
ea0029p708
Safety and efficacy of linagliptin in type 2 diabetes (T2D) patients (pts) with common renal and cardiovascular risk factors
ea0029p709
Effects of flaxseed oil on anti-oxidative system and membrane deformation of human erythrocytes in high glucose level
ea0029p710
Rapidly and strong suppression of human acylated ghrelin serum concentrations during infusion of des-acyl ghrelin in obese diabetic subjects.
ea0029p711
Educating educators - the way to improve health outcomes of people with diabetes
ea0029p712
Reducing Residual Vascular Risk Through combination Therapy with Fenofibrate and Alpha-Lipoic Acid in Patients with Ischemic Heart Disease and Type 2 Diabetes Mellitus
ea0029p713
Antidiabetic therapies and malignancy: a retrospective study in oncological cases.
ea0029p714
Adding Liraglutide to insulin treated obese type 2 diabetics improves glycaemic control with sustained weight reduction and low hypoglycaemia rate
ea0029p715
Clinical and Patient Reported Outcomes over the 24 Months of Insulin Therapy in Patients with Type 2 Diabetes in Greece: Data from The Instigate Study
ea0029p716
The outcome of Beta cell function after early insulin therapy in the recently diagnosed type 2 diabetes (in Egyptian population) our experience in EL-Minia university hospital
ea0029p717
Gender differences in metabolic outcomes of continuous subcutaneous insulin infusion therapy
ea0029p718
Continuous subcutaneous insulin infusion systems: experience in 92 patients with type 1 diabetes
ea0029p719
A 52-week efficacy and safety profile of sitagliptin in Japanese type 2 diabetic patients in clinical settings
ea0029p720
Short-term liraglutide therapy as compared with basal insulin therapy on restoration effect of insulin secretion in Japanese patients with type 2 diabetes
ea0029p721
Vitamin B-12 deficiency associated with metformin treatment of type 2 diabetes mellitus in daily practice: Clinical consequences
ea0029p722
A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50 and human insulin: a randomized, quadruple crossover study
ea0029p723
Resource utilization and patient satisfaction associated with switching insulin in Greece (Subanalysis of the SWING study).
ea0029p724
Inpatient Hypoglycaemia Management
ea0029p725
Study of the outcomes of application of ISPAS versus ADA guidelines of diabetic Ketoacidosis in type 1 diabetic children
ea0029p726
Subcutaneous use of rapid insulin analog: an alternative treatment for patients with mild to moderate diabetic ketoacidosis
ea0029p727
Planning Treatment of Diabetic Patients with Chronic Renal Disease Using Pre-mixed Insulins Having Higher Proportion of Soluble Insulin
ea0029p728
Study on cases with hypoglycemia carried to the emergency room in the last two years
ea0029p729
Treatment of obese type 2 Diabetes Mellitus patients with CSII Humulin U-500 Regular Insulin infusion vs. CSII Aspart insulin infusion coupled with basal insulin and metformin
ea0029p730
Effects of DPP-IV inhibitors on the changes of glycemic and lipid control of type 2 diabetes patients at the great east Japan earthquake
ea0029p731
Exenatide versus insulin glargine in type 2 diabetes inadequately treated with metformin
ea0029p732
Vitamin D3 deficiency effect on the HbA1c in type 2 diabetic Population
ea0029p733
Salsalate effect on BRACHIAL FLOW-MEDIATED DILATION in early diagnosed Diabetes mellitus
ea0029p734
Differences in health related resource use and costs before and in 24 months after insulin initiation in patients with type 2 diabetes: final data from instigate study
ea0029p735
Clinical Findings on the Effect of Early Insulin Therapy in Newly Diagnosed Type 2 Diabetes
ea0029p736
The effect of nighttime glargine with morning NPH in type 2 DM.
ea0029p737
Telemedicine and Type 1 diabetes: A pilot project
ea0029p738
The State of Therapeutic Patient Education in Diabetes
ea0029p739
Diabetes mellitus management in elderly over 80 years old.
ea0029p740
Improving health numeracy: utilizing objective parameters to improve shared decision making for insulin initiation
ea0029p741
Challenges and problems in the management of glycemia in patients with co-existing diabetes mellitus and a malignant disease in the Gerontology Institute - Hospice
ea0029p742
Efficacy and Safety of Insulin Glargine in Type-2 Diabetes Mellitus Patients with Moderate Renal Failure
ea0029p743
The weight reduction could be achieved on DPP-IV inhibitors in very obese T2D patients
ea0029p744
Diabetes Mellitus Control Status of Turkish Diabetic Patients
ea0029p745
Insulin analogues in the treatment of diabetes
ea0029p746
Endocrine Disruptors
Effects of octylphenol and bisphenol A on the expressions of calcium transport genes during pregnancy in mice
ea0029p747
Effects of Quercetin on mRNA expression of Steroidogenesis genes in Primary Cultures of Interstitial Leydig cells treated with Atrazine
ea0029p748
Octylphenol and triclosan induced proliferation of human breast cancer cells via an estrogen receptor-mediated signaling in vitro
ea0029p749
Endocrine disrupting chemicals induced alteration of cell cycle related genes resulting in proliferation of human breast cancer cells via an estrogen receptor-mediated signaling pathway in vitro
ea0029p750
Bisphenol A and phthalate stimulated the growth of human prostate cancer cells and altered downstream target genes of ras signaling pathway
ea0029p751
Treatment with resveratrol resulted in an inhibition of cell proliferation induced by 17 [beta]-estradiol or various endocrine disrupting chemicals via down-regulating the cell cycle progression in BG-1 ovarian cancer cells
ea0029p752
Perinatal exposure to a commercial formulation of glyphosate reduces the mRNA expression and increases the protein content of beta TSH in the pituitary of male offspring.
ea0029p753
Synergistic effects of bisphenol A and paraben on the induction of calbindin-D9k and progesterone receptors via an estrogen receptor pathway in rat pituitary GH3 cells
ea0029p754
Benzophenone-1 promoted cell growth of BG-1 ovarian cancer cells with estrogen receptors via progression of cell cycle
ea0029p755
A phytoestrogen, genistein, reversed 17 [beta]-estradiol or bisphenol A-induced cell growth via downregulation of the cell cycle progression in BG-1 ovarian cancer cells
ea0029p756
Proliferative and apoptotic effects of bisphenol A and its combination with estradiol in human breast carcinoma cells
ea0029p757
Parabens inhibit ovarian follicle development of neonatal female rats
ea0029p758
Bisphenol-A exposure from electronic gadgets: A risk assessment
ea0029p759
Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes
ea0029p760
Measurement of estrogen receptor alpha homodimerization caused by xenoestrogens using bimolecular fluorescence complementation
ea0029p761
The effects of BPA exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women.
ea0029p762
The effects of endocrine disruptor compounds on the hormone release of rat pituitary in vitro
ea0029p763
Activation of the enzymes of phase I (CYP1A1 and CYP2B1/2) and phase II (SULT1A and COMT) metabolism by BDE-47 in the ovary.
ea0029p764
Changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
ea0029p765
The relation for normal fasting plasma glucose levels and metabolic syndrome in normoglycemic adults.
ea0029p766
Effects of neonatal exposure to thyroid hormones on gene expression profile of the pituitary-thyroid-liver axis in rats
ea0029p767
Apoptosis induced by arsenic is partially reverted by antioxidants in anterior pituitary cells.
ea0029p768
Nigella Sativa oil alleviating the reproductive toxicity of chlorpyrifos in male rat
ea0029p769
The Interference Endocrinous - Metabolic in Thyro-gonadal Failure
ea0029p770
The Therapeutic Attitude Differentiated in Thyroadenitis
ea0029p771
Hypertension - Endocrinous Causes - Therapeutic Attitude
ea0029p772
Endocrine tumours and neoplasia
New insights into the molecular and cellular pathogenesis of human craniopharyngioma: do pituitary stem cells underlie the origin of these tumours?
ea0029p773
Diagnostic and Prognostic Role of 68GA-Dotatate in Patients with Neuroendocrine Tumors
ea0029p774
Meta-analysis of mRNA, microRNA expression and chromosome aberrations in phaeochromocytoma and neuroblastoma
ea0029p775
Metformin inhibits the androgen mediated up-regulation of Insulin Growth Factor-I Receptor in prostate cancer cells
ea0029p776
Investigations into the epigenetic mechanisms regulating the prostanoid receptor EP2 in estrogen dependent breast cancer
ea0029p777
GPR30, the non classical membrane G protein related estrogen receptor (GPER), is overexpressed in human seminoma and promotes seminoma cell proliferation.
ea0029p778
Sorafenib stops disease progression in the majority of patients with advanced differentiated thyroid cancer refractory to radioactive iodine.
ea0029p779
The pilot study on clinical presentation of pituitary adenomas (Pa) in patients with multiple endocrine neoplasia type 1 (Men1) phenotype with and without Men1 mutation
ea0029p780
Hepatocellular carcinoma (HCC) as a neuroendocrine tumor: a preliminar molecular study.
ea0029p781
Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma
ea0029p782
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels
ea0029p783
TNF[alpha] induced aromatase expression is mediated by the Early Growth Response transcription factors in breast adipose
ea0029p784
Mitochondrial respiratory chain defects: a novel molecular mechanism of Mitotane for treatment of Adrenocortical Carcinoma
ea0029p785
Screening of AIP mutations in young Romanian patients with sporadic pituitary adenomas
ea0029p786
Expression of a novel isoform of thyroid peroxidase (TPO) gene in breast cancer (BC)
ea0029p787
Is combined radionuclide therapy with 90y-Dotatate and 177lu-Dotatate an effective treatment option for patients with metastasised neuroendocrine tumours? An ongoing study
ea0029p788
The pathogenesis of non functioning pituitary adenoma with positive staining for glycoproteins is associated with MEG3/DLK1 underexpression/GSTP1 overexpression and modulated by microRNAs (miRNAs)
ea0029p789
The influence of surgery in the management of recurrent adrenocortical carcinoma.
ea0029p790
Over-expression of AIP protein in GH3 cells reduces cAMP signalling and Growth hormone secretion
ea0029p791
Novel 45A>G [amp] 46D>G mutation of SDHB Exon-1 in a Patient with Urinary Bladder [amp] Posterior Mediastinum Paraganglioma.
ea0029p792
Refractory Seizures as a Presenting Feature of Insulinoma
ea0029p793
Rare Case of Atypical Pituitary Adenoma: Intermediate form of Adenoma between the common Benign Adenoma [amp] exceedingly rare Pituitary Carcinoma
ea0029p794
A novel mutation of the MEN1 gene in an Italian family with Multiple endocrine Neoplasia type 1
ea0029p795
Pheochromocytoma releasing ACTH: two in one.
ea0029p796
Hypergastrinemia in a Patient with Lymphocytic Colitis and Chronic Gastritis
ea0029p797
Primary hyperparathyroidism due to a parathyroid adenoma, a parathyroid carcinoma and a subsequent adenoma: A case report
ea0029p798
Neuroendocrine Tumor with Clinical Characteristics of Insulinoma
ea0029p799
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth
ea0029p800
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures
ea0029p801
Disturbed alternative splicing of growth hormone is associated with increased expression of SF2/ASF oncogene in pituitary adenoma
ea0029p802
Estradiol Potentiates the Inhibitory Effects of SOM230 on Prostate Cells in vitro Up-regulating Ligand Binding Domain Expression of SSTR2 and 5
ea0029p803
[beta]-Catenin signaling controls tumorigenesis in menin-deficient insulinoma
ea0029p804
Hypermethylated in cancer 1 (HIC1), a tumour suppressor gene epigenetically deregulated in hyperparathyroid tumours by histone modification
ea0029p805
Stem cell genes are deregulated in parathyroid tumours
ea0029p806
Long-acting somatostatin analogues are highly effective in men1 patients with early stage duodeno-pancreatic neuroendocrine tumors
ea0029p807
Insulin, IGF-II and a low-affinity insulin analog differentially regulate insulin receptor isoform A trafficking and induce a different balance of metabolic and mitogenic effects
ea0029p808
Immunohistochemical, ChIP, and microarray analysis reveals how stromal AR controls prostate cancer outcome through fibroblast specific action of androgen signalling on ECM production and DNA licensing
ea0029p809
Looking for the molecular bridge between sex hormone-binding globulin (SHBG) and breast cancer cells
ea0029p810
Parathyroid atypical adenomas: mutational screening of CDC73/HRPT2 gene
ea0029p811
Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
ea0029p812
Clinical and biochemical characteristics of succinate dehydrogenase (SDH) mutation carriers
ea0029p813
Efficacy of Everolimus to prevent hypoglycemia in patients with metastatic insulinomas: for the French group of endocrine tumors (GTE-Renaten)
ea0029p814
Differential TNF[alpha] -synthesis and signaling in endocrine tumors after treatment with the Tumor-Vascular-Disrupting Agent ASA404 (vadimezan)
ea0029p815
Anti-proliferative effect of GHRH antagonist JMR-132 on ovarian cancer cell via EGFR-Akt pathway
ea0029p816
Characterization of circulating tumor cells in prostate cancer patients
ea0029p817
Mitotane Inhibits Cell Growth Proliferation and Modulates MRP1 Protein Expression In Different Human Cancer Cell Lines
ea0029p818
Hormone combinations produce unique steroid receptor binding and regulatory profiles in breast cancer cells
ea0029p819
Medical and Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Well and Moderately Differentiated Neuroendocrine Tumours
ea0029p820
Expression of ErbB2 in craniopharyngiomas: Possible therapeutic implications
ea0029p821
Wnt-signalling in human insulinomas
ea0029p822
How clinical presentation of insulinoma is changing
ea0029p823
Effects of mitotane on gene expression in the NCI-H295R cell line
ea0029p824
Ouabain as an antiproliferative agent on adrenocortical cell models and on primary adrenocortical tumor cells
ea0029p825
Profile of Patients with Pheochromocytoma [amp] Paraganglioma
ea0029p826
The role of circulating and tumor infiltrating T-cells on clinical outcome in adrenocortical carcinoma
ea0029p827
Surgical management of primary hyperparathyroidism in a unit where Intra-operative PTH (IOPTH) monitoring is not routinely performed
ea0029p828
Enhanced antitumor efficacy of fructose conjugated-gefitinib on lung cancer cell lines in vitro and in vivo
ea0029p829
Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland
ea0029p830
Non pituitary effects of GnRH analogues in prostate cancer cells: revertion of maligant phenotype and synergism with bicalutamide and radiotherapy
ea0029p831
Histone deacetylase inhibitor belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth in hormone refractory models
ea0029p832
Confirmation of pathogenicity of the MEN1 missense mutations by analysis of protein instability and aberrant splicing
ea0029p833
Expression of MAPK7 and CCNL1 in corticotrophinomas and functional analysis of miR-143 and miR-145 in corticotrophic tumoral lineage AtT20
ea0029p834
Tc- 99m Sestamibi parathyroid scan in primary hyperparathyroidism and surgical outcomes
ea0029p835
Vitamin D from genetics to the clinical in prostate cancer
ea0029p836
Progesterone receptor B induces autophagy antagonizing the phosphatidylinositol-3 kinase PI3K/AKT pathway in breast cancer cell lines
ea0029p837
Insulinoma in patients with multiple endocrine neoplasia type 1
ea0029p838
Multiple endocrine neoplasia syndrome type 1 (MEN-1) in Sardinian population: low prevalence of Men-1 mutations and detection of a new inactivating mutation of the CDKI gene p27
ea0029p839
Atypical paragangliomas responsible for adrenaline-dominant catecholamine secretion due to ectopic expression of phenylethanolamine-N-methyltransferase
ea0029p840
Evaluation of patients with adrenal diseases operated laparoscopically between 1997 and 2011
ea0029p841
Immunohistochemical detection of FSH receptors in endocrine tumors
ea0029p842
Tumour-asssociated myofibroblasts in parathyroid tumours
ea0029p843
Establishment of a Multidisciplinary Tumor Board for Patients with Neuroendocrine Neoplasms
ea0029p844
Low detection Rate of Primary Aldosteronism when Screening Among Hypertensive Patients with Ongoing Medication
ea0029p845
B-Lymphocyte Stimulator in neuroendocrine tumors: a new prognostic marker?
ea0029p846
Clinical and morphological characterization of C cell hyperplastic and neoplastic lesions of thyroid
ea0029p847
Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models
ea0029p848
Gene expression profile of LNCaP human prostate cancer cells after treatment with an antagonist of growth hormone-releasing hormone
ea0029p849
Evaluation of beta-cell function and insulin sensitivity in a large series of insulinomas in one single tertiary centre
ea0029p850
Can proteomic approach help us in diagnosis of Riedel's thyroiditis? A case report
ea0029p851
Effect of dopamine agonists on the tumor size of prolactinomas: are suppressive doses different from those that normalize prolactin serum levels?
ea0029p852
Expressions of estrogen receptor-[beta] splicing variants in papillary thyroid cancer
ea0029p853
The high-mobility group A1-oestrogen receptor [beta] nuclear interaction impairs in human testicular seminomas
ea0029p854
Long-term outcome of primary endocrine non-Hodgkin lymphomas
ea0029p855
Performances of a new automated chromogranin-A assay
ea0029p856
Virilization due to adrenocortical carcinoma in a 7 years-old female: a case report
ea0029p857
Diagnosis and treatment of the surgical pathology of the suprarrenales glands. Bibliographical revision
ea0029p858
1,25-Dihydroxyvitamin D inhibits cell proliferation by promoting cell-cycle arrest in the human adrenocortical cancer cell line nci-h295r
ea0029p859
A case of multiple endocrine neoplasia type 2a associated with rectal adenocarcinoma
ea0029p860
Leptin affects gene expression in OVCAR-3 ovarian cancer cells. Effects on cell proliferation and apoptosis
ea0029p861
Malignant adrenal incidentaloma
ea0029p862
Maxillary gland could harbor a neuroendocrine metastasis
ea0029p863
Circadian rhythm of prolactin release in patients with breast cancer
ea0029p864
Non-medullary neuroendocrine carcinoma in the thyroid gland: a case-report
ea0029p865
Adrenal myelolipomas in CAH: is there role for ultrasound screening of the adrenal glands?
ea0029p866
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family
ea0029p867
Medullary thyroid carcinoma with liver metastasis presenting as watery diarrhea for 1 year
ea0029p868
Antiproliferative effect and control of catecholamine release with octreotide in a patient with giant bilateral pheochromocytoma
ea0029p869
Survival of patients with adrenocortical carcinoma: experience of one center
ea0029p870
Leydig cell tumor of ovary: a rare case of virilization
ea0029p871
Lutetium-177 DOTATATE for paraganglioma refractory to conventional chemotherapy: a single case report
ea0029p872
Hypoglycemia by insulinoma: for the purposes of a case
ea0029p873
Atypical presentation of type 1 gastric neuroendocrine tumor should increase our awareness
ea0029p874
A case of multiple endocrine neoplasia type 1 associated with multicentric VIPoma
ea0029p875
Disseminated insulinoma in 13-year-old patient
ea0029p876
Management of ectopic Cushing's syndrome caused by bronchial carcinoid: four case reports
ea0029p877
Metastatic malignant insulinoma
ea0029p878
A rare case of hirsutism: mucinous cystoadenoma of the ovary with stromal luteinization and hilar cell hyperplasia
ea0029p879
Neuroendocrine tumors of the gastrointestinal tract: a descriptive study
ea0029p880
Prediction of remission of gestational trophoblastic disease based on initial levels of prolactin
ea0029p881
Radioguided cortical-sparing approach for recurrent pheocromocytoma/paragangliomas
ea0029p882
Clinically palpable parathyroid adenoma
ea0029p883
Special diagnostic, therapeutic and evolutive aspects of insulinoma: a tunisian experience
ea0029p884
Female Reproduction
The ovarian failure associated Y235 residue of human BMP15 gene is target of evolutionary positive selection
ea0029p885
Coordinate regulation of heterogeneous nuclear ribonucleoprotein dynamics by steroid hormones in the human Fallopian tube and endometrium in vivo and in vitro
ea0029p886
Role of the CRH receptors and brainstem noradrenergic nuclei in the gonadotropins secretion induced by acute stress at proestrus morning
ea0029p887
An invdup (15) associated with premature ovarian insufficiency
ea0029p888
Impact of thyroid status and thyroid autoimmunity on assisted reproduction technology outcome
ea0029p889
The association of thyroid hormones with menstrually related mood disorder, sexual abuse histories and mood symptoms
ea0029p890
Androgen profiling in adolescent females by liquid chromatography-tandem mass spectrometry
ea0029p891
Expression of CRH/urocortin gene family in mouse gestational tissues during late pregnancy
ea0029p892
Hypoxia-induced oxidative stress regulates the expressions of calcium transport channels in the duodenum, kidney and placenta of rats
ea0029p893
Daily serum testosterone during the menstrual cycle by ID-LC-MS/MS
ea0029p894
NT-pro-BNP levels in patients with polycystic ovarian syndrome
ea0029p895
Differential expression and regulation of Mg2+ inorganic phosphate transport channels by hypoxia stress in human placental cells
ea0029p896
Progesterone levels on the hCG day and outcomes IVF in women with polycystic ovary syndrome
ea0029p897
State of care in women affected by early premature ovarian failure (ePOF) within the first two years of treatment in a center for reproductive medicine and endocrinology (RME)
ea0029p898
Nutritional status and reproductive morbidity among women (age 15-40 years) in Dhaka city
ea0029p899
Anthropometric indices of visceral obesity and cardiovascular risk factors in patients with polycystic ovarian syndrome
ea0029p900
Health related behaviour and understanding of menopausal therapies among women with premature menopause
ea0029p901
The effects of the therapy with ethinylestradiol 30 [mu]g-drospirenone+metformin on endothelial dysfunction in the polycystic ovary syndrome
ea0029p902
Hormonal contraception and female sexual function
ea0029p903
Metformin in treatment of polycystic ovaries syndrome in women of birthing age
ea0029p904
Letrozole induces metabolic and reproductive disorders in female rats: a dose response study
ea0029p905
Increased prevalence of polycystic ovary syndrome in overweight and obese premenopausal women with nonalcoholic fatty liver disease
ea0029p906
Association of the (TAAAA)n repeat polymorphism of SHBG gene with age at menopause in Greek postmenopausal women
ea0029p907
Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome: according to the recently defined criteria
ea0029p908
Most of type 2 diabetes associated loci identified in genome-wide association studies are not associated with polycystic ovary syndrome
ea0029p909
Optimization of a uterine leiomyoma xenograft model using different immunodeficient mice and grafting procedures
ea0029p910
The polymorphic variants K121Q of the plasma cell membrane glycoprotein and G972R of the insulin receptor substrate-1 modulate in opposite ways the clinical and biochemical profiles of women with polycystic ovary syndrome
ea0029p911
Exposure to soy isoflavones during postnatal life disrupts structural development of reproductive organs in female mice
ea0029p912
The kisspeptin levels in girls
ea0029p913
Subcutaneous adipose tissue in women with polycystic ovary syndrome
ea0029p914
Plasma anti-Mullerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus
ea0029p915
The role of subclinical hypothyroidism and vitamin D deficiency in the development of menstrual disorders in women with PCOS
ea0029p916
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate vs low-dose pioglitazone-flutamide-metformin
ea0029p917
Hyperandrogenism is related to adipose tissue dysfunction as reflected by VAI in polycystic ovary syndrome patients
ea0029p918
Effects of berberine on the clinical, metabolic and reproductive features of obese polycystic ovary syndrome women
ea0029p919
Large-for-gestational-age and macrosomic neonates born by women with gestational diabetes mellitus diagnosed by the new IADPSG criteria: a case-control study of 301 patients and 839 controls
ea0029p920
Factors affecting time to pregnancy: lithuanian women cohort study
ea0029p921
Insulin and androgens but not androgen receptor CAGn polymorphysm are determinant factors for hirsutism severity in PCOS
ea0029p922
Frequency of insulin resistance, assessed by the glucose clamp technique, in 132 PCOS women
ea0029p923
Propranolol prevents stress induced polycystic ovary syndrome
ea0029p924
Variants of the NR5A1 gene in a large cohort of patients with primary ovarian insufficiency
ea0029p925
Aberrant expression of TRAIL in placenta and maternal serum in early pregancy complications
ea0029p926
Blood cell mitochondrial DNA content and premature ovarian aging
ea0029p927
Fetal growth parameters and outcome of pregnancies complicated with thyroid disease
ea0029p928
Endocrine effects of the FSHB-211 promoter polymorphism in females
ea0029p929
The prevalence of endometrial hyperplasia and endometrial cancer in Danish women with PCOS or hyperandrogenism
ea0029p930
Conformational control of P450aromatase by lipid membrane interactions and protein associations
ea0029p931
Metabolic characteristics in women with polycystic ovary syndrome by phenotypes based on various diagnostic criteria
ea0029p932
Prevalence of chronic autoimmune thyroiditis in patients with polycystic ovary syndrome
ea0029p933
Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance
ea0029p934
Candidate pathway genetic analysis of PCOS
ea0029p935
Sex hormones and sexual function in postmenopause
ea0029p936
Hypoandrogenemia at women with hypogonadotropic hypogonadism
ea0029p937
Nonalcoholic fatty liver disease in pregnant women.
ea0029p938
AMH and INSL3 levels in ovulatory and anovulatory women with the polycystic ovary syndrome
ea0029p939
Increased risk of glucose metabolism impairment after gestational diabetes in polycystic ovary syndrome
ea0029p940
Effect of antiandrogens on spontaneous apoptosis in cultured porcine granulosa cells
ea0029p941
Prenatal exposure to anti-androgen flutamide influences connexin 43 expression in the porcine fetal gonads
ea0029p942
Long term health status of POI Patients
ea0029p943
Neonates of women with polycystic ovary syndrome display increased oxidative stress markers and metabolic aberrations comparable to gestational diabetes offspring
ea0029p944
Impact of dietary advanced glycation end products modifications on metabolic and hormonal profile in women with polycystic ovary syndrome
ea0029p945
Inhibin-[alpha] gene promoter polymorphisms in patients with idiopathic premature ovarian failure
ea0029p946
Skeletal frame size in females with polycystic ovary syndrome
ea0029p947
Quality of life and the frequency of anxiety and depression in women with PCOS
ea0029p948
Examination of the generation of vaginal epithelium of the new vagina formed using oxidized regenerated cellulose
ea0029p949
Efficacy of sex hormone replacement therapy on induction of puberty in patients with Turner syndrome
ea0029p950
Different effects of electrical and manual acupuncture stimulation on estrous cyclicity and neuroendocrine function in rats with DHT-induced polycystic ovary syndrome
ea0029p951
The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters in women with polycystic ovary syndrome
ea0029p952
Androgens profile in Cushing's disease with hirsutism
ea0029p953
Action of elevated leptin levels on steroidogenic enzymes expression in porcine small and medium size follicles collected from prepubertal and cycling pig
ea0029p954
The role and mechanisms of action of leptin in control of ovarian functions
ea0029p955
What is the earliest predictor of atherosclerosis in normal weight polycystic ovary syndrome; carotid intima media thickness or visceral fat ratio?
ea0029p956
Prevalence of hyperandrogenism, polycystic ovary syndrome and metabolic syndrome in female-to-male transsexuals
ea0029p957
Examination of the role of gynecologists in the management of patients with disorders of sex development
ea0029p958
Polycystic ovary syndrome, hyperprolactinemia, hyperinsulinemia and congenital adrenal hyperplasia
ea0029p959
The future of HRT
ea0029p960
Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study
ea0029p961
Impaired beta cell function in Chinese women with polycystic ovary syndrome
ea0029p962
Epicardial adipose tissue thickness in patients with polycystic ovary syndrome
ea0029p963
High plasma level of long pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome
ea0029p964
Sertoli cells ovarian tumor- an ovarian incidentaloma?
ea0029p965
Clinical, hormonal and metabolic profile in overweight and obese women with polycystic ovary syndrome
ea0029p966
Serum 17[beta]-estradiol concentration and depression symptoms presence in climacteric women
ea0029p967
Assessment of insulin resistance and carotid intima media thickness, cardiovascular risk factors in PCOS with normal OGTT
ea0029p968
Relation of hyperandrogenism and metabolic derangements in women with polycystic ovary syndrome
ea0029p969
Micronized progesterone: a beneficial new modality of treatment for Egyptian patients with hyperemesis gravidarum
ea0029p970
Significance of obesity in the genesis of metabolic syndrome in women with polycystic ovary syndrome
ea0029p971
Lipid accumulation product as a marker of metabolic syndrome in women with polycystic ovary syndrome
ea0029p972
Serum 25-hydroxyvitamin D and hsCRP levels in young obese women with polycystic ovary syndrome
ea0029p973
Association of metabolic disturbances and carotid intima-media thickness in women with polycystic ovary syndrome
ea0029p974
Prevalence of dyslipidemia in Algerian PCOS women
ea0029p975
Serial serum levels of vitamin D in lean and obese pregnant women
ea0029p976
Erythrocytosis and thrombocytosis secondary to hypertestosteronemia caused by ovarian leydig cell tumor
ea0029p977
Quality of life in patients affected by polycystic ovary syndrome
ea0029p978
Effects of dopamine agonist administration during seasonal cyclicity in the mare
ea0029p979
Differences in gonadal axis reaction to ketoconasole between PCOS and healthy individuals
ea0029p980
Metabolic and hormonal parameters in lean PCOS women
ea0029p981
Adiponectin, resistin, leptin and selected cytokines in association with insulin resistance in lean women with polycystic ovary syndrome
ea0029p982
Solution of an old endocrinological puzzle the rise and fall of an endocrinological doctrine Dr. Laszlo Makay, DVM H-2000 Szentendre, Sztaravodai u. 42, Hungary Tel./Fax: +36 26 316 791 E-mail:
[email protected]
ea0029p983
Growth hormone IGF axis - basic
Evidence of direct mitogenic activity of insulin and the insulin receptor in prostate cancer cell lines
ea0029p984
Insulin receptor compensates for IGF1R inhibition and induces mitogenic activity in prostate cancer cell lines
ea0029p985
Designing long acting recombinant proteins: from bench to clinics
ea0029p986
GH harmonisation: it sounds simple...,?
ea0029p987
Plasma ghrelin levels appeared to be elevated in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II: evidence for that acyl-CoA is the substrate for ghrelin acylation
ea0029p988
Ghrelin suppresses angiotensin II-induced tissue damages by reducing oxidative stress
ea0029p989
The effect of ghrelin on the mitochondrial dysfunction in muscle and physical disability associated with aging
ea0029p990
Health related quality of life and psychological functioning of short statured German children and adolescents: findings form the quality of life in short stature youth study
ea0029p991
C677T methylenetetrahydrofolate reductase gene polymorphism and colorectal neoplasms in acromegalic patients
ea0029p992
Clinical characteristics and outcome of acromegaly induced by ectopic secretion of GHRH: a French nationwide series of 21 cases
ea0029p993
Comparison of intuitiveness, ease of use and preference in two disposable GH injection devices
ea0029p994
Diabetic retinopathy and GH the case of acromegaly
ea0029p995
Assessing the quality of life of children and adolescents with short stature: development and psychometric testing of the QOLISSY: instrument
ea0029p996
Factors affecting IGF1 response to GH during transition
ea0029p997
Quality of life in adult patients with GH deficiency and neurosecretory dysfunction at the end of GH therapy
ea0029p998
Hypertension and cardiovascular risk factors in GH deficiency
ea0029p999
Anti-androgen flutamide alters gene expression in the porcine fetal ovary
ea0029p1000
Relationship between GH activity and reproductive hormones: a randomized cross-over study in healthy male volunteers treated with GH and a GH receptor antagonist for three weeks
ea0029p1001
Baseline characteristics and differences in short- and long-term response to rhGH between GHD adults with craniopharyngioma and nonfunctioning pituitary adenoma
ea0029p1002
A new somavert (pegvisomant) 30 mg/ml formulation compared to the currently marketed 15 mg/ml formulation: pharmacokinetics, safety, and tolerability in healthy subjects
ea0029p1003
Thyroid function during long-term GH treatment in children affected by idiopathic GH deficiency
ea0029p1004
Variations of IGF1 in GH deficiency and Algerian health children
ea0029p1005
Association Turner's syndrome and GH deficiency
ea0029p1006
Male Reproduction
The homologous hormones lutropin and choriogonadotropin are interacting differently with the LH/CG receptor
ea0029p1007
Differential expression of pseudoautosomal region genes in patients with Klinefelter syndrome
ea0029p1008
Rab-like 2 (RABL2) function in male fertility, intra-flagella transport and sperm tail assembly
ea0029p1009
Prevalence of olfactory and other developmental anomalies in patients with central hypogonadotropic hypogonadism
ea0029p1010
Abstract unavailable
ea0029p1011
Total Testosterone levels and predisposing criteria for metabolic syndrome in healthy young men
ea0029p1012
Functional status of pituitary--gonads axis in males with obesity
ea0029p1013
Deletion of FSTL3 increases testicular size and delays testicular regression
ea0029p1014
High prevalence and interaction of hypogonadism and the metabolic syndrome in long-term survivors with germ cell tumours
ea0029p1015
Mutation analysis of NR5A1 gene encoding steroidogenic factor 1 in cryptorchidism and male infertility
ea0029p1016
The Muenster EXAKT project: cardiovascular risk factors in Klinefelter patients and healthy controls
ea0029p1017
Cellular distribution, regulated expression and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis
ea0029p1018
Neurocognitive phenotype and personality profile in men with Klinefelter syndrome and their vulnerability to psychiatric symptoms
ea0029p1019
FSHB promotor polymorphism influences male reproductive parameters
ea0029p1020
Side effect profile of long-term treatment of hypogonadal men with testosterone undecanoate
ea0029p1021
Effect of testosterone on seminal proteome in male hypogonadism
ea0029p1022
Comparing effects of weight loss on sexual, urinary and endothelial function, insulin resistance and quality of life in obese men with and without erectile dysfunction
ea0029p1023
Inhibitors of 5[alpha]-reductase-related side effects in patients seeking medical care for sexual dysfunction
ea0029p1024
Multiplex ligation dependent probe amplification analysis of KAL1, GnRH1, GnRHR, PROK2 and PROKR2 in male patients with idiopathic hypogonadotropic hypogonadism
ea0029p1025
Cimetidine induces testosterone reduction and impairs leydig cell-microvasculature paracrine interaction in adult rats
ea0029p1026
Gonadal status in adult male survivors of childhood cancer
ea0029p1027
Cyclooxygenase-1 (COX-1) and COX-2, differently expressed in human sperm from normal and pathological patients, might be considered molecular markers in the diagnosis of male infertility disorders
ea0029p1028
Activation of selective human sperm functions by EGF and TGF-[beta]3 is mediated by an ERK-depended mechanism
ea0029p1029
Leydig and sertoli cell failure in myotonic dystrophy
ea0029p1030
Decreased osteoprotegerin levels during testosterone therapy in ageing men were associated with changed distribution of regional fat
ea0029p1031
New insights into sperm DNA methylation: intra-and inter individual stability and a comparative analysis versus somatic cells
ea0029p1032
Complete reversal of isolated idiopathic hypogonadothropic hypogonadism in men
ea0029p1033
G protein-coupled estrogen receptor 1- and estrogen receptor [alpha]-dependent pathways regulate spermatocytes apoptosis
ea0029p1034
Single nucleotide polymorphism (SNP) of endothelial nitric oxide synthase (eNOS) gene (Glu298Asp variant) in infertile men with asthenozoospermia
ea0029p1035
Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction
ea0029p1036
The protective role of ginger against Di-(2-ethylhexyl) phthalate-induced reproductive toxicity and oxidative stress in male rabbits
ea0029p1037
Mutations and polymorphism of FSH and LH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa
ea0029p1038
Poor response to alprostadil ici test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events
ea0029p1039
Hormonal associations and sexual dysfunctions in patients with impaired fasting glucose
ea0029p1040
The relationship between total testosterone, cognitive function, depressive behavior and sleep quality in chronic renal failure patients not on dialysis
ea0029p1041
Premature ejaculation and erectile dysfunction in a cohort of infertility men: clinical and ultrasonographic correlations
ea0029p1042
Maternal malnutrition alters the leptin expression in the rats epididymis
ea0029p1043
Scrotal and transrectal ultrasound correlates of prostatitis-like symptoms in a cohort of infertility patients
ea0029p1044
Elevated body mass index correlates with higher seminal interleukin 8 levels and ultrasound prostate abnormalities in infertile men
ea0029p1045
Ultrasonographic and clinical correlates of seminal plasma interleukin 8 levels in patients attending an Andrology Clinic for infertility
ea0029p1046
Visceral adiposity index and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism
ea0029p1047
Prevalence of erectile dysfunction is greater in young middle-aged HIV-infected men than in hiv-uninfected men
ea0029p1048
Effectiveness of gonadotropin treatment for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism
ea0029p1049
Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats
ea0029p1050
Ten years of EAA/EMQN quality control scheme for microdeletions of the Y chromosome
ea0029p1051
SIEDY scale 3, a new instrument to detect intrapsychic component in subjects with erectile dysfunction
ea0029p1052
Immunogold localization of testosterone and immunohistochemical detection of AR, SHBG, CYP1A1, ER[beta] and PCNA indicate a participation of steroid hormones in primordial germ cells of adult male bullfrogs
ea0029p1053
The high prevalence of testosterone deficiency in population of Polish men over 65 years with erectile dysfunction
ea0029p1054
Production of nitric oxide and peroxynitrite by human spermatozoa and their possible role on sperm motility
ea0029p1055
Two infertile patients with 45X/46XY mosaicism and structural rearrangements of chromosome Y present with different phenotypes
ea0029p1056
Abstract unavailable
ea0029p1057
Seminal vesicles ultrasound features in a cohort of infertility patients
ea0029p1058
Nitric oxide synthase and tyrosine nitration in idiopathic asthenozoospermia: an immunohistochemical study
ea0029p1059
Testosterone replacement therapy: A comparison of testosterone mixed esters, extended release testosterone implants and testosterone undecanoate depot
ea0029p1060
Abstract unavailable
ea0029p1061
Reduced fatigue and improved sexual function in hypogonadal men treated with TESTIM in routine daily practice
ea0029p1062
The mitochondrial citrate carrier regulates insulin secretion by human male gamete
ea0029p1063
Mild androgen insensitivity syndrome due to novel mutation in androgen receptor gene
ea0029p1064
Semen quality in patients with newly diagnosed Hodgkin's disease
ea0029p1065
Subcutaneous gonadotropin therapy for male infertility by hypogonadotropic hypogonadism
ea0029p1066
Translation of EMAS sexual functions questionnaire from English to Lithuanian
ea0029p1067
A surprising diagnosis in a man with high testosterone levels
ea0029p1068
Recapture of the study on the reproductive function of Estonian, Latvian and Lithuanian Young Men after 8 years
ea0029p1069
Neuroendocrinology
SNPs and CNVs genotyping analysis of patients with idiopathic central hypogonadism (ICH). A novel approach to detect new candidate mechanisms
ea0029p1070
Cidea as a posible mediator of ghrelin resistance induced by high fat diet
ea0029p1071
Effects of obestatin on proliferation and survival of adult rat hippocampal progenitor cells
ea0029p1072
Normalization of cortisol levels in Cushing's disease after medical pretreatment before surgery: effects on somatostatin receptor subtype expression and in vitro response to somatostatin analogs.
ea0029p1073
Mechanisms for the protective effects of 17-[beta]-estradiol: relevance to depressive symptoms in Parkinson's disease
ea0029p1074
Transient inhibition of the resolvin system in the hypothalamus of diet-induced obese mice
ea0029p1075
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas
ea0029p1076
Shift work at young age is associated with elevated long-term cortisol levels and body mass index
ea0029p1077
The limited screening value of insulin-like growth factor-I as a marker for alterations in body composition in very long term adult survivors of childhood cancer
ea0029p1078
Timing determines the suppressive effect of sleep loss on testosterone
ea0029p1079
CT Scan of the anterior skull base in Kallmann syndrome reveals specific ethmoid abnormalities
ea0029p1080
Wrist actigraphy detects sleep disorders in patients with Cushing's syndrome
ea0029p1081
Comparison of Chinese herbal mixture and electro-acupuncture on regulating endocrine disturbances and hypothalamic androgen receptor in rats with DHT-induced PCOS
ea0029p1082
Endogenous estradiol levels in female acute stroke patients: an independent determinant of stroke severity and early outcome
ea0029p1083
Long term evolution of patients with transsphenoidal surgery due to pituitary adenomas
ea0029p1084
Panhypopituitarism treated and untreated with GH: long term evolution of echocardiographic parameters
ea0029p1085
Relationship between sex hormones, cognitive performance and substance use
ea0029p1086
The proliferation and apoptosis activity of blood lymphocytes in acromegaly
ea0029p1087
Long term evolution of patients with prolactinoma in a neuroendocrinology unit
ea0029p1088
Influence of various doses of Cabergoline in dynamics of long-term treatment on the level of blood soluble apoptosis markers in patients with inactive pituitary adenomas
ea0029p1089
The blood lymphocytes oxidoreductases activity in patients with active acromegaly
ea0029p1090
Hypercortisolism in patients with diabetes mellitus, adrenal incidentaloma and obesity
ea0029p1091
Levothyroxine therapy in patients with secondary hypothyroidism in nonfunctioning pituitary adenomas
ea0029p1092
Neuroendocrine abnormalities in adolescents with the Turkish saddle volume formations
ea0029p1093
Somatostatin analogue treatment of acromegaly
ea0029p1094
Clinical manifestations of depression in patients with primary hyperparathyroidism
ea0029p1095
Discovery of a novel peptide, neuroendocrine regulatory peptide-2 regulating feeding behavior and glucose metabolism
ea0029p1096
Effects of low sodium concentrations on neuronal cell models
ea0029p1097
SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development
ea0029p1098
Stimulatory role of neurokinin B in the control of the gonadotropic axis in the rat: developmental changes, sexual dimorphism and regulation by gonadal steroids
ea0029p1099
Intracerebroventricular administration of metformin inhibits ghrelin-induced hypothalamic AMP-kinase signalling and food intake
ea0029p1100
Genetic variation of the hypothalamo-pituitary axis may increase susceptibility of postnatal depression
ea0029p1101
Differential diagnosis of acromegaly: a new gene for pachydermoperiostosis
ea0029p1102
Magnetic risonance imaging (mri) of olfactory bulbs and other brain structures in kallmann syndrome
ea0029p1103
Kisspeptin is the peptide linking metabolism and reproduction
ea0029p1104
Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice
ea0029p1105
Insulin improves memory and cognition via protein kinase c delta ([delta])
ea0029p1106
The Tuebingen Cushing's disease quality of life inventory: development and normative data from 1784 healthy people
ea0029p1107
Oligogenicity in the idiopathic central hypogonadism
ea0029p1108
Investigating glucose responsive neuropeptide release using a static hypothalamic incubation system
ea0029p1109
Expanding the clinical and genetic spectrum of the reversal of congenital hypogonadotropic hypogonadism
ea0029p1110
Retinoic acid regulates growth-related gene expression in the rat hypothalamus
ea0029p1111
Crf type 2 receptor mediates estradiol-induced increase in hypothalamic leptin sensitivity
ea0029p1112
Retinal growth hormone: local regulation by GH-releasing hormone (GHRH)?
ea0029p1113
Cu-gnrh and pacap-induced cAMP/PKA and cGMP/PKG pathways activity in anterior pituitary cells in vitro.
ea0029p1114
Corticosterone interferes with the stimulatory effect of cAMP on proTRH transcription by promoting a GR-PKAc interaction and not through chromatin remodelling
ea0029p1115
Effects of mineralocorticoid agonists and antagonists on survival, proliferation and differentiation of adult rat hippocampal progenitor cells
ea0029p1116
Sleep deprivation-induced changes in rat hypothalamic arginine-vasopressin content
ea0029p1117
Abstract unavailable
ea0029p1118
Ghrelin, leptin and adiponectin plasma levels in narcolepsy with cataplexy
ea0029p1119
High serum cortisol levels in patients with Alzheimer's Disease
ea0029p1120
Melatonin levels, sleep and psychosocial impairment in patients after radiotherapy for brain tumors or leukemia
ea0029p1121
Ten years of gastroenteropancreatic neuroendocrine tumours: evolution of the classification and correlation with follow-up in 50 patients
ea0029p1122
Orexigenic neuropeptide 26RFa: new evidence for an adaptive profile of appetite regulation in anorexia nervosa
ea0029p1123
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment
ea0029p1124
Contemporary microsurgical treatment of Cushing's disease
ea0029p1125
Effect of ghrelin on aromatase gene expression and estradiol 17-[beta] concentrations in ventromedial and lateral hypothalamic area
ea0029p1126
Regional distributions of kisspeptin and gonadotropin-inhibiting hormone peptides in ovine and rat brains
ea0029p1127
Right hemicolectomy in the treatment of patients with appendiceal neuroendocrine tumors: does size matter?
ea0029p1128
Delay in the onset of puberty of intrauterine growth retarded female rats cannot be rescued by hypernutrition after birth
ea0029p1129
Fasting induces a delayed increase of thyrotropin-releasing hormone degrading ectoenzyme activity in the tanycytes of the median eminence of the rat hypothalamus
ea0029p1130
Estradiol effects on hypothalamic stat3 phosphorylation induced by leptin
ea0029p1131
Evaluation of cushings disease remission and serum cortisol dynamic early after transsphenoidal surgery
ea0029p1132
Hyponatremia in hospitalised patients: are we investigating and managing them properly?
ea0029p1133
Epidemiology, clinical behaviour and prognostic factors of gastroenteropancreatic neuroendocrine tumours in Castilla-La Mancha (Spain) from 1995 to 2010
ea0029p1134
Effect of galanin on aromataze gene expression and estradiol 17-[beta] concentrations in ventromedial and lateral hypothalamic area
ea0029p1135
Leptin resistance and desensitization of hypophagia during prolonged inflammatory challenge are associated with high ptp1b expression in the hypothalamus
ea0029p1136
Obestatin does not modify weight and nutritional behavior but is associated to metabolic syndrome in old women
ea0029p1137
Hypopituitarism 3 and 12 months after TBI and SAH
ea0029p1138
Pituitary incidentaloma: clinical presentation and endocrine evaluation in a Spanish population
ea0029p1139
Comparison of the effect of chronic restraint and crowding on hypothalamic-pituitary-adrenocortical response to acute restraint stress
ea0029p1140
Circulating interleukin 6 and soluble forms of interleukin 6 receptor and glycoprotein 130 in women with anorexia nervosa
ea0029p1141
Ghrelin and growth hormone levels are decreased in Saudi autistic children
ea0029p1142
Basal and stimulated GH secretion in active cushing's syndrome and 2 years after remission
ea0029p1143
Overly rapid correction of severe hyponatremia with vasopressin receptor antagonists poses a risk of inducing osmotic demyelination syndrome
ea0029p1144
Relationship between leptin, markers of bone turnover, bone mineral density, and body weight in patients with schizophrenia treated with long acting risperidone (LAIR)
ea0029p1145
Estrogen receptor alpha PvuII polymorphism in female acute stroke patients: no associations with disease severity and short-term prognosis
ea0029p1146
The incidence of acromegaly in iceland from 1955 through 2010
ea0029p1147
The incidence of hypoglycaemia in non-diabetic hospital patients outside critical care estimated by a capture-recapture technique: retrospective analysis
ea0029p1148
An initial dose of 7.5 mg Tolvaptan is safe and effective in the treatment of hyponatremia caused by SIADH
ea0029p1149
Role of endocrine nurse in simultaneous bilateral inferior petrosal sinus sampling (BIPSS): single center experience
ea0029p1150
PTHrP-induced hypercalcemia: a rare and challenging presentation in metastatic pancreatic neuroendocrine tumour
ea0029p1151
Profile of neurosarcoidosis observed in internal medecine practice
ea0029p1152
Nuclear receptors and Signal transduction
Effects of estradiol on tight junction in the human breast cancer cell line MCF-7
ea0029p1153
Insufficiency of the chaperones GRP78 and GRP94 links TLR4 signaling to endoplasmic reticulum stress
ea0029p1154
Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking the oxysterol receptor liver X receptor [beta]
ea0029p1155
PAK1-Nck interaction regulates prolactin-dependent cyclin D1 promoter activity
ea0029p1156
Estrogen priming is critical for effective progesterone receptor engagement with DNA in breast cancer cells: ChIP sequencing and microarray studies
ea0029p1157
Hypoxia-induced estrogen receptor alpha activation is mediated by both the MAPK and PI3K phosphorylation pathways
ea0029p1158
GH-STAT5 signaling pathway is down-regulated by Liver X Receptor agonists in liver
ea0029p1159
Post-translational modification of the thyroid hormone receptor interferes with its transcriptional activity
ea0029p1160
Impact of receptor tyrosine kinase ErbB2/Her-2 and chemokine receptor CXCR4 crosstalk on estrogen receptor [beta] activity
ea0029p1161
Characterisation of the N321K mutation in the type-2 vasopressin receptor causing nephrogenic diabetes insipidus
ea0029p1162
Protein metabolism in human skeletal muscle after 72 h fasting; increased muscle protein breakdown and impaired insulin signaling
ea0029p1163
Chronic and acute effect of IL1[bata] on sex hormone-binding globulin by decreasing HNF-4[alpha] via JNK/c-Jun pathway
ea0029p1164
LPS administration modulates hypothalamic AMPK and glucose homeostasis in mice
ea0029p1165
Evaluation of K[plus] flux-dependent regulation of mitochondrial potential ([Delta][Phi]m) by [alpha]-adrenergic agonist phenylephrine in single hepatocytes
ea0029p1166
Altered muscle mitochondrial amount and physical performance in 5/6 nephrectomy CKD model mice
ea0029p1167
PPAR[gamma] activator may improve sepsis symptom by inhibiting inflammation in adipose tissue
ea0029p1168
Effects of benzbromarone on serum CRP in patients with gout
ea0029p1169
Obesity
Association of 3111t/c polymorphism of the clock gene with binge eating disorder in obese children and adolescents
ea0029p1170
Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase
ea0029p1171
Ac 2-26, an annexin A1-derived peptide, reduces inflammation in human SGBS adipocytes after hypoxia treatment
ea0029p1172
Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects
ea0029p1173
Zinc-[alpha]2-glycoprotein in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients
ea0029p1174
Longitudinal changes in body mass index and body composition among 417 adult survivors of childhood cancer
ea0029p1175
Brown rice and its component, [gamma]-oryzanol, attenuate the preference for dietary fat by decreasing hypothalamic endoplasmic reticulum stress in mice
ea0029p1176
Weight-perception in male career US firefighters and its association with cardiovascular risk factors
ea0029p1177
GH secretagogue receptor gene 171 C/T polymorphism association with metabolic features in obese children and adolescents
ea0029p1178
Using 1H-nuclear magnetic resonance spectroscopy to identify changes in the plasma metabolome of rats fed low-carbohydrate/high fat diets
ea0029p1179
Metabolic syndrome after liver transplantation: pre- and post-operative risk factors
ea0029p1180
Metformin in normoglycemic obesity: a systematic review
ea0029p1181
Growth differentiation factor-15 and transforming growth factor-[beta]1 in healthy adults with and without obesity
ea0029p1182
Abstract unavailable
ea0029p1183
The effect of 'The Programme of weight loss' in women, Arkhangelsk, Russia
ea0029p1184
Efficacy of orlistat vs placebo in the improvement of lipid profile among overweight and obese patients: a meta-analysis
ea0029p1185
Insulin resistance and acne: a new risk factor for men?
ea0029p1186
Metabolic syndrome in benign and malignant nodular thyroid diseases
ea0029p1187
Abstract unavailable
ea0029p1188
A pilot study in obese patients who refer to plastic surgery: temperamental-personality traits
ea0029p1189
Evaluation of success of an obesity consultation (2004-2010)
ea0029p1190
Regulation of lipid droplet function in adipocytes: role of RAB18
ea0029p1191
Frequency of obesity, insulin resistance, cardio-metabolic risk factors and genetic variation in the genes encoding ADIPOQ and PPAR-[gamma] in urban adults
ea0029p1192
Melanocortin 4 receptor genetics in defining the morbid obesity in general population: common polymorphisms vs mutations
ea0029p1193
Effects of bezafibrate treatment on pancreatic remodeling and insulin resistance in ovariectomized C57BL/6 mice fed high-fat diet
ea0029p1194
Abstract unavailable
ea0029p1195
Prediabetes in adult GH deficiency is associated with a substantial reduction in serum and adipose tissue expression levels of zinc-[alpha]2-glycoprotein
ea0029p1196
Signalling properties of the melanocortin 3 receptor are modified by interaction with different ghrelin receptor variants in heterodimers
ea0029p1197
Metabolic signature of visceral and subcutaneous obese adipose tissue secretomes reveal altered tissular amino acid metabolism
ea0029p1198
Time-course of changes of GLUT4 expression in insulin-sensitive tissues in an animal model of metabolic syndrome
ea0029p1199
Acute ghrelin effects on depressive-like behavior in bulbectomyced mice: a possible mechanism of action
ea0029p1200
Association of the obesity/type 2 diabetes-related genetic variants with visceral fat acccumulation in obese, overweight and lean subjects
ea0029p1201
Abstract unavailable
ea0029p1202
Loss of hypothalamic-pituitary-adrenal axis improves obese phenotype and restores hypothalamic agouti-related protein mRNA in leptin-deficient ob/ob mice
ea0029p1203
Different metabolic response to intagastric balloon treatment between non-morbid and morbid type of obesity
ea0029p1204
Metabolic and hormonal consequences of circadian rhythm disruption in Bmal1 null mice
ea0029p1205
Aldosterone increases oxidative stress in differentiated, but not in undifferentiated 3T3-L1 adipocytes via activation of mineralocorticoid receptors
ea0029p1206
Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit
ea0029p1207
GPR83 in interaction with GHSR and MC3R: lessons from in vitro studies
ea0029p1208
Metabolic effects of 3-iodothyronamine in hepatocytes
ea0029p1209
The adipokines TNF-[alpha] and IL6 predicted incident cancer development in a Chinese community-based cohort
ea0029p1210
ASP injection promotes macrophage infiltration and M1 polarization in obese adipose tissue
ea0029p1211
Regulation of adiponectin by free fatty acids in lean and obese subjects
ea0029p1212
SUR2a gene is upregulated in skeletal muscle insulin resistance of obese rats: correlation with GLUT4 gene
ea0029p1213
Circulating oxidized LDL in patients with visceral obesity
ea0029p1214
Leptin modulates brain neural activity associated with feeding behavior in patients with lipodystrophy
ea0029p1215
Age variations in adiposity and body fat composition among spanish women
ea0029p1216
Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in chinese young adults
ea0029p1217
Gender differences in measurements of total and regional body composition in preschool children
ea0029p1218
Comparison of serum high-molecular-weight (HMW) adiponectin and homeostasis model assessment of insulin resistance (HOMA-IR) as markers for metabolic syndrome (MS) in estonian adult population
ea0029p1219
Local inflammatory response in adipose tissue dysfunction
ea0029p1220
Effect of two different types of bariatric surgery on metabolic profile in obese type 2 diabetic women
ea0029p1221
Visceral-to-subcutaneous fat ratio using fat measurement CT is essential for the assessment of risk for diabetes, hypertension and early atherosclerosis
ea0029p1222
Effect of obesity on vitamin d and parathormone levels
ea0029p1223
Limited effects of leptin and adiponectin on proliferation and protein metabolism of porcine myoblasts under serum-free culture conditions
ea0029p1224
Effect of secreted frizzled-related protein 2 (sFRP2) from adipose tissue on pancreatic cell function
ea0029p1225
Curcumin inhibits the upregulation of cathepsin L by palmitate in fat
ea0029p1226
Preventing childhood obesity by community based intervention approaches
ea0029p1227
Reduction of body weight and waist circumference after long-term treatment of hypogonadal men with testosterone undecanoate
ea0029p1228
Connection of adipocitokines and inflammatory markers in obese woman: influence of body weight reduction
ea0029p1229
Proteomic analysis identifies adiponectin as a key plasma protein associated to vitamin D deficiency in pediatric obesity
ea0029p1230
Plasma adipokines and improvement of insulin sensitivity during multi-phase long-term dietary intervention
ea0029p1231
Obesity the first year of life: influence of glycemia at pregnancy, breastfeeding and sleep
ea0029p1232
Anthropometric, hormonal and nutritional correlates of epicardial fat in obese women
ea0029p1233
How informative is visceral fat measurement by bioelectrical impedance?
ea0029p1234
A selective androgen receptor modulator, S42 possesses beneficial metabolic effects
ea0029p1235
Effect of orlistat in Russian adolescents with metabolic syndrome: a randomized controlled trial
ea0029p1236
Extreme obesity partly blunts the discriminative metabolic effects of polycystic ovary syndrome (PCOS)
ea0029p1237
Low dose 3-iodothyronamine increases acute lipolysis followed by protein catabolism in mouse
ea0029p1238
Lipid metabolism is impaired in obesity/diabetes model mice
ea0029p1239
Comparing effects of lifestyle modification-induced weight loss on androgen levels, endothelial, sexual and urinary function, and quality of life in obese men with and without androgen deficiency
ea0029p1240
How safe is the use of herbal weight-loss products sold over the Internet?
ea0029p1241
Obesity related comorbidities 2 years following bariatric surgery in a group of 215 German subjects
ea0029p1242
Changes in gut hormone levels and glucose homeostasis in obese patients during the first year after laparoscopic sleeve gastrectomy
ea0029p1243
Changes of peripheral [alpha]-melanocortin stimulating hormone ([alpha]-MSH) in childhood craniopharyngioma patients in comparison with other forms of childhood obesity
ea0029p1244
Measurement of serum high-molecular-weight (HMW) adiponectin level using recently-developed chemiluminescence enzyme immunoassay (CLEIA) at health check-up
ea0029p1245
Anti-inflammatory effects of full-length and globular protein fragments of the new adipokine CTRP-3
ea0029p1246
Cholinergic and purinergic markers are increased in lymphocytes of patients with Metabolic Syndrome
ea0029p1247
Association between osteocalcin and insulin resistance in obese women
ea0029p1248
Serum leptin levels in patients with type 1 gaucher disease
ea0029p1249
Relationship between neck circumference and cardiometabolic parameters in non-obese brazilian adult population
ea0029p1250
A different method in obesity treatment; external gastric balloon
ea0029p1251
Hyperuricemia and components of metabolic syndrome among patients of different age
ea0029p1252
The comparison of obesity treatment with intragastric balloon and bihevioral-cognitive approach
ea0029p1253
Therapeutic efficacy of obesity treatment methods in teenagers
ea0029p1254
Insulin and C-peptide response after a test meal in obese patients before and 5 days after bariatric gastric by pass surgery
ea0029p1255
The oxidative stress parameters within the context of metabolic syndrome evolution in men
ea0029p1256
Relationships between metabolic syndrome components and bone mineral density in ukrainian postmenopausal women
ea0029p1257
Allograft inflammatory factor 1 is a new human adipokine regulating adipose inflammation
ea0029p1258
Body composition and radiation exposure in the Adult Health Study
ea0029p1259
Usefulness of preoperativee exenatide in control of risk factors for bariatric surgery on type 2 diabetic patients with morbid obesity
ea0029p1260
Preclinical anti-obesity activity and safety assessment of a novel drug affecting CB1 receptor
ea0029p1261
Green tea consumption, weight loss and resting energy expenditure
ea0029p1262
Waist and abdominal circumference in seven years old children: relationship between methods
ea0029p1263
Bariatric surgery in men: effects on gonadal hormones, body composition, glucose, lipid and bone metabolism
ea0029p1264
Outcome of obese adults after laparoscopic adjustable gastric banding: a retrospective follow-up study
ea0029p1265
Proteomic analysis of adipose tissue in health and disease
ea0029p1266
Is fat mass index superior to total fat mass percentage in predicting the metabolic syndrome?
ea0029p1267
Relationships between hypovitaminosis D, low-grade chronic inflammation, and leptin-to-adiponectin ratio in PCOS: is this a matter of fatness?
ea0029p1268
Incidence of glucose and lipid metabolism disorders in overweight children and adolescents in Croatia
ea0029p1269
Factors determining weight gain in adults and relation with glucose tolerance
ea0029p1270
Obesity prevention: main findings of the EPODE European network project
ea0029p1271
Dietary habits and body weight in an unselected population of Italian high-school students
ea0029p1272
Relationship between obesity and Leptin (G-2548A) and Leptin receptor (668A[gt]G (Q223R)) gene polymorphisms in Turkish population
ea0029p1273
Atherosclerosis risk factors before and 90 days after bariatric surgery
ea0029p1274
Obesity prevalence in west black sea region of turkey, the Melen Study
ea0029p1275
Association between metabolic syndrome and serum leptin level in postmenopausal women
ea0029p1276
Effects of diet and physical activity-induced weight loss on insulin resistance in severely obese patients
ea0029p1277
Evaluation of depressive symptoms and quality of life in obese patients
ea0029p1278
Plantar heel pain and relation with different diseases in obese Turkish patients
ea0029p1279
Relationship between visceral fat and neck circumference in patients with metabolic syndrome
ea0029p1280
Morbid child obesity-possible Rohhadnet syndrome: case report
ea0029p1281
The correlation between metabolic syndrome and serum resistin, adiponectin, TNF[alpha], leptin levels and abdominal adipose tissue thickness
ea0029p1282
Study of insulin resistance in overweight and obese children by: M Hesham El Hefnawy and Ibrahim Emara
ea0029p1283
Paediatric endocrinology
Insulin secretion and sensitivity in GH deficient children at the end of rhGH therapy and after 1 year of follow-up: influences of d3GH receptor polymorphism on metabolic parameters
ea0029p1284
ACTH and cortisol are differently associated with metabolic syndrome components in a large cohort of Caucasian obese children and adolescents
ea0029p1285
Subclinical hypothyroidism in obese children and metabolic implications
ea0029p1286
Addressing issues of diabetes patients community: Role of NGO's in resource poor settings
ea0029p1287
Influence of cranial and craniospinal irradiation in childhood on reproductive system of women and men cancer survivals
ea0029p1288
Etiology of delay of puberty in adolescents with different neuroendocrine diseases
ea0029p1289
Noonan syndrome: short stature and pubertal delay
ea0029p1290
The neuroendocrine complications of teenagers with diabetes insipidus of central genesis
ea0029p1291
Systemic administration of C-type natriuretic peptide rescues impaired endochondral bone growth in mice model of achondroplasia
ea0029p1292
Exclusion of aldosterone signaling pathway genes as candidates for renal pseudohypoaldosteronism type 1 in 32 families
ea0029p1293
Serum adiponectin levels in adolescents and young adults with GH deficiency
ea0029p1294
Serum concentrations of chemerin, omentin and vaspin in girls with anorexia nervosa
ea0029p1295
Evaluation of circulating kisspeptin as a biomarker for differential diagnostic of central precocious puberty
ea0029p1296
Two novel IGF1R gene heterozygous mutations in two unrelated children with pre and postnatal growth retardation, and microcephaly
ea0029p1297
Pediatric and adolescent somatotrop adenomas
ea0029p1298
Wolfram syndrome: new cases and new mutations
ea0029p1299
Growth and response to rhGH treatment in patients with congenital combined pituitary hormone deficiency younger than 3 years of age
ea0029p1300
Hyperandrogenism and PCOS in adolescent girls with type 1 diabetes treated with intensive and continous insulin therapy
ea0029p1301
Diagnosis of glycemic abnormalities in thalassemic adolescents: continuous glucose monitoring versus glucose tolerance, and insulin: glucose parameters
ea0029p1302
Linear growth of children with congenital hypothyroidism detected by neonatal screening compared to normal children and their mid-parental height
ea0029p1303
A novel splicing mutation of the POU1F1 gene in Japanese identical twins with mild combined pituitary hormone deficiency
ea0029p1304
Analysis of selected FOXP3 gene polymorphisms in children and adolescents with Graves' disease and Hashimoto's thyroiditis
ea0029p1305
Characterization of a population of patients with 46,XX disorders of sex development followed at a Pediatric Center of Argentina
ea0029p1306
Randomized multicenter trial on patients with childhood craniopharyngioma (KRANIOPHARYNGEOM 2007): update after 49 months of recruitment
ea0029p1307
Effect of calcitriol on bone metabolism in adolescents with type 1 diabetes
ea0029p1308
Vitamin D levels in a paediatric population of normal weight and obese subjects
ea0029p1309
A particular phenotype in a case of Down-Turner syndrome
ea0029p1310
Dysfunction of adrenal steroidgenesis in preterm infants with late-onset circulatory collapse
ea0029p1311
Thyroid abnormalities in a 13 year old girl with an androgen secreting juvenile granulosa cell tumor of the ovary: insight into the thyroid-androgen axis in girls
ea0029p1312
Clinical practice guideline on linear growth measurement of children
ea0029p1313
The presence of thyroid nodules in our morbid obese patients and its relation with metabolic parameters
ea0029p1314
Mutations of the SRD5A2 gene in patients with 5 [alpha]-steroid reductase deficiency
ea0029p1315
Lipid storage myopathy in a child with idiopathic short stature
ea0029p1316
Care of patients with childhood onset growth hormone deficiency before and after the transition period
ea0029p1317
Psychiatric symptoms in Addison's crisis in childhood: the complexity of diagnosis
ea0029p1318
Insulin like growth factor-I (IGF-I) levels and metabolic parameters in a population of obese children and adolescents
ea0029p1319
The median age of the onset of puberty in Uzbek boys of Tashkent city
ea0029p1320
Thyroid function in a group of type 1 diabetes children without clinical evidence of thyroid diseases
ea0029p1321
The EURO-WABB project
ea0029p1322
Kearns-Sayre syndrome: clinical and molecular diagnosis of the disease and treatment with recombinant GH (rGH) complicated by a severe cardiac conduction deficit and cardiomyopathy
ea0029p1323
Newborn screening for congenital hypothyreoidism(CH) in Georgia
ea0029p1324
GH deficiency in the transitional age: retesting and reassessment of ninety personal cases
ea0029p1325
Building a Brazilian national network for pediatric endocrinology: the RUTE SIG experience
ea0029p1326
Peculiarities of autoimmune thyroiditis in children
ea0029p1327
Short stature due to late-onset congenital adrenal hyperplasia
ea0029p1328
Actual preparation of the growth hormone treatment for small-for-gestational-age children
ea0029p1329
47XYY syndrome is one of the cause of tall in children
ea0029p1330
Pituitary Basic
A recessive mutation resulting in a disabling amino acid substitution (T194R) in the LHX3 homeodomain causes combined pituitary hormone deficiency
ea0029p1331
Evidence of the involvement of gherline and obestatin in the regulation of GH secretion during pubertal development in boys
ea0029p1332
T3 and T4 rapidly regulate the TSH, FSH and LH [alpha] subunit gene expression at posttranscriptional level
ea0029p1333
Development of novel AIP (Aryl hydrocarbon receptor-interacting protein) gene study models using the fruitfly and the zebrafish
ea0029p1334
Multiple enhancers regulate expression of the human LHX3 gene in the developing pituitary
ea0029p1335
Role of a preformed signalosome in GnRH-stimulated FAK and paxillin phosphorylation by ERK at focal adhesions: possible role in gonadotropes migration
ea0029p1336
T3 acts posttranscriptionally reducing the poly(a) tail length and the translational rate of alpha and beta TSH mRNA in T[alpha]T1 cells
ea0029p1337
Estradiol induces the rapid trafficking of membrane-associated ER[alpha] isoforms in pituitary cells
ea0029p1338
Pasireotide (SOM230) prevents sulfonylurea-induced hypoglycemia in fasted male rats
ea0029p1339
mTOR inhibitor Torin1 induces antiproliferative effects in MtT/E cell line and human pituitary tumors
ea0029p1340
Effect of estrogen and FGF-2 interaction on lactotroph cell proliferation mediated by membrane-initiated signaling
ea0029p1341
Importance of topoisomerase II[alpha] and Ki-67 as markers of invasiveness and predictors of recurrence in pituitary tumours
ea0029p1342
Aryl hydrocarbon receptor interacting protein in somatotroph adenomas: a molecular target for somatostatin analogues?
ea0029p1343
Estradiol regulates the expression of c-FLIP in anterior pituitary cells
ea0029p1344
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region
ea0029p1345
Expression of Ras related proteins in ES cell-derived AVP secreting cells
ea0029p1346
Inhibition of methylation stimulates POMC expression and ACTH secretion in human pituitary ACTH-secreting tumors
ea0029p1347
Effect of valproate on inositol 1,4,5 triphosphate and protein kinase C pathways activity in anterior pituitary cells of female rat
ea0029p1348
The role of familial pituitary adenoma gene, aryl hydrocarbon receptor-interacting protein, in the proliferative and invasive activity of a malignant pancreatic cell line
ea0029p1349
Combined intra- and inter-individual variability in macroprolactinaemia
ea0029p1350
Reduced expression of glucocorticoid stimulated genes in large and dedifferentiated corticotroph adenomas
ea0029p1351
Effects of the combined treatment with AMPK activator and somatostatin-14 on hormone secretion and cell proliferation in cultured GH-secreting pituitary tumor cells
ea0029p1352
The relationship between Ki-67 labeling index and p53 with age, gender, number of surgeries, cure after surgery and cavernous sinus invasion in pituitary adenomas of patients with acromegaly
ea0029p1353
Characterization of mutant AIPV49M in somatotroph cells
ea0029p1354
Lycopene and [beta]-carotene induce growth-inhibitory and proapoptotic effects on pituitary tumor cells: the mechanism could involve Connexin 43
ea0029p1355
Somatostatine receptors expression in various pathological types of clinically non-functioning pituitary adenomas
ea0029p1356
Lymphocyte subpopulations in Sheehan's syndrome
ea0029p1357
Modulation of intrapituitary CRH gene expression
ea0029p1358
Resveratrol induces apoptosis in GH3 pituitary adenoma cells of the rat
ea0029p1359
Effects of Brazilian palm tree extract on ACTH-secreting mouse pituitary tumor cells
ea0029p1360
Pituitary Clinical
Case series of diabetic ketoacidosis as the first presentation of 860 patients with acromegaly
ea0029p1361
Markers of recurrence and long-term morbidity in craniopharyngioma
ea0029p1362
Familial isolated pituitary adenoma: review of four families
ea0029p1363
A prospective study of cardiac valvular status in patients treated with cabergoline for endocrine disease
ea0029p1364
IGF1 as a risk factor for insulin resisitance and glucose intolerance in acromegaly
ea0029p1365
An insight into the mechanisms underlying the sympathoinhibition of acromegaly
ea0029p1366
Aneurysmal subarachnoid haemorrhage is a rare cause of acute glucocorticoid deficiency and long term hypopituitarism
ea0029p1367
Hyponatraemia in aneurysmal subarachnoid haemorrhage is due to the syndrome of inappropriate antidiuresis and acute glucocorticoid deficiency
ea0029p1368
Pregnancy outcomes following cabergoline treatment in hyperprolactinemic patients: an observational survey study
ea0029p1369
Sleep apnea in acromegaly: pathogenetic factors and long-term follow up
ea0029p1370
Japan National Survey of metastatic pituitary tumor: preliminary report on 164 cases
ea0029p1371
Effects of previous GH excess and current medical treatment for acromegaly on cognition
ea0029p1372
Abstract unavailable
ea0029p1373
Circulating total and high molecular weight adiponectin levels are lower in adult GH deficient subjects
ea0029p1374
Quality of life and mood disturbances in patients with acromegaly followed-up in a single center
ea0029p1375
Low total cortisol correlates closely with low free cortisol in traumatic brain injury and predicts mortality and long term hypopituitarism
ea0029p1376
Array-comparative genomic hybridization in congenital morphological alteration of the pituitary gland
ea0029p1377
Low IGF1 levels are associated with a lower prevalence and incidence of anxiety disorders in primary care patients (DETECT cohort) and the general population (SHIP cohort)
ea0029p1378
Epidemiology, histophatological characteristics and clinical manifestations of aggressive pituitary tumors, evaluated on the basis of KI-67 immunostaining: a single center experiense
ea0029p1379
Congenital hypopituitarism with ectopic posterior pituitary and pulmonic stenosis: hormonal and radiologic followup into adulthood
ea0029p1380
Childhood onset craniopharyngiomas have normal selfrating quality of life but impaired neurocognitive function in adult life
ea0029p1381
Orexin A concentration is reduced in acromegaly, regardless activity of the disease
ea0029p1382
No evidence for detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly
ea0029p1383
Prevalence and incidence of pituitary adenomas; a population based study in Malta
ea0029p1384
Markers of disease activity correlate with cephalometric parameters in acromegalic patients
ea0029p1385
Management of giant cystic invasive prolactinoma-the role of medical therapy revisited
ea0029p1386
Surveillance study on the prevalence of manifestations, complications and illness associated to acromegaly
ea0029p1387
Diabetes insipidus could be the initial sign of primary hypophysitis
ea0029p1388
Evaluation of metabolic parameters in patients with craniopharyngiomas using visceral adiposity index
ea0029p1389
Oxidative stress and reduced anti-oxidative status, along with endothelial dysfunction in acromegaly
ea0029p1390
Evaluation of clinical presentation, treatment approach and outcome of a cohort of patients with acromegaly: a single centre experience
ea0029p1391
Permanent panhypopituitarism is a rare complication of acute bacterial sinusitis
ea0029p1392
Carboplatin is a novel cause of the syndrome of inappropriate antidiuresis
ea0029p1393
Evaluation of ejaculatory function in acromegalic men: preliminary study
ea0029p1394
Evaluation of male sexual function in active acromegalic patients and after disease remission: preliminary study
ea0029p1395
The clinical outcome of pituitary adenomas in the cavernous sinus
ea0029p1396
Outcome of transsphenoidal surgery for Cushing's disease dependent on tumor size: a single center experience
ea0029p1397
Effects of medical therapy of acromegaly on glucose metabolism
ea0029p1398
Insulin resistance and the effect of treatment on insulin resistance in patients with prolactinoma
ea0029p1399
Effects on GH/IGF1 hypersecretion and tumor size of long-acting somatostatin analogue (Sandostatin LAR) in patients with untreated acromegaly and in previously treated with surgery and/or radiotherapy
ea0029p1400
Management of hyponatremia in the hospital: interim results from a prospective, observational, multi-center, global registry
ea0029p1401
Cardiac magnetic resonance imaging detects myocardial fibrosis in patients with active acromegaly
ea0029p1402
Pregnancies in a large cohort of patients on growth hormone replacement therapy
ea0029p1403
Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study
ea0029p1404
Long-term use of pasireotide in Cushing's disease: 24-month safety results from a randomized phase III study
ea0029p1405
Pasireotide treatment is associated with improvements in hypertension: 12-month results from a large phase III study in Cushing's disease
ea0029p1406
GH Secretion response to triple secretagogue stimulus (ghrh, ghrelin and arginine) is gender and BMI dependent in healthy postmenopausal women and older men
ea0029p1407
Pasireotide treatment is associated with clinically meaningful improvements in health-related quality of life in Cushing's disease: results from a large, randomized, double-blind phase III trial
ea0029p1408
Increased risk of hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors with the use of concurrent chemo-irradiation
ea0029p1409
Long-term pasireotide use leads to improvements in the biochemical parameters of Cushing's disease: 24-month results from a randomized phase III study
ea0029p1410
Hyperprolactinemic patients are prone to increased protein oxidation: a risk for low grade inflammation?
ea0029p1411
Fifteen years of GH replacement improves body composition and metabolic parameters
ea0029p1412
Incidence of hypogonadism and evaluation of its impact on cardiovascular risk factors and quality of life in acromegalic patients
ea0029p1413
GH secretory function is well preserved in surgically cured acromegalics
ea0029p1414
The effect of GH replacement therapy on exercise capacity, fat mass, ectopic lipids intramyocellular and intrahepatocellular lipids and insulin resistance in hypopituitary patients with GH deficiency
ea0029p1415
Prevalence of central adrenal insufficiency during lifespan in Prader-Willi syndrome
ea0029p1416
Limited effects of temozolomide monotherapy on aggressive pituitary tumors. -Based on our own experiences of three cases-
ea0029p1417
The impact of long-acting somatostatin analogs treatment on glucose tolerance and insulin resistance in acromegaly.
ea0029p1418
Immunohistochemical detection of sstr2 and 5 ligand binding domains in 110 pituitary tumors
ea0029p1419
Symptomatic hypotonic hyponatraemia after endoscopic transsphenoidal surgery: results from two large series
ea0029p1420
Audit of pituitary dysfunction after traumatic brain injury: caution in interpretation of glucagon stimulation test in diagnosis of GH and ACTH deficiency.
ea0029p1421
Body composition has a higher impact on peak GH during the pyridostigmine-GHRH test than the insulin tolerance test in healthy individuals
ea0029p1422
Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study
ea0029p1423
Cavernous Sinus Sampling (CSS) - a specific method for localization of minute ACTH secreting adenomas in Cushing Disease (CD)
ea0029p1424
Effects of medical treatment on proliferation parameters MIB-1 and topoisomerase-II[alpha] in GH secreting pituitary adenomas
ea0029p1425
Comprasion of cycline D1 gene (Ccnd1) polymorphism in invasive and non-invasive prolactinomas
ea0029p1426
Control of GH and IGF1 in acromegaly in the UK: responses to medical treatment
ea0029p1427
Low tumoral mRNA IGF2 might balance the mechanism of tumorigenesis in GH-secreting adenomas
ea0029p1428
Synergistic effects of combined stimulation with CRH+ghrelin on ACTH and cortisol responses in patients with Cushing's disease: a pilot study
ea0029p1429
Bone turnover in patients with active acromegaly in relation to glucose metabolism
ea0029p1430
Relationship between gsp mutations and clinico-pathological features in GH producing pituitary adenomas
ea0029p1431
Decreased IGF1 levels and GH-resistant hepatic state to estrogens during the first trimester of pregnancy in non-acromegalic women
ea0029p1432
Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas
ea0029p1433
Mortality rates in childhood and adult onset GH deficient patients enrolled in the Global Hypopituitary Control and Complications Study (HypoCCS)
ea0029p1434
Experience in the use of tolvaptan in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH)
ea0029p1435
Blast concussion is associated with high frequency of pituitary dysfunction
ea0029p1436
Efficacy of transsphenoidal surgery for Cushing's disease: the role of combined dexamethasone desmopressin test
ea0029p1437
Improved renal function after five years of GH therapy in GH deficient (GHD) adult survivors of childhood leukaemia
ea0029p1438
Thyrotropin-secreting pituitary adenomas: experience of a single centre
ea0029p1439
Detection of somatostatin receptors in aggressive non-functioning pituitary adenomas and effects of somatostatin analogs therapy in these tumors
ea0029p1440
Effect of a modulation of somatostatin release on TSH secretion in healthy volunteers
ea0029p1441
Are ''in silico'' predictions reliable regarding splice-site mutations? - Studies in the aryl hydrocarbon receptor-interacting protein (AIP)
ea0029p1442
Effectiveness of cyberknife in the management of pituitary adenomas and craniopharyngiomas
ea0029p1443
Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects
ea0029p1444
Pituitary tumor apoplexy: overview of 14 cases diagnosed during the last 12 years at a central hospital
ea0029p1445
Copeptin is not associated with menstrual cycle hormones
ea0029p1446
Acylated ghrelin as provocative test for the diagnosis of gh deficiency in adults
ea0029p1447
National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden
ea0029p1448
High mean platelet volume and lipid abnormalities in prolactinoma patients without insulin resistance
ea0029p1449
Asymptomatic nonfunctioning pituitary macroadenomas take advantage of surgery
ea0029p1450
Mortality and survival in a large series of adult patients with hypopituitarism followed for 10 years
ea0029p1451
Gastric and colonic pathology at patients with active acromegaly
ea0029p1452
Pituitary dysfunction in adult patients after cranial radiotherapy for non-pituitary tumors: a long-term follow-up study
ea0029p1453
The treatment of results of endoscopic transsphenoidal surgery for GH-secreting pituitary adenomas
ea0029p1454
Glucose metabolism in children with GH deficiency before and after GH therapy
ea0029p1455
Endocrine disturbances and quality of life in adult patients after multimodal treatment for brain tumors or leukemia
ea0029p1456
Anterior pituitary autoantibodies in patients with diabetes mellitus
ea0029p1457
Pitfalls in Cushing's disease: report of an ectopic ACTH-producing pituitary adenoma in the sphenoid sinus
ea0029p1458
The effect of Ki67 index on tumor behavior in proloctanimas
ea0029p1459
Cyclin D1 gene exon 4/intron 4 region A / G polymorphism and allele ratios in patients with prolactinoma
ea0029p1460
Cancer detection in long-term follow-up of patients with acromegaly
ea0029p1461
Study on IGF(CA)19 gene polymorphism in adults with GH deficiency
ea0029p1462
META-analysis on the effects of octreotide on tumor mass in acromegaly
ea0029p1463
Parasellar masses: experience in 47 patients
ea0029p1464
Colonic neoplasms in acromegaly: are there serum risk factors?
ea0029p1465
No long-term weight reduction after gastric banding in obese patients with craniopharyngioma involving hypothalamic structures: experiences from KRANIOPHARYNGEOM 2000
ea0029p1466
Predictors of the acromegaly-associated mortality in the last decade
ea0029p1467
Endoscopic transsphenoidal surgery as the therapy of choice for acromegaly: a 13-year experience in a single centre
ea0029p1468
MALE macroprolactinomas: response to medical treatement
ea0029p1469
Evaluation of pituitary gland with magnetic resonance imaging in hypogonadic patients
ea0029p1470
Is acromegaly associated with irritable bowel syndrome?
ea0029p1471
Acromegaly, does tumor size matters?
ea0029p1472
Clinical and histological characteristics of giant GH producing pituitary adenomas
ea0029p1473
Long-term outcomes after sterotactic radiosurgery for non-functioning pituitary adenomas
ea0029p1474
Long-term outcomes after sterotactic radiosurgery for functioning pituitary adenomas
ea0029p1475
Comparison of immunoassay and mass spectrometry measurement of cortisol during ACTH1-24 stimulation tests
ea0029p1476
Cushing's disease: prospective assessment of factors influencing the efficacy of transsphenoidal surgery
ea0029p1477
The results of surgical treatment on prolactinomas in females of child bearing ages
ea0029p1478
Treatment outcomes in prolactinomas with and without cavernous sinus invasion
ea0029p1479
Change in somatostatinergic tone of acromegalic patients according to the size of GH-producing pituitary tumors
ea0029p1480
Two cases of sever congenital central hypothyroidism with TSH and prolactin deficiency-possible new syndrome
ea0029p1481
Treatment response and comorbilities in acromegalic patients
ea0029p1482
Reproductive function in acromegalic women: a one-center experience
ea0029p1483
Evaluation of bone mass and fracture in patients with prolactinoma
ea0029p1484
Prolactin levels are correlated with tumor size and invasiveness in prolactinomas
ea0029p1485
Is every joint symptom related to acromegaly?
ea0029p1486
Acromegaly and pregnancy: case reports
ea0029p1487
Pegvisomant and cabergoline combination therapy in acromegaly
ea0029p1488
Influence of the family environment during the early years in life in the vulnerability to the development of pituitary adenomas
ea0029p1489
Hyperprolactinemia in polycystic ovary syndrome- diagnostic and therapeutic approach
ea0029p1490
Hypothalamo-pituitary dysfunction in patients with chronic subdural hematoma
ea0029p1491
Mood Disorders and Quality of Life in Patients with Acromegaly after Pituitary Adenomas
ea0029p1492
Although dentists are frequently visited by acromegaly patients they do not diagnose the disease
ea0029p1493
The long term recurrence rates of cushing's disease in turkish patients after transsphenodal surgery: a single-center experience
ea0029p1494
Xanthoma disseminatum with cutaneous and pituitary stalk involvement
ea0029p1495
Acromegaly and charles bonnet syndrome
ea0029p1496
Planning for the future: preparing the endocrine specialist nurse of tomorrow
ea0029p1497
Changes in body composition in patients with acromegaly
ea0029p1498
Complications of pure endoscopic transsphenoidal surgery for pituitary adenoma
ea0029p1499
A case of nephrotic syndrome hidden by cushing's disease
ea0029p1500
Preliminary report of hypoglycemic response in obese metabolic syndrome males treated with metformin after weight loss intervention
ea0029p1501
A difficult case of hyponatraemia in a neurosurgical patient
ea0029p1502
Invasive and giant pituitary adenomas in the elderly
ea0029p1503
Hyperprolactinemia: prolactinoma or pregnancy?
ea0029p1504
DHEAS: a new marker in Cushing's disease? Preliminary results of 32 patients
ea0029p1505
Clinical experience with acromegalic patients who have macroadenomas and long term follow-up results
ea0029p1506
Glucose metabolism and lipid disturbances in acromegalic patients before and during treatment with long-acting somatostatin analogues
ea0029p1507
The therapy with cabergoline evaluation of men with macroprolactinoma
ea0029p1508
Efficacy of testerone 2% gel replacement therapy on erectile function, muscle strenght and general wellbeing in men affected by normo-hypogonadotropic hypogonadism
ea0029p1509
Follow up of pituitary incidentaloma: a study in 140 patients
ea0029p1510
Macroprolactin levels in healthy blood donors
ea0029p1511
Sleep apnoea syndrome in acromegaly
ea0029p1512
Therapeutic trends, long-term outcome and efficacy of different treatment modalities in acromegaly: a single center registry covering a 40 year period
ea0029p1513
Prevalence of the metabolic syndrome in patients with adult growth hormone deficiency before GH treatment
ea0029p1514
Familial central diabetes insipidus with extremely high water intake
ea0029p1515
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients
ea0029p1516
Isolated diabetes insipidus happened during premenopause solution ten years after
ea0029p1517
Metaplastic Rathke's cyst leading to hypopituitarism
ea0029p1518
Pituitary macroadenomas: benefit from early GH substitution after surgery
ea0029p1519
Pituitary insufficiency in the acute phase of traumatic brain injury or subarachnoid hemorrhage, prevalence and predictive factors: a prospective, population based study
ea0029p1520
Difference of response to TRH (thyrotropin releasing hormone) stimulation according to octreotide response and the size of GH-producing pituitary adenomas
ea0029p1521
Ovarian hyperstimulation syndrome due to a functioning gonadotroph adenoma
ea0029p1522
GH deficiency after treatment of medulloblastoma and thyroid cancer: is this the case for GH therapy?
ea0029p1523
Thyrotropinoma. A rare case report of hyperthyroidism
ea0029p1524
The dermatologic evaluation of acromegaly patients
ea0029p1525
Growth hormone effects on lipid profile in patients with acromegaly
ea0029p1526
Pituitary lesions: Pituitary adenomas and what else?
ea0029p1527
Progressive combined pituitary hormone deficiency produced by Prop1 gene mutation
ea0029p1528
Neurohypohysis tumors: about two cases
ea0029p1529
Hypersomatotropism and glucose metabolism disorders
ea0029p1530
Hyperprolactinemia: etiology, diagnosis and therapeutic aspects
ea0029p1531
Clinical, biological and radiological confrontation in Cushing disease
ea0029p1532
Characteristics of giant and huge male prolactinomas
ea0029p1533
A case of acromegaly in the presence of coincidental liver cirrhosis
ea0029p1534
Adiponectin and cardiac structure in acromegaly
ea0029p1535
A case of acromegaly diagnosed with diabetic ketoacidosis as a primary manifestation
ea0029p1536
The role of long acting somatostatin analogues on glucose homeostasis in acromegaly
ea0029p1537
Clinical features of inferior and lateral invasive expansion of GH-producing adenoma
ea0029p1538
Predictive value of acute octreotide supression test in newly diagnosed acromegaly
ea0029p1539
An unusual plurihormonal pituitary adenoma
ea0029p1540
Results of pegvisomant therapy in patients with acromegaly
ea0029p1541
Panhypopituitarism and central diabetes insipidus: a case report
ea0029p1542
Evaluation of the efficacy and safety of pasireotide LAR in patients with mild-to-moderate cushing's disease: a randomized, double-blind, multicenter, phase III study design
ea0029p1542.1
Steroid metabolism + action
Anti-inflammatory effect of a high dose of corticosteroids is associated with some paradoxical pro-inflammatory effects
ea0029p1543
Acute and chronic effects of low dose prednisolone on carbohydrate metabolism in subjects with inflammatory rheumatologic disease
ea0029p1544
The influence of aromatizable and non-aromatizable steroids on anthropometric parameters
ea0029p1545
Effect of smoking cessation on hormonal balance
ea0029p1546
Conversion of 7[alpha]-hydroxyDHEA into 7-ketoDHEA: Role of type 2 11[beta]-hydroxysteroid dehydrogenase
ea0029p1547
Steroid derivatives as pure antagonists of the androgen receptor
ea0029p1548
The cellular fate of CYP19A1 (aromatase) protein
ea0029p1549
Detection of BclI and A3669G polymorphisms in glucocorticoid receptor gene in patients with rheumatoid arthritis
ea0029p1550
Aromatase activity after a short-course of Letrozole administration in adult men at sea level and in men at high altitude (with or without excessive erythrocytosis)
ea0029p1551
Myostatin and Follistatin expression in orchidectomized rats submitted to exercise
ea0029p1552
The role of long-acting parenteral testosterone undecanoate compound (Nebid 1000 mg) in the induction of secondary sexual characteristics (SSC) in males with hypogonadotropic hypogonadism (HH)
ea0029p1553
IL-6, Cortisol and early morning stiffness in patients with rheumatoid arthritis: endocrine changes associated with clinical improvement in a chronic autoimmune disease
ea0029p1554
Abstract unavailable
ea0029p1555
Fetal liver may reinstate activity of GABAergic steroids inactivated by placental oxidoreductases
ea0029p1556
Unconjugated steroids and steroid sulfates in maternal blood show comparable predictivity for assessment of gestational age from the 28th to 41st week of pregnancy
ea0029p1557
Anabolic hormones in acute exacerbation of chronic obstructive pulmonary disease: relation of hypogonadism with indexes of severity and phlogosis
ea0029p1558
Long-term evaluation of cross-sex hormone treatment in transsexual persons
ea0029p1559
Physiological relevance of peripherally produced gabaergic and glycinergic steroids in human late pregnancy and around parturition
ea0029p1560
Influence of endogenous hormones and testosterone in the prostate cancer
ea0029p1561
Thyroid (non-cancer)
Hypothyroidism is associated with increased intestinally derived lipoprotein particles and postprandial endothelial dysfunction
ea0029p1562
P1563
ea0029p1563
Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism
ea0029p1564
Potassium iodide, but not potassium iodate, as a potential protective agent against oxidative damage to membrane lipids in porcine thyroid
ea0029p1565
Response to high dose glucocorticoid therapy in patients with dysthyroid optic neuropathy (DON)
ea0029p1566
Effect of environmental nitrates on the thyroid and salivary glands in the population affected by the chernobyl fall-out
ea0029p1567
Quantitative comparison of deiodinase I and II mRNA expression in ovine tissues
ea0029p1568
Correlation between thyroid volume and body mass index 2 and 6 years later
ea0029p1569
The relation between severity of obstructive sleep apnea and diagnosis of Hashimoto's thyroiditis
ea0029p1570
An audit and patient satisfaction survey of the telephone endocrine clinic at University Hospital Lewisham, London
ea0029p1571
Gestational hyperthyroidism in women from mild to moderate iodine deficiency (ID) areas
ea0029p1572
The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels in euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis
ea0029p1573
Adaptation of the hypothalamo-pituitary-thyroid axis to pubertal development and exposure to acute and chronic physical stresses
ea0029p1574
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study
ea0029p1575
Predictors of long-term remission in patients with Graves' disease-a single centre experience
ea0029p1576
The effect of L-thyroxine substitution on lipid profile, glucose homeostasis and coagulation in patients with subclinical hypothyroidism
ea0029p1577
A novel familial variation of the thyroid hormone receptor beta gene (I276N) associated with resistance to thyroid hormone
ea0029p1578
Short-term combined treatment with L-thyroxine plus L-triiodothyronine in drops (LT4 plus LT3) in patients with persistent hypothyroidism and malabsorption during replacement therapy with L-T4.
ea0029p1579
The role of surgery in the treatment of amiodarone-induced thyrotoxicosis (AIT)
ea0029p1580
Carbimazole induced ANCA associated renal vasculitis
ea0029p1581
Thyroid dysfunction following cranial and craniospinal radiation in young adults
ea0029p1582
Multi nodular goitre: when is it time for the surgeon?
ea0029p1583
Amiodarone- induced thyroid dysfunction in an iodine- deficient region
ea0029p1584
Hashimoto thyroiditis and carbohydrate metabolism disorders in patients hospitalized in Department of Endocrinology and Diabetology of Ludwik Rydygier Collegium Medicum in Bydgoszcz between 2001 and 2010
ea0029p1585
Endocrine bioengineering: reconstruction of a bioartificial thyroid lobe using its natural, three-dimensional (3D) stromal / vascular matrix as a scaffold
ea0029p1586
Thyroid hormone stimulates hepatic fatty acid metabolism via lipophagy
ea0029p1587
Linking thyroid and central nervous system functions of cathepsin K: Implications for non-classical thyroid regulation
ea0029p1588
SECISBP2 syndrome: Mouse models for an atypical form of resistance to thyroid hormone
ea0029p1589
Polymorphism of the PPAR-[gamma]2 gene and Graves' orbitopathy: the Ala variant confers decreased risk of eye symptoms
ea0029p1590
Thyroid hormone T3 induces ovarian activity in rat follicles and granulosa cells
ea0029p1591
Recurrence of Amiodarone induced thyrotoxicosis after reinstitution of this drug
ea0029p1592
Subclinical and overt hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005
ea0029p1593
Enhanced expression of the B cell activation factor (BAFF) and baff-receptor (BAFF-R) in the thyroid and in the orbital adipose tissue from patients with graves' disease (GD) and associated orbitopathy (GO)
ea0029p1594
Utility of thiazide diuretics in the management of post- thyroidectomy hypocalcemia: a pilot study
ea0029p1595
Maternal Graves' disease induces more perinatal complications and higher risk of thyroid dysfunction at early childhood
ea0029p1596
No Correlations between TSH receptor antibody levels assayed with Elecsys TRAb and the activity or severity of Graves' ophthalmopathy
ea0029p1597
The influence of recombinant human thyroid stimulating hormone (rhTSH) on the efficacy of radioiodine therapy in patients with toxic nodular goitre with low RAIU
ea0029p1598
Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease
ea0029p1599
Individual plasma ghrelin changes evaluated in the same patients in hyperthyroidism, hypothyroidism and euthyroidism
ea0029p1600
The effect of radioiodine therapy in 950 patients with subclinical hyperthyroidism
ea0029p1601
Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in anti-inflammatory cytokine genes
ea0029p1602
The T and B cell subsets in thyroids of children with Graves' disease and Hashimoto's thyroiditis
ea0029p1603
The thyroid gland is another victim of the insulin resistance syndrome university
ea0029p1604
Four families with nonautoimmune hyperthyroidism harboring the same thyrotropin receptor germline mutation (Asn406Ser) in Kumamoto Prefecture, Japan
ea0029p1605
Antigen mimicry between aeroallergens and thyroid antigens can modify the levels of thyroid hormones and antibodies in thyroid autoimmunity
ea0029p1606
Diagnostic accuracy of elastography in thyroid nodule ultrasound evaluation. A prospective multicenter trial
ea0029p1607
FOXA1 and FOXA2 oppositely regulate human type 1 Iodothyronine deiodinase gene in liver
ea0029p1608
Dyrk1A (dual-specificity thyrosine (Y)-phosphorylation regulated kinase 1A) overexpression is linked to congenital hypothyroidism in Down syndrome
ea0029p1609
Impaired absorption of thyroxine in occult celiac disease
ea0029p1610
Frequency of PDE8B gene polymorphisms in patients affected by sporadic and familiar nonautoimmune subclinical hypothyroidism
ea0029p1611
MicroRNA expression profile helps to distinguish benign and malignant thyroid nodules starting from cells of fine needle aspiration
ea0029p1612
Effect of combination therapy with potassium iodide and 15 mg of methimazole for Graves' hyperthyroidism
ea0029p1613
Estrogens block the apoptotic action of tgfb in human thyrocytes
ea0029p1614
TRAb level and ophthalmopathy index as predictive factors of poor response and of severity of Graves ophthalmopathy in patients treated with anti-thyroid drugs and radioiodine
ea0029p1615
A possible common link between Graves' disease and allergic immune response
ea0029p1616
Subclinical hyperthyroidism (SH) in the elderly: symptoms, depression and quality of life (QoL) and relationship with TSH concentration in a prospective cohort of 110 patients
ea0029p1617
Thyroid function of Japanese elderly
ea0029p1618
Assessment of cognitive function in hypothyroidism using P300 evoked potentials
ea0029p1619
Successful treatment of hyperthyroidism is associated with significant risks of overweight/obesity independent of the treatment modality employed
ea0029p1620
Oral anticoagulant therapy: is it the same in hyperthyroid patients?
ea0029p1621
Thyroid hormone abnormalities in haemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality
ea0029p1622
Perioperative clinical outcomes after robot-assited thyroid surgery by transaxillary approach
ea0029p1623
Hyperthyroidism in patients with acute atrial fibrillation attended at an emergency room
ea0029p1624
Alterations in adiponectin concentration in hyper- and hypothyroid patients; possible underlying mechanisms and role of metformin treatment in experimental animals
ea0029p1625
A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4
ea0029p1626
Serum chemokine CXCL10 is increased in chronic autoimmune thyroiditis associated with autoimmune gastritis
ea0029p1627
Association between preoperative value of TSH and pathological findings in nodular thyroid disease
ea0029p1628
Clinical presentation (symptoms and complications) of hyperthyroidism in a cohort of 1,144 patients: results of the Thyrdel study
ea0029p1629
Beta (CCL2) and alpha (CXCL10) chemokines modulation by cytokines and by peroxisome proliferator-activated receptor-alpha agonists in Graves' ophthalmopathy
ea0029p1630
Thyroid function in large elderly population - results of multicenter study performed in Poland
ea0029p1631
Late manifestation of subclinical hyperthyroidism after goitrogenesis in an index patient with a N 670 S TSH receptor germline mutation causing familial non-autoimmune autosomal dominant hyperthyroidism (FNAH)
ea0029p1632
The alterations of the endothelial function, haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism
ea0029p1633
Prediction of remission rate in the patients with Graves' disease after treatment with a minimum maintenance dose of Methimazole
ea0029p1634
Predictors of relapse of Graves' disease after thionamide drugs treatment in clinical practice
ea0029p1635
The significance of TSH receptor blocking antibody levels in gestational stage
ea0029p1636
Evidence of humoral response to extracellular matrix proteins in Grave's diseace and thyroid associated ophtalmopathy
ea0029p1637
Thyroid dysfunction in rheumatoid arthritis
ea0029p1638
The usable markers of atherosclerosis measured by Doppler Ultrasound of lower limb artery in treatment- naive hypothyroid females
ea0029p1639
Maternal-neonatal relationship of iodine metabolism in perinatal period: Changes in urinary iodine excretion in Japanese mothers and newborn infants
ea0029p1640
Is Japan an iodine excess country? Current iodine status assessed by urinary iodine and food frequency questionnaire
ea0029p1641
Determinants of children's iodine nutrition and epidemiological features of children's goiter and nodule in iodine-excessive areas
ea0029p1642
Control of 217 hypothyroid women during pregnancy
ea0029p1643
Vitamin D deficiency is not associated with thyroid autoimmunity
ea0029p1644
Iodine prophylaxis in pregnant women: effects on offspring and the mother's thyroid hormones
ea0029p1645
Low prevalence of postpartum hyperthyroidism in women after radioiodine treatment for Graves' disease before the pregnancy
ea0029p1646
The outcome of radioiodine therapy after five years in patient with non-toxic nodular goitre
ea0029p1647
Langerhans cell histiocytosis of the thyroid and pituitary gland
ea0029p1648
Celiac disease in patients with autoimunne thyroiditis - pilot study
ea0029p1649
Is thyroid volume (TV) in children related to the urinary iodine concentration (UIC) in urine spot sample?
ea0029p1650
Evaluation of health related quality of life and general symptoms in Hashimoto's thyroiditis: are factors other than thyroid function effective? Analysis of preliminary results
ea0029p1651
Proptosis reduction in patients with Graves' orbitopaty (go) at 12 weeks after intravenous steroid therapy is associated to disease inactivation
ea0029p1652
Evaluation of the effect of radioactive iodine treatment on urea breath test
ea0029p1653
Review of a thyrotoxicosis shared-care scheme: treatment choice and outcomes
ea0029p1654
Left-shifted set point of calcium/PTH-relation in patients with Grave's thyrotoxicosis
ea0029p1655
Correlation between thyroid hormone values and carotid intima media thickness in patients with subclinical hypothyroidism
ea0029p1656
miRNA expression of the thyroid after goiter formation and involution using different iodine regimens
ea0029p1657
Autoimmune thyroid disease and cardiovascular risk factors
ea0029p1658
The syndromes of thyroid autoimmunity among patients with antiphospholipid syndrome
ea0029p1659
Anti neutrophil cytoplasmic antibody levels in graves patients using propylthiourasil
ea0029p1660
A rare case of interferon-[alpha]-induced hyperthyroidism in a patient with chronic hepatitis C with granulocytopaenia and transaminasemia treated successfully with radioiodine
ea0029p1661
Elastography in the differential diagnosis of thyroid nodules
ea0029p1662
Assessment of left atrial mechanical function in thyroid dysfunction
ea0029p1663
Prevalence, risk and clinical features of subclinical hyperthyroidism in patients with type 2 diabetes
ea0029p1664
Softgel capsules of levothyroxine in the treatment of patients with gastric disorders: preliminary results
ea0029p1665
Serum thyrotropin, leptin concentrations, thyroid autoimmunity and smoking status, in an euthyroid, iodine-sufficient, Mediterranean population with different body mass index
ea0029p1666
Resistance to thyroid hormone: clinical, biochemical and genetic features of Mediterranean population
ea0029p1667
Diagnosis and therapeutic practices of hyperthyroidism in france. results of a survey on 263 endocrinologists and 1214 patients (the thyrdel study)
ea0029p1668
The impact of TSH on diffusion of thyroglobulin through follicular lumina: possible relation to hormone formation
ea0029p1669
Iodine supply and prevalence of thyroid autoimmunity and autoimmune thyroiditis in children and adolescents between 1 and 16 years old in our city
ea0029p1670
Prevalence of thyroid diseases in a population of non-endocrine tumors in north-east Italy
ea0029p1671
Serum concentrations of thrombospondin-1 and adiponectin in patients with hyperthyroidism before and after normalisation of thyroid function
ea0029p1672
Changes in serum homocysteine, lipid, vitamin B12, folate levels and glomerular filtration rate before and after treatment in overt hypothyroidism
ea0029p1673
Decreased echogenicity and increased vascularization of fetal thyroid on 2D-ultrasonography caused by mother's Graves' disease
ea0029p1674
Measurement of TSH, FT4 and FT3 with immunoassays based on LOCI technology
ea0029p1675
Thyroid function tests in acute kidney injury
ea0029p1676
Spectrum and prevalence of thyroid diseases detected by ultrasonographic examination in west black sea region of Turkey, the MELEN study
ea0029p1677
Optimal timing of thyroxine dose adjustment for treating patients with primary hypothyroidism: what is the estimated time required to reach stable TSH levels?
ea0029p1678
The concept of ultrasonographic thyroid pattern: re-evaluation after 10 years
ea0029p1679
The role of color-flow Doppler ultrasonography for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease
ea0029p1680
The prevalence of hypercreatininemia in patients with primary hypothyroidism
ea0029p1681
Prevalence of thyroid diseases in patients with colon cancer and benign colon polyps
ea0029p1682
'Racing heart': a case of unrecognized hyperthyroidism presenting as monomorphic ventricular tachycardia
ea0029p1683
A rare case of periodic hypokalaemic paralysis secondary to Graves' thyrotoxicosis
ea0029p1684
Ultrasonographic aspects in post-partum thyroiditis
ea0029p1685
Primary and secondary autoimmune thyroiditis in rheumatoid patients
ea0029p1686
The effect of radio-iodine treatment on Helicobacter pylori eradication
ea0029p1687
Hashimoto's (chronic) thyroiditis in perimenopausal women
ea0029p1688
Hyperglycaemia in hyperthyroidism predictive factors
ea0029p1689
An unusual case of hyperthyroidism
ea0029p1690
Do thyroid hormone levels in critical illness predict outcome? Experience from a medical ICU in north east India
ea0029p1691
Vitamin E and selenium have a protective role in apoptosis induced by H2O2 in human thyrocytes
ea0029p1692
Exophtalmoses due to a bilateral lacrymal gland MALT lymphoma in first occurrence of Graves'disease
ea0029p1693
A correlation study of thyroid nodule cytopathology and histopathology
ea0029p1694
Prevalence of thyroid dysfunction in a subgroup of male patients with HIV
ea0029p1695
Thyroid concentrations and leptin levels in patients with anorexia nervosa
ea0029p1696
Congenital hypothyroidism as a rare cause of precocious puberty
ea0029p1697
Evaluation of subclinical thyroiditis among Egyptian type 1 diabetic patients by Hesham El-Hefnawy, Atef Bassyouni*, Mohamed Abdel-Kareem**, Nibal Abdel-Rahman***, Mary Aziz****And Ibrahim Emara****
ea0029p1698
Significant immune associations in chronic thyroiditis
ea0029p1699
On cohorts (over 1000 patients), there are relationships between antithyroperoxydase antibody levels and thyroid function in chronic thyroiditis
ea0029p1700
How evolves thyroid function in Hashimoto thyroiditis and related disorders
ea0029p1701
Influence of thyroxin replacement therapy on cardiovascular system in patients with primary hypothyroidism and arterial hypertension
ea0029p1702
Psychosis in hyperthyroidism: a case report
ea0029p1703
TSH receptor antibody measurement in the diagnosis and management of Graves disease
ea0029p1704
Life-threatening amiodarone induced thyrotoxicosis: optimizing the treatment and choosing radical therapy according to clinical course: own experience
ea0029p1705
Thyroid hemiagenesis and bilateral parathyroid adenoma
ea0029p1706
Laminin and poly-laminin, a polymeric form of laminin assembled at acidic pH, differentially modulate PCCL3 thyroid cell behavior
ea0029p1707
Steroid-responsive encephalopathy associated with Graves' disease
ea0029p1708
Evaluation of the cytopathologic findings of the thyroid nodules which include macrocalcification
ea0029p1709
Autoimmune and allergic diseases associated with autoimmune thyroid diseases
ea0029p1710
L-Thyroxine therapy and depression in subclinical hypothyroidism
ea0029p1711
'Too slow for the heart to go': a case of hypothyroidism-induced cardiomyopathy presenting as acute cardiogenic shock
ea0029p1712
Graves' disease and gene polymorphism of TNF-[alpha], IL2, IL6, IL12, and IFN-[gamma]
ea0029p1713
Evaluation of CD4+CD161+CD196+ and CD4+IL17+ Th17 cells in the peripheral blood of young patients with Graves' disease and Hashimoto's thyroiditis
ea0029p1714
Study thyroid function in patients with acromegaly
ea0029p1715
Subclinical hypothyroidism and thyroid autoimmunity during the 1st quarter of pregnancy in oran area
ea0029p1716
Evaluation of hearing and balance functions in patients with Hashimoto's thyroiditis
ea0029p1717
Stessful life events and Graves' disease
ea0029p1718
Thyrotoxic storm: clinical challenges
ea0029p1719
A case of toxic multinoduler goiter coexists in TSH-producing pituitary tumor
ea0029p1720
Pattern of thyroid dysfunction in metabolic syndrome
ea0029p1721
Alteration of clinical characteristics of subacute thyroiditis in last two decades in our hospital
ea0029p1722
Disseminated tuberculosis involving the thyroid: an unlikely scenario
ea0029p1723
Prevalence of goiter and thyroid nodular disease in patients with class III obesity
ea0029p1724
Serum nesfatin-1 levels in overt and subclinical hyperthyroidism
ea0029p1725
Spontaneous splenic rupture following plasmapheresis in a patient with refractory amiodarone-induced thyrotoxicosis
ea0029p1726
Does serum inflammatory and cytokine profile influence graves disease severity at diagnosis?
ea0029p1727
TSH according to age and sex. The future of normality
ea0029p1728
Evaluation of the psychoemotional status of patients after surgical treatment of Graves' disease by catamnesis data
ea0029p1729
Quality of life of patients after surgical treatment of Graves' disease by catamnesis data
ea0029p1730
Thyroid dysfunctions in patients with chronic hepatitis c virus infection with and without interferon therapy
ea0029p1731
Elevated levels of thyroid hormones without TSH suppression in two patients
ea0029p1732
Hyper - and hypothyroidism without symptoms - how much can a patient tolerate ?
ea0029p1733
The influence of chronic stimulation of thyrotropin on nodular thyroid goiter
ea0029p1734
Ischemic stroke without cardiac arrhythmia in a middle age female with thyrotoxicosis
ea0029p1735
Middle age female with long standing multinodular goiter, cardiac arrhythmia and thyroid dysfunction: the endocrinology and cardiology connection
ea0029p1736
Body Mass Index and goiter in school children. Are there any relationship?
ea0029p1737
The concept 'one thyroid specific immune mechanism - a specific thyroid disease'. Pleading for adoption of a new nomenclature for immune thyroid diseases
ea0029p1738
The metabolic syndrome in thyroid disorders
ea0029p1739
The influence of cure of subclinical hyperthyroidism on the level of serum triglycerides and cholesterol fractions
ea0029p1740
Increase of Serum Adiponectin And Stable Concentrations of Matrix Metalloproteinases Confirm Safety of Radioiodine Treatment of Thyrotoxicosis
ea0029p1741
Hyperthyroidism and Pregnancy
ea0029p1742
Histopathological results of patients that were undergone thyroidectomy due to results of repeated non-diagnostic cytology
ea0029p1743
Chlorpyrifos induced alterations in serum electrolytes (calcium, phosphate and magnesium) and endocrine glands (calcitonin cells and parathyroid gland) of Wistar rat
ea0029p1744
Utility of sonographic features and citology obtained by ultrasound-guided fine needle aspiration in preoperative management of thyroid nodules
ea0029p1745
Thyroid disorders and lipid abnormalities: An association between primary hypothyroidism and lipid profile pattern
ea0029p1746
Clinical experience in a high-resolution thyroid nodule clinic
ea0029p1747
Hypothyroxinemia and pregnancy
ea0029p1748
A case of subacute thyroiditis in a patient on Adalimumab for treatment of refractory palmo-plantar pustular psoriasis
ea0029p1749
Thyroid cancer
Indoleamine 2,3-dioxygenase 1 (IDO1) and thyroid carcinoma: Ret/PTC appears as a strong genetic determinant for IDO1 expression
ea0029p1750
Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers
ea0029p1751
cAMP analogs as potential therapeutic agents for poorly differentiated thyroid cancer
ea0029p1752
The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer cells
ea0029p1753
Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology
ea0029p1754
The TRHR gene is associated to hypothalamo-pituitary sensitivity to levothyroxine in thyroidectomized patients
ea0029p1755
Role of cAMP analogs in the therapy of medullary thyroid cancer
ea0029p1756
Optimal prophylactic and definitive therapy for bicalutamide induced gynaecomastia: results of meta-analysis
ea0029p1757
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated thyroid cancer patients: a 5 year follow up study
ea0029p1758
Is elevated preoperative TSH level predictive for differentiated thyroid cancer
ea0029p1759
Remarkable enhance in CYP24A1 expression in human thyroid cancer tissue
ea0029p1760
Differential proteomics in human normal or papillary thyroid carcinoma cell cultures
ea0029p1761
Lymphocytic chronic thyroiditis and papillary thyroid carcinoma: relation with prognostic factors
ea0029p1762
Ultrasound-guided fine-needle aspiration biopsy (US-FNAB) of thyroid nodules: effects of the operator's experience on adequacy of sampling: the MoCyThy (Modena's Cytology of the Thyroid) DATABASE
ea0029p1763
Value of repeated US-guided fine-needle aspirations (US-FNAB) in the follow-up of thyroid nodules: the MoCyThy (Modena's Cytology of the Thyroid) DATABASE
ea0029p1764
The Association between thyroid carcinoma and Hashimoto's thyroiditis: is really Hashimoto's thyroiditis increase the risk of thyroid cancer?
ea0029p1765
Clinicopathological characteristics of patients with thyroid papillary microcarcinoma: preliminary results
ea0029p1766
Differentiated carcinoma in dysembriogenetic thyroid lesions
ea0029p1767
Nursing assistance increases the efficiency of ultrasound-guided fine-needle aspiration biopsy (US-FNAB) in the management of thyroid nodules: the MoCyThy (Modena's Cytology of the Thyroid) DATABASE
ea0029p1768
Multiplicity as a prognostic factor of papillary thyroid carcinoma
ea0029p1769
Frequency and predictive factors of malignancy in residual thyroid tissue after partial thyroidectomy for differentiated thyroid cancer
ea0029p1770
Ultrasound (US) features of thyroid nodules with cytology suspicious for malignancy
ea0029p1771
Incidence of ultrasound thyroid scan anomalies in healthy volunteers in modena, italy
ea0029p1772
Surgical treatment of locally advanced thyroid carcinoma with larynx infiltration: case report
ea0029p1773
Role of intensity modulated radiation therapy in patients with non-anaplastic thyroid carcinoma: king fahad medical city experience
ea0029p1774
Urine neopterin levels in differentiated thyroid cancer
ea0029p1775
Hyperthyroidism and thyroid cancer-a prospective study
ea0029p1776
Coexistence of chronic lymphocytic thyroiditis and well differentiated thyroid cancer-a prospective study
ea0029p1777
Thyroid papillary carcinoma, 30 years of experience
ea0029p1778
Thyroid cancer in multinodular toxic goiter: A report of two cases in the philippines
ea0029p1779
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo
ea0029p1780
PI3K/HIF and ATM signalling in radio-resistance of thyroid-carcinoma: new therapeutic implications?
ea0029p1781
Functional and molecular characterization of cancer stem cells in anaplastic thyroid carcinoma
ea0029p1782
Regulation of hPTTG expression and phosphorylation: autocrine interactions with growth factors in thyroid cells
ea0029p1783
Mass spectrometry allows accurate measurement of serum thyroglobulin (Tg) in the presence of anti-thyroglobulin auto-antibodies (TgAB)
ea0029p1784
Dual specificity phosphatase 5 (DUSP5), a specific negative feedback regulator of ERK signaling, is controlled by serum response factor (SRF) and Elk-1 transcription factors
ea0029p1785
Is thyroid cancer recurrence risk increased after transplantation?
ea0029p1786
Simultaneous occurrence of BRAF mutation and RET/PTC rearrangement is frequent in papillary thyroid carcinoma
ea0029p1787
Immunohistochemical expression of [beta]III-tubulin and cell-cell adhesion proteins in papillary thyroid carcinoma: a preliminary report
ea0029p1788
The occurrence of mutations in the CHEK2 gene in patients with papillary thyroid carcinoma and its impact on the course of the disease and the coexistence of other neoplasms
ea0029p1789
Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. A systematic review
ea0029p1790
Desmoplastic stromal reaction and extrathyroidal invasion predict lymph node involvement in sporadic macro medullary thyroid cancer
ea0029p1791
Circulating BRAFV600E in the diagnosis and follow up of differentiated thyroid cancer
ea0029p1792
Screening for thyroid diseases in people from former Soviet Union emigrated in USA after Chernobyl accident
ea0029p1793
About the reproducibility of a Thyroglobulin assay
ea0029p1794
Ret somatic mutations are not an early event in the tumoral transformation of sporadic medullary thyroid cancer
ea0029p1795
A proposal of a new clinical, ultrasonographic and cytological scoring system for thyroid nodules: the 'cut' score
ea0029p1796
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate
ea0029p1797
Sentinel lymph node biopsy in differentiated thyroid carcinoma and decision for selective modified radical neck dissection
ea0029p1798
Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer
ea0029p1799
High prevalence of BRAFV600E mutation in the papillary thyroid carcinomas in Korea by peptide nucleic acid clamp real-time PCR
ea0029p1800
Role of realtime elastography in diagnostic of thyroid cancer
ea0029p1801
Coexistence of multiple lipomatosis and differentiated thyroid cancer: more than a coincidence?
ea0029p1802
Thyroid follicular lesion of undetermined significance - the risk of malignancy in postendemic area
ea0029p1803
TSH levels do not associate with the risk of papillary thyroid microcarcinoma in Korean patients
ea0029p1804
Differentiated thyroid cancer and hemodialysis: Long-term outcomes and safety after radioiodine use.
ea0029p1805
Utility of repeated recombinant human TSH (rhTSH)-stimulated tiroglobulin (Tg) test in patients with differentiated thyroid carcinoma (DTC) without evidence of disease at their initial rh-TSH-stimulation test
ea0029p1806
Epidemiology of refractory thyroid cancer
ea0029p1807
Glucagonlike Peptide-1 Receptor Imaging as diagnostic tool in patients with Medullary Thyroid Carcinoma (MTC) - preliminary report.
ea0029p1808
ARG982CYS is a new variant of the RET proto-oncogene: is it a polymorphism or a transforming mutation?
ea0029p1809
Utility of the perciutaneous ethanol injection (PEI) in the treatment of metastatic adenopathies of thyroid carcinoma
ea0029p1810
Genotype - phenotype correlations and timing of prophylactic thyroidectomy in patients with familial medullary thyroid carcinoma
ea0029p1811
Morphology and metastatic potential of papillary thyroid carcinoma
ea0029p1812
Surgical Management of Primary Thyroid Carcinoma Arising in Thyroglossal Duct Cyst
ea0029p1813
Differentiation of thyroid nodules using Acoustic Radiation Force Impulse Imaging
ea0029p1814
Calcitonin levels in washout of cytology needle on thyroid nodule without suspicion of medullary thyroid carcinoma
ea0029p1815
Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results
ea0029p1816
Clinical trial of thyroid RFA for papillary microcarcinomas
ea0029p1817
Intraoperative calcitonin stimulation testing in an individualized surgical strategy of medullary thyroid cancer - primum non nocere
ea0029p1818
Detection of novel genetic changes in the ras genes in papillary thyroid carcinoma
ea0029p1819
Elastosonographical characteristics, cytological results and histopathological features of nodules in patients with hurthle cells
ea0029p1820
Usefulness of selective sentinel lymph node biopsy in determining the surgical approach of papillary thyroid cancer
ea0029p1821
Prevalence of differentiated thyroid cancer is relevant in patiens with familial adenomatous polyposis: a case-control prospective study
ea0029p1822
The role of serum levels of selenium, superoxide dismutase, catalase and thiobarbituric acid reactive substances in the association between Hashimoto's thyroiditis and papillary thyroid cancer
ea0029p1823
Iodine-131 lung uptake in bronchiectasis: a potential pitfall in the follow up of differentiated thyroid carcinoma (DTC)
ea0029p1824
Prognostic markers in Papillary Thyroid Cancer by immunohistochemistry
ea0029p1825
Cytological thyroid: comparison (intra and interobserver) of results issued by pathologists with different skills of experience
ea0029p1826
Follicular Neoplasms: Clinical, Sonographic and Cytological Determinants and its Histological Correlation
ea0029p1827
Ultrasoundelastography: a useful tool to differentiate benign and malignant thyroid nodules?
ea0029p1828
Differentiated Thyroid Cancer in Diabetic Patients
ea0029p1829
Diagnostic value of thyroglobulin and antithyroglobulin antibody in the early follow-up of well differentiated thyroid carcinoma
ea0029p1830
Prostate and bladder metastasis of Medullary Thyroid Carcinoma
ea0029p1831
Role of FGR2 in thyroid tumor progression and their involement in the correlation between thyroid cancer and melanoma
ea0029p1832
Clinical and Pathological Features of Pediatric Thyroid Carcinoma
ea0029p1833
Malignancy rate of thyroid nodules which defined as follicular lesion of undetermined significance in thyroid cytopathology
ea0029p1834
Appearance of secondary primary malignancies in patients with differentiated tumours of the thyroid gland
ea0029p1835
Histological features of thyroid cancer in childhood and adolescence
ea0029p1836
A novel tandem germline RET mutations on the same allele in a patient with MEN 2B
ea0029p1837
Comparative examination of somatic oncogene mutation normal and pathologic thyroid tissues of Hungarian patients
ea0029p1838
Thyroid Metastasis of Clear Cell Renal Carcinoma
ea0029p1839
Diagnostic power of conventional and doppler ultrasound in identifying malignancy in thyroid nodules
ea0029p1840
Malignancy rate of thyroid nodules which defined as atypia of undetermined significance in the thyroid cytopathology
ea0029p1841
Rradioiodine-thyroid cancer link: re-evaluation of Chernobyl consequences
ea0029p1842
Hyperfunctioning thyroid nodule and thyroid cancer
ea0029p1843
Benefits and complications of total thyroidectomy as a surgical treatment for Graves'disease and for thyroid cancer
ea0029p1844
Bilateral adrenal metastases due to follicular thyroid carcinoma: case report and litterature review.
ea0029p1845
Primary Thyroid Lymphoma Diagnosed During Pregnancy: Report of a Case
ea0029p1846
The efficacy of 50mCi versus 100mCi radioactive iodine for thyroid remnant ablation after total thyroidectomy among patients with low stage differentiated thyroid cancer
ea0029p1847
Radioiodine ablation can be avoided in intrathyroidal papillary thyroid cancers [le]2 cm (pT1N0M0)
ea0029p1848
Hurthle cell thyroid carcinoma metastatic to the choroid detected by radioiodine scintigraphy: a case report
ea0029p1849
Features of incidental thyroid carcinoma in Gohierri county.
ea0029p1850
The evaluation of fine needle aspiration biopsy results in thyroid nodules below and above one centimeter diameter
ea0029p1851
Sonographic characteristics of thyroid nodules and the corresponding cytological results from the fine-needle aspiration biopsies
ea0029p1852
Surgery of Papillary Thyroid Carcinoma in Children and Adolescents
ea0029p1853
Diffuse Large B Cell Lymphoma of Thyroid Gland Presenting With Acute Tracheal Compression
ea0029p1854
Papillary thyroid carcinoma with a sollitary central nervous system metastasis
ea0029p1855
Papillary carcinoma in a hyperfunctioning thyroid nodule
ea0029p1856
Concomitant hyperthyroidism and thyroid carcinoma
ea0029p1857